Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",A1BG,Alpha-1B-glycoprotein,11702,87,0.92 [0.30-2.90],0.8928570021674668
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AAMDC,Mth938 domain-containing protein,11368,85,0.87 [0.59-1.28],0.4769049248350604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AARSD1,Alanyl-tRNA editing protein Aarsd1,13429,102,0.94 [0.69-1.28],0.7072646575059365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABCA2,ATP-binding cassette sub-family A member 2,11332,84,0.79 [0.44-1.44],0.4450093835129632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABHD14B,Protein ABHD14B,13360,101,0.88 [0.66-1.19],0.4221360872257181
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABL1,Tyrosine-protein kinase ABL1,13429,102,0.82 [0.63-1.08],0.1536427234284764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABO,Histo-blood group ABO system transferase,11690,85,0.93 [0.80-1.07],0.3061006266190352
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABRAXAS2,BRISC complex subunit Abraxas 2,11332,84,0.94 [0.68-1.29],0.6925536463448952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",13187,100,1.02 [0.83-1.27],0.8321715743808966
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",11438,86,1.00 [0.75-1.33],0.979919059504897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",11692,85,0.90 [0.71-1.14],0.3940907188388894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACAN,Aggrecan core protein,13384,104,0.61 [0.33-1.11],0.1070637418638996
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACE,Angiotensin-converting enzyme,11690,85,0.52 [0.23-1.15],0.104690255170197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACE2,Angiotensin-converting enzyme 2,13267,101,0.98 [0.66-1.46],0.938269854182365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACHE,Acetylcholinesterase,11422,85,0.78 [0.40-1.53],0.4634887560088222
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACOT13,Acyl-coenzyme A thioesterase 13,11626,86,0.93 [0.78-1.12],0.4566620910781104
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,13500,104,1.02 [0.72-1.45],0.905549208791495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACP1,Low molecular weight phosphotyrosine protein phosphatase,11358,82,0.97 [0.60-1.55],0.8837254328742107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACP5,Tartrate-resistant acid phosphatase type 5,13543,100,0.78 [0.45-1.35],0.3726346409869396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACP6,Lysophosphatidic acid phosphatase type 6,13599,100,0.95 [0.73-1.23],0.67786108424657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACRBP,Acrosin-binding protein,11611,85,1.02 [0.59-1.78],0.9391284932711016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACRV1,Acrosomal protein SP-10,11358,82,0.96 [0.53-1.73],0.8905827563363437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACSL1,Long-chain-fatty-acid--CoA ligase 1,11332,84,1.08 [0.63-1.85],0.7760359038274187
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACTA2,"Actin, aortic smooth muscle",13267,101,0.66 [0.41-1.06],0.086385455378705
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACTN2,Alpha-actinin-2,11332,84,0.92 [0.62-1.37],0.66935665954208
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACTN4,Alpha-actinin-4,13235,101,0.73 [0.38-1.39],0.331766812271676
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACVRL1,Serine/threonine-protein kinase receptor R3,13390,102,0.72 [0.33-1.59],0.4190756465274656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACY1,Aminoacylase-1,13500,104,1.03 [0.77-1.38],0.821732290830339
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,11332,84,1.00 [0.69-1.45],0.9914039687647564
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACYP1,Acylphosphatase-1,11373,85,0.76 [0.55-1.04],0.0889984557070879
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADA,Adenosine deaminase,13652,101,0.90 [0.54-1.49],0.6727946884435007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADA2,Adenosine deaminase 2,13376,98,0.75 [0.48-1.16],0.1959261204320654
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,11358,82,0.82 [0.43-1.57],0.552817955293428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,13267,101,0.88 [0.49-1.58],0.6611455140318834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,13411,102,0.46 [0.28-0.76],0.0023307260861972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,13652,101,0.79 [0.49-1.26],0.3182899119853742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,13606,102,0.83 [0.44-1.55],0.5554997085012064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,11626,86,0.84 [0.42-1.70],0.629873341817677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,11358,82,1.06 [0.57-1.97],0.8483944605237436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,13658,103,1.14 [0.52-2.47],0.7490175279993891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,13429,102,0.87 [0.60-1.24],0.4358290561743189
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,13267,101,0.48 [0.24-0.98],0.0432844059581467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,11358,82,0.60 [0.32-1.13],0.1137374724516061
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,13527,102,0.93 [0.63-1.36],0.6974837684475794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTSL2,ADAMTS-like protein 2,11671,86,0.88 [0.44-1.77],0.7305252904375941
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTSL4,ADAMTS-like protein 4,11368,85,0.36 [0.15-0.86],0.0220951807042883
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTSL5,ADAMTS-like protein 5,11692,85,0.87 [0.51-1.48],0.6174893983306484
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,13187,100,1.11 [0.72-1.71],0.6461431061577873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADD1,Alpha-adducin,11422,85,0.90 [0.67-1.22],0.5060828360868546
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRB3,Adhesion G protein-coupled receptor B3,13390,102,0.72 [0.42-1.24],0.2335637910872488
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRD1,Adhesion G-protein coupled receptor D1,11422,85,0.73 [0.40-1.32],0.2942206194696103
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRE1,Adhesion G protein-coupled receptor E1,11626,86,1.17 [0.81-1.70],0.4003767740865662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRE2,Adhesion G protein-coupled receptor E2,13555,104,0.68 [0.37-1.28],0.2314178287882094
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRE5,Adhesion G protein-coupled receptor E5,13579,100,0.67 [0.36-1.24],0.2012350438253361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRF5,Adhesion G protein-coupled receptor F5,11692,85,0.75 [0.38-1.48],0.4039003771166297
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRG1,Adhesion G-protein coupled receptor G1,13429,102,0.73 [0.45-1.16],0.1791259905446917
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRG2,Adhesion G-protein coupled receptor G2,13500,104,1.19 [0.62-2.27],0.6022288365732651
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRV1,Adhesion G-protein coupled receptor V1,11347,80,0.69 [0.47-1.01],0.0580981713812774
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADH1B,All-trans-retinol dehydrogenase,11422,85,0.96 [0.73-1.28],0.8040292149154264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,13267,101,0.94 [0.77-1.17],0.5972916230416871
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADIPOQ,Adiponectin,11702,87,1.18 [0.86-1.61],0.3012143490622442
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADM,Pro-adrenomedullin,13620,100,0.56 [0.31-0.99],0.0473341625401962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADRA2A,Alpha-2A adrenergic receptor,11332,84,0.92 [0.68-1.25],0.5862006959395595
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AFAP1,Actin filament-associated protein 1,11422,85,0.91 [0.70-1.17],0.4415581411856993
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AFM,Afamin,11702,87,0.96 [0.32-2.88],0.9375943869555018
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AFP,Alpha-fetoprotein,13375,102,0.94 [0.73-1.22],0.6574984977810525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGBL2,Cytosolic carboxypeptidase 2,11347,80,0.78 [0.65-0.94],0.0069994692031106
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGER,Advanced glycosylation end product-specific receptor,13466,104,0.79 [0.51-1.21],0.2758310588804621
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGR2,Anterior gradient protein 2 homolog,13036,97,0.91 [0.76-1.09],0.311130840335279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGR3,Anterior gradient protein 3,13168,100,0.84 [0.61-1.16],0.2820393531514604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGRN,Agrin,13555,104,0.73 [0.42-1.29],0.2842744631901361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGRP,Agouti-related protein,13652,101,0.92 [0.67-1.26],0.6028692116328231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGT,Angiotensinogen,11690,85,0.68 [0.26-1.80],0.442874629178382
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGXT,Serine--pyruvate aminotransferase,13500,104,1.16 [0.94-1.43],0.1674009608832302
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHCY,Adenosylhomocysteinase,13500,104,0.87 [0.67-1.12],0.2867959529538273
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHNAK,Neuroblast differentiation-associated protein AHNAK,11368,85,0.62 [0.31-1.24],0.1772556082973618
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHNAK2,Protein AHNAK2,11368,85,0.55 [0.25-1.20],0.1318428900612191
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,11611,85,0.57 [0.38-0.85],0.0061337329601878
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHSG,Alpha-2-HS-glycoprotein,11690,85,0.74 [0.34-1.58],0.4343923192235946
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHSP,Alpha-hemoglobin-stabilizing protein,13475,100,1.04 [0.86-1.26],0.6949556329238704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIDA,"Axin interactor, dorsalization-associated protein",11351,84,0.90 [0.69-1.18],0.4469806788023268
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIF1,Allograft inflammatory factor 1,13187,100,0.95 [0.68-1.34],0.789868549969585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIF1L,Allograft inflammatory factor 1-like,11368,85,1.08 [0.78-1.50],0.6482632128917176
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",13399,102,0.89 [0.75-1.06],0.1945995467591048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AK1,Adenylate kinase isoenzyme 1,13500,104,0.94 [0.72-1.23],0.6735711924107428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AK2,"Adenylate kinase 2, mitochondrial",11656,85,0.86 [0.70-1.04],0.1144147087387163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKAP12,A-kinase anchor protein 12,11422,85,0.60 [0.21-1.72],0.3392020927636131
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR1B1,Aldo-keto reductase family 1 member B1,13187,100,0.84 [0.66-1.06],0.1352354367857535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR1B10,Aldo-keto reductase family 1 member B10,11351,84,1.01 [0.71-1.44],0.945239748569019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR1C4,Aldo-keto reductase family 1 member C4,13267,101,1.11 [0.82-1.49],0.4944502001419703
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR7L,Aflatoxin B1 aldehyde reductase member 4,11358,82,0.86 [0.62-1.19],0.3526262334392184
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKT1S1,Proline-rich AKT1 substrate 1,13156,97,0.80 [0.61-1.05],0.1074886432283317
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKT2,RAC-beta serine/threonine-protein kinase,11674,86,0.90 [0.76-1.06],0.1939662257924416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKT3,RAC-gamma serine/threonine-protein kinase,13120,100,0.80 [0.59-1.10],0.1746287397745896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALCAM,CD166 antigen,13658,103,0.87 [0.35-2.17],0.7678517601532153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH1A1,Retinal dehydrogenase 1,13496,100,1.09 [0.79-1.50],0.5888449217693057
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH2,"Aldehyde dehydrogenase, mitochondrial",11611,85,0.84 [0.53-1.33],0.4458509027281087
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",13467,101,1.06 [0.81-1.40],0.6578420155098201
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",11674,86,0.99 [0.64-1.53],0.9755807222809753
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALMS1,Alstrom syndrome protein 1,11438,86,0.74 [0.44-1.26],0.2735974959275429
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALPI,Intestinal-type alkaline phosphatase,11358,82,0.90 [0.75-1.08],0.2637736608196729
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALPP,"Alkaline phosphatase, placental type",13429,102,1.10 [0.92-1.31],0.2835945373327805
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMBN,Ameloblastin,13235,101,0.63 [0.30-1.32],0.2189307419811138
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMBP,Protein AMBP,13604,99,0.41 [0.16-1.01],0.0527308511866636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,11671,86,0.90 [0.41-2.02],0.8067803430688749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMFR,E3 ubiquitin-protein ligase AMFR,13156,97,1.20 [0.95-1.52],0.128634492549329
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMIGO1,Amphoterin-induced protein 1,11351,84,0.71 [0.44-1.17],0.1800459701965119
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMIGO2,Amphoterin-induced protein 2,13429,102,0.66 [0.30-1.45],0.3048831856717949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMN,Protein amnionless,13235,101,0.99 [0.69-1.43],0.9582758333832376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMOT,Angiomotin,11422,85,0.91 [0.56-1.49],0.7099409736256117
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMOTL2,Angiomotin-like protein 2,11585,85,0.67 [0.40-1.12],0.1279729871531317
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMPD3,AMP deaminase 3,11656,85,1.04 [0.79-1.37],0.7943273152243955
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,10953,79,0.51 [0.31-0.83],0.0072114876416781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY2A,Pancreatic alpha-amylase,12981,98,0.60 [0.41-0.88],0.0086771621309324
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY2B,Alpha-amylase 2B,12568,92,0.58 [0.39-0.86],0.0066248992024295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANG,Angiogenin,13417,99,1.35 [0.84-2.17],0.219138727296835
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPT1,Angiopoietin-1,13454,104,0.91 [0.75-1.11],0.3456290975473489
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPT2,Angiopoietin-2,13620,100,1.03 [0.66-1.60],0.9118271400843474
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL1,Angiopoietin-related protein 1,13315,104,0.76 [0.42-1.36],0.3516252161086872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL2,Angiopoietin-related protein 2,13517,104,1.01 [0.65-1.57],0.9663432735216088
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL3,Angiopoietin-related protein 3,13468,102,0.88 [0.55-1.43],0.6120128621566756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL4,Angiopoietin-related protein 4,13534,104,0.98 [0.68-1.42],0.9246111471449924
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL7,Angiopoietin-related protein 7,13620,100,0.74 [0.45-1.20],0.2233094070612856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANK2,Ankyrin-2,11332,84,1.07 [0.82-1.42],0.6071466370654652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,11358,82,0.86 [0.66-1.13],0.2786819772757283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANKRA2,Ankyrin repeat family A protein 2,11269,84,1.01 [0.70-1.48],0.9438677818161988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANKRD54,Ankyrin repeat domain-containing protein 54,13187,100,0.74 [0.52-1.05],0.0886955308767551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,11368,85,0.73 [0.39-1.34],0.3085070628514506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANPEP,Aminopeptidase N,13476,102,1.35 [0.75-2.45],0.3190155518766603
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA1,Annexin A1,11343,85,0.98 [0.61-1.57],0.9279437247522214
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA10,Annexin A10,13156,97,1.01 [0.80-1.27],0.9597437432103244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA11,Annexin A11,13465,101,0.90 [0.70-1.16],0.4143395334927715
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA2,Annexin A2,11195,85,1.00 [0.74-1.36],0.9779387141347412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA3,Annexin A3,13606,102,0.83 [0.65-1.07],0.1462977516450029
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA4,Annexin A4,13427,104,0.85 [0.67-1.09],0.1938813058368877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA5,Annexin A5,13118,97,0.94 [0.52-1.70],0.8373473347542126
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AOC1,Amiloride-sensitive amine oxidase [copper-containing],13235,101,1.01 [0.74-1.38],0.928787604759596
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AOC3,Membrane primary amine oxidase,13507,102,1.14 [0.64-2.02],0.6583005826128296
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP1G2,AP-1 complex subunit gamma-like 2,11611,85,0.72 [0.54-0.94],0.0169777013354449
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP2B1,AP-2 complex subunit beta,11351,84,0.83 [0.52-1.31],0.4225988022014616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP3B1,AP-3 complex subunit beta-1,11626,86,0.90 [0.68-1.18],0.4373369110044448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP3S2,AP-3 complex subunit sigma-2,11656,85,0.67 [0.41-1.08],0.099840187093605
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,13429,102,0.86 [0.58-1.29],0.4666135881793969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APCS,Serum amyloid P-component,11602,86,1.63 [0.92-2.89],0.0918147525773723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,13580,100,0.84 [0.63-1.14],0.2717279777884828
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APLP1,Amyloid-like protein 1,13500,104,1.09 [0.78-1.52],0.6154771187871163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOA1,Apolipoprotein A-I,11702,87,0.95 [0.45-1.98],0.883133218035929
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOA2,Apolipoprotein A-II,11690,85,0.93 [0.60-1.44],0.7414644868860882
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOA4,Apolipoprotein A-IV,11702,87,0.78 [0.43-1.43],0.4217116080225733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOB,Apolipoprotein B-100,11690,85,0.41 [0.18-0.96],0.0407308462813299
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOBR,Apolipoprotein B receptor,11368,85,0.94 [0.58-1.53],0.8111299915986295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOC1,Apolipoprotein C-I,11676,87,1.05 [0.61-1.81],0.8468190858284179
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOD,Apolipoprotein D,11139,82,0.94 [0.57-1.55],0.7985748171357336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOE,Apolipoprotein E,11702,87,0.77 [0.54-1.11],0.1649726361822105
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOF,Apolipoprotein F,11690,85,0.67 [0.34-1.32],0.2458105588036312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOH,Beta-2-glycoprotein 1,13496,100,1.40 [0.88-2.22],0.1613586650946725
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOL1,Apolipoprotein L1,11690,85,1.06 [0.79-1.41],0.7163523932302427
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOM,Apolipoprotein M,13489,102,1.33 [0.68-2.58],0.4068750207405833
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APP,Amyloid-beta precursor protein,13470,100,0.86 [0.66-1.12],0.2712291075007969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APPL2,DCC-interacting protein 13-beta,11422,85,0.89 [0.74-1.06],0.1939883904805163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APRT,Adenine phosphoribosyltransferase,13393,102,0.82 [0.58-1.17],0.2772571660529192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARAF,Serine/threonine-protein kinase A-Raf,11438,86,0.83 [0.60-1.15],0.2708539694689756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AREG,Amphiregulin,13429,102,1.24 [0.90-1.71],0.1843777281777947
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARF6,ADP-ribosylation factor 6,11626,86,0.93 [0.77-1.13],0.4642241470954692
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARFIP1,Arfaptin-1,11674,86,0.86 [0.64-1.17],0.3398609682425831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARG1,Arginase-1,13442,100,1.17 [0.85-1.62],0.3286440768672058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARG2,"Arginase-2, mitochondrial",11611,85,1.05 [0.67-1.64],0.8278752395389039
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP1,Rho GTPase-activating protein 1,13187,100,0.85 [0.58-1.24],0.3918334980057517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP25,Rho GTPase-activating protein 25,13187,100,1.03 [0.78-1.38],0.8260381214485111
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP30,Rho GTPase-activating protein 30,11438,86,0.61 [0.30-1.22],0.1617656797467357
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP45,Rho GTPase-activating protein 45,11422,85,0.85 [0.66-1.10],0.2261906370306141
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP5,Rho GTPase-activating protein 5,11269,84,0.81 [0.59-1.12],0.2010438206194935
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF1,Rho guanine nucleotide exchange factor 1,11656,85,0.88 [0.70-1.11],0.2821791659066014
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF10,Rho guanine nucleotide exchange factor 10,11674,86,0.86 [0.68-1.07],0.1786502688911513
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF12,Rho guanine nucleotide exchange factor 12,13483,101,0.89 [0.75-1.05],0.1752942599134646
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF5,Rho guanine nucleotide exchange factor 5,11347,80,0.95 [0.71-1.28],0.7321377672314922
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARID3A,AT-rich interactive domain-containing protein 3A,11347,80,0.91 [0.52-1.57],0.7281093324928325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARID4B,AT-rich interactive domain-containing protein 4B,13156,97,1.08 [0.73-1.59],0.7137543873407101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARL13B,ADP-ribosylation factor-like protein 13B,11332,84,0.93 [0.68-1.27],0.648541991929388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,11332,84,0.68 [0.40-1.17],0.1622076559288695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARMCX2,Armadillo repeat-containing X-linked protein 2,11347,80,1.02 [0.74-1.41],0.9034172884597994
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARNT,Aryl hydrocarbon receptor nuclear translocator,13235,101,0.48 [0.27-0.85],0.0118113487610087
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,11332,84,1.03 [0.71-1.51],0.8650386113862096
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARSA,Arylsulfatase A,13496,100,0.87 [0.58-1.30],0.4980185755470284
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARSB,Arylsulfatase B,13429,102,0.83 [0.60-1.14],0.2482974894126293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ART3,Ecto-ADP-ribosyltransferase 3,13507,102,0.76 [0.44-1.31],0.3206499296917749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ART5,Ecto-ADP-ribosyltransferase 5,11347,80,0.57 [0.34-0.95],0.0301346768171774
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARTN,Artemin,13235,101,0.82 [0.53-1.27],0.378502258897321
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASAH1,Acid ceramidase,11576,86,0.80 [0.50-1.27],0.344723795940147
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASAH2,Neutral ceramidase,13411,102,1.39 [0.97-1.99],0.0765762349779645
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASGR1,Asialoglycoprotein receptor 1,13411,102,0.60 [0.32-1.12],0.11141453769696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASGR2,Asialoglycoprotein receptor 2,11690,85,0.91 [0.40-2.06],0.8227936527674843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASPN,Asporin,11692,85,0.48 [0.21-1.11],0.0869534958871301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASPSCR1,Tether containing UBX domain for GLUT4,11674,86,0.78 [0.57-1.05],0.1020969078340529
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASRGL1,Isoaspartyl peptidase/L-asparaginase,11368,85,0.85 [0.69-1.05],0.1272493728559077
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASS1,Argininosuccinate synthase,11332,84,1.09 [0.84-1.40],0.5276223843717314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATF2,Cyclic AMP-dependent transcription factor ATF-2,13156,97,0.87 [0.64-1.18],0.3623079898429118
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATF4,Cyclic AMP-dependent transcription factor ATF-4,11269,84,0.57 [0.29-1.14],0.1109520816138542
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATG16L1,Autophagy-related protein 16-1,11626,86,0.90 [0.70-1.14],0.379657118478103
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATG4A,Cysteine protease ATG4A,13187,100,0.82 [0.61-1.12],0.2177171244998457
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATOX1,Copper transport protein ATOX1,13527,102,0.84 [0.67-1.07],0.1549320273831624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,11332,84,0.81 [0.49-1.34],0.4038977967453498
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,11332,84,0.80 [0.40-1.60],0.5195809066448033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,11332,84,0.93 [0.55-1.59],0.801624199294002
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B4,Protein ATP1B4,11269,84,0.72 [0.41-1.26],0.2499442756094432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP2B4,Plasma membrane calcium-transporting ATPase 4,11332,84,0.91 [0.64-1.30],0.6062426758656613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP5F1D,"ATP synthase subunit delta, mitochondrial",11332,84,0.99 [0.67-1.47],0.9676651075987484
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP5IF1,"ATPase inhibitor, mitochondrial",13555,104,0.88 [0.75-1.02],0.0877679580708129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP5PO,"ATP synthase subunit O, mitochondrial",13156,97,0.83 [0.54-1.30],0.4219111235502597
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6AP2,Renin receptor,13187,100,1.01 [0.67-1.53],0.9453357883926872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1D,V-type proton ATPase subunit D,13429,102,0.57 [0.27-1.18],0.1275458667826373
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1F,V-type proton ATPase subunit F,13127,97,0.93 [0.70-1.22],0.5885832533296097
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1G1,V-type proton ATPase subunit G 1,11368,85,0.86 [0.64-1.15],0.3059141629619847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1G2,V-type proton ATPase subunit G 2,11332,84,1.07 [0.88-1.31],0.4824479762637023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATRAID,All-trans retinoic acid-induced differentiation factor,11626,86,0.85 [0.40-1.82],0.6809192036529184
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATRN,"Attractin, Isoform 2",11702,87,1.67 [0.48-5.78],0.4206381035367669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN10,Ataxin-10,13156,97,1.13 [0.87-1.45],0.3582980909189303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN2,Ataxin-2,11347,80,0.97 [0.80-1.18],0.7764340396473866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN2L,Ataxin-2-like protein,11674,86,0.76 [0.47-1.22],0.2504601512940381
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN3,Ataxin-3,11656,85,0.88 [0.64-1.23],0.4602107394036043
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AXIN1,Axin-1,13483,101,0.86 [0.71-1.03],0.1011072449815441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AXL,Tyrosine-protein kinase receptor UFO,13507,102,1.02 [0.54-1.94],0.9488654475074938
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AZI2,5-azacytidine-induced protein 2,11674,86,0.78 [0.53-1.15],0.2156523074702424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AZU1,Azurocidin,13061,97,1.16 [0.95-1.42],0.1498668788335349
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B2M,Beta-2-microglobulin,11702,87,0.95 [0.48-1.85],0.8717459860027696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,11332,84,0.33 [0.11-0.98],0.0457117673958164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",11368,85,0.55 [0.32-0.96],0.0367568037713283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B4GALT1,"Beta-1,4-galactosyltransferase 1",13555,104,0.78 [0.41-1.50],0.4578590282308391
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B4GAT1,"Beta-1,4-glucuronyltransferase 1",13496,100,0.67 [0.32-1.38],0.2754783957194596
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BABAM1,BRISC and BRCA1-A complex member 1,11358,82,0.37 [0.16-0.85],0.0201947170652119
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BACH1,Transcription regulator protein BACH1,13483,101,0.82 [0.64-1.06],0.1261287777679242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAG3,BAG family molecular chaperone regulator 3,13390,102,0.88 [0.58-1.35],0.5646874086943374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAG4,BAG family molecular chaperone regulator 4,11358,82,0.75 [0.47-1.19],0.2236077751129194
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAG6,Large proline-rich protein BAG6,13267,101,0.84 [0.51-1.37],0.4796338659219249
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,13187,100,0.98 [0.73-1.31],0.8711784857797235
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAMBI,BMP and activin membrane-bound inhibitor homolog,13187,100,0.54 [0.29-1.03],0.0602680821608866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BANK1,B-cell scaffold protein with ankyrin repeats,13483,101,0.94 [0.80-1.10],0.4367471601875053
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAP18,Chromatin complexes subunit BAP18,11656,85,0.97 [0.71-1.32],0.8337997049887322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BATF,Basic leucine zipper transcriptional factor ATF-like,11351,84,1.04 [0.83-1.31],0.7037530998950376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAX,Apoptosis regulator BAX,13137,97,0.85 [0.69-1.04],0.115972609909448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAM,Basal cell adhesion molecule,13496,100,0.46 [0.21-0.99],0.0483191302783316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAN,Brevican core protein,13411,102,0.89 [0.52-1.51],0.6687155467146095
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",11692,85,0.76 [0.37-1.56],0.4582504623842707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",11347,80,0.62 [0.37-1.03],0.0663257975643753
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCHE,Cholinesterase,11461,84,2.20 [1.03-4.69],0.0413491381782221
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2,Apoptosis regulator Bcl-2,11626,86,1.37 [1.04-1.79],0.0244142906704243
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2L1,Bcl-2-like protein 1,11656,85,0.86 [0.70-1.06],0.1576282029681804
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",13483,101,0.85 [0.59-1.21],0.3678835394398667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2L15,Bcl-2-like protein 15,11358,82,0.83 [0.56-1.24],0.3592974342428805
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL7A,B-cell CLL/lymphoma 7 protein family member A,11269,84,0.69 [0.46-1.02],0.0646355195899077
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL7B,B-cell CLL/lymphoma 7 protein family member B,11611,85,0.95 [0.61-1.50],0.8356976576533873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCR,Breakpoint cluster region protein,13483,101,0.86 [0.71-1.05],0.1415533321717753
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BDNF,Brain-derived neurotrophic factor,11671,86,0.89 [0.70-1.13],0.3250974127667413
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BECN1,Beclin-1,11368,85,0.77 [0.54-1.10],0.1548553645665721
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BEX3,Protein BEX3,11269,84,0.87 [0.54-1.41],0.5729752648680987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BGLAP,Osteocalcin,11671,86,0.84 [0.67-1.04],0.1134346948632167
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BGN,Biglycan,13169,99,1.12 [0.97-1.29],0.1346987075510776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BHLHE40,Class E basic helix-loop-helix protein 40,11347,80,0.81 [0.58-1.13],0.210865199555387
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,11332,84,0.59 [0.27-1.30],0.1878488140568305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BID,BH3-interacting domain death agonist,13483,101,0.73 [0.55-0.96],0.0248634601352145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BIN2,Bridging integrator 2,13496,100,0.89 [0.73-1.09],0.260277112062299
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BIRC2,Baculoviral IAP repeat-containing protein 2,13187,100,0.84 [0.63-1.12],0.2393805841980072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLMH,Bleomycin hydrolase,13658,103,0.70 [0.42-1.19],0.1878588532380488
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLNK,B-cell linker protein,11358,82,0.80 [0.43-1.47],0.4627829340243836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,11347,80,0.71 [0.50-1.01],0.0602820717793101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,11656,85,0.66 [0.38-1.16],0.1508845418276799
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLVRB,Flavin reductase,13496,100,1.11 [0.87-1.42],0.4115697689925779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMP10,Bone morphogenetic protein 10,11422,85,0.81 [0.39-1.67],0.5709360708644684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMP4,Bone morphogenetic protein 4,13390,102,0.81 [0.54-1.22],0.3128420087529601
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMP6,Bone morphogenetic protein 6,13240,99,0.79 [0.53-1.17],0.2418470390177902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMPER,BMP-binding endothelial regulator protein,11422,85,1.25 [0.50-3.15],0.6304950962635731
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,11692,85,0.57 [0.30-1.08],0.0840787150521607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,11358,82,0.83 [0.50-1.36],0.4612572871286285
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BOC,Brother of CDO,13267,101,0.70 [0.33-1.48],0.3528675524557041
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BOLA1,BolA-like protein 1,11347,80,0.79 [0.52-1.19],0.2574486980488025
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BOLA2_BOLA2B,BolA-like protein 2,11368,85,0.88 [0.61-1.27],0.5037645058385304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BPIFA2,BPI fold-containing family A member 2,10962,82,0.80 [0.65-0.98],0.0276960573678752
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BPIFB1,BPI fold-containing family B member 1,13474,99,0.93 [0.70-1.24],0.627091932218635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BPIFB2,BPI fold-containing family B member 2,11673,85,1.02 [0.74-1.42],0.8848968145673923
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRAP,BRCA1-associated protein,11533,85,0.99 [0.82-1.20],0.9532230067827726
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRD1,Bromodomain-containing protein 1,11438,86,0.61 [0.28-1.31],0.2082810528855288
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRD2,Bromodomain-containing protein 2,11347,80,0.55 [0.26-1.17],0.1200468825116836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRD3,Bromodomain-containing protein 3,11332,84,0.76 [0.45-1.26],0.2804245552338126
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRDT,Bromodomain testis-specific protein,11332,84,0.69 [0.38-1.24],0.2167196232008155
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRK1,Protein BRICK1,13156,97,0.95 [0.63-1.43],0.8115225762062304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRME1,Break repair meiotic recombinase recruitment factor 1,11347,80,0.62 [0.34-1.15],0.1285368348492638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRSK2,Serine/threonine-protein kinase BRSK2,11674,86,0.44 [0.23-0.82],0.0093475415514835
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BSG,Basigin,13625,100,0.57 [0.25-1.28],0.1703312636736452
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BSND,Barttin,11269,84,0.56 [0.27-1.16],0.1188635205959779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,13626,102,0.83 [0.61-1.13],0.2389059646292876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BST2,Bone marrow stromal antigen 2,13626,102,0.88 [0.62-1.26],0.4928250309020535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTC,Probetacellulin,13187,100,0.89 [0.70-1.15],0.3811330176761974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTD,Biotinidase,11702,87,1.92 [0.71-5.21],0.2004584530159945
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTLA,B- and T-lymphocyte attenuator,11269,84,0.81 [0.60-1.10],0.1781244213402331
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTN1A1,Butyrophilin subfamily 1 member A1,11591,85,0.37 [0.19-0.73],0.0043546586971789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTN2A1,Butyrophilin subfamily 2 member A1,13555,104,0.52 [0.30-0.89],0.0167117447534706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTN3A2,Butyrophilin subfamily 3 member A2,13483,101,0.71 [0.44-1.14],0.1601021206309069
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTNL10,Butyrophilin-like protein 10,11269,84,0.49 [0.24-1.01],0.0521349201570322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C19orf12,Protein C19orf12,13156,97,1.00 [0.74-1.35],0.9842396768026552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1GALT1C1,C1GALT1-specific chaperone 1,11332,84,0.54 [0.26-1.10],0.0903501522634639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QA,Complement C1q subcomponent subunit A,13578,100,0.62 [0.29-1.33],0.2236504496927013
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",11674,86,1.01 [0.74-1.37],0.95540200195667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QL2,Complement C1q-like protein 2,11358,82,0.82 [0.49-1.37],0.4446155252321527
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,13507,102,1.17 [0.78-1.76],0.4413834740270553
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,11422,85,1.23 [0.70-2.15],0.4642742213279707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,11674,86,0.69 [0.34-1.40],0.3013414947974231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,11397,85,0.99 [0.65-1.52],0.9776395927341656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1R,Complement C1r subcomponent,11702,87,0.95 [0.33-2.75],0.919710061836262
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1RL,Complement C1r subcomponent-like protein,11682,87,1.17 [0.41-3.37],0.772403108022462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1S,Complement C1s subcomponent,11702,87,1.23 [0.46-3.24],0.6810264100024006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C2,Complement C2,13489,102,2.05 [0.89-4.73],0.0908946142626598
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C2CD2L,Phospholipid transfer protein C2CD2L,13127,97,0.75 [0.48-1.17],0.2048693637441663
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C2orf69,UPF0565 protein C2orf69,11351,84,0.79 [0.52-1.19],0.2605713731371166
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C3,Complement C3,11104,80,0.79 [0.48-1.33],0.3796503405540772
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C4BPB,C4b-binding protein beta chain,13527,102,1.04 [0.68-1.60],0.8400502383480414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C5,Complement C5,11702,87,0.39 [0.10-1.56],0.1841772797590029
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C7,Complement component C7,11431,85,0.85 [0.44-1.65],0.6287578689876625
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C7orf50,Uncharacterized protein C7orf50,11656,85,0.50 [0.15-1.67],0.258817892612952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C8B,Complement component C8 beta chain,11702,87,1.29 [0.66-2.50],0.4533939538358911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C9,Complement component C9,11690,85,0.98 [0.63-1.50],0.9128331443045292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C9orf40,Uncharacterized protein C9orf40,11626,86,1.11 [0.88-1.41],0.3710990419281376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA1,Carbonic anhydrase 1,13146,93,1.12 [0.85-1.50],0.4217884009951247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA11,Carbonic anhydrase-related protein 11,13187,100,0.82 [0.44-1.55],0.5457321018522815
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA12,Carbonic anhydrase 12,13429,102,0.81 [0.46-1.43],0.4677459195576139
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA13,Carbonic anhydrase 13,13338,102,0.91 [0.78-1.07],0.265985910916144
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA14,Carbonic anhydrase 14,13620,100,0.96 [0.57-1.63],0.8921938343855846
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA2,Carbonic anhydrase 2,13454,100,1.05 [0.83-1.34],0.6847560288305619
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA3,Carbonic anhydrase 3,13633,102,1.10 [0.84-1.44],0.4719418975064522
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA4,Carbonic anhydrase 4,13658,103,0.46 [0.22-0.96],0.0386239129043396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA5A,"Carbonic anhydrase 5A, mitochondrial",13267,101,1.06 [0.87-1.28],0.5754134880577264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA6,Carbonic anhydrase 6,13458,99,1.29 [0.98-1.71],0.0733785200760183
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA7,Carbonic anhydrase 7,11438,86,0.54 [0.27-1.09],0.0869648310721168
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA8,Carbonic anhydrase-related protein,11358,82,0.77 [0.31-1.92],0.5784405378051745
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA9,Carbonic anhydrase 9,13620,100,1.24 [0.83-1.85],0.29436268797796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CABP2,Calcium-binding protein 2,11351,84,0.81 [0.57-1.14],0.2243597881531178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,11347,80,0.51 [0.24-1.11],0.0888826261988213
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,11332,84,1.02 [0.73-1.44],0.8870200491356299
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,11347,80,0.85 [0.58-1.26],0.4257732471782944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,11674,86,0.80 [0.63-1.02],0.0761118480148005
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACYBP,Calcyclin-binding protein,11393,85,0.89 [0.73-1.09],0.2666631036177734
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CADPS,Calcium-dependent secretion activator 1,11351,84,0.72 [0.41-1.27],0.2526057484558871
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALB1,Calbindin,13429,102,0.82 [0.55-1.22],0.3345118659588301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALB2,Calretinin,13156,97,0.82 [0.44-1.53],0.5317263704901019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCA,Calcitonin,13382,102,1.11 [0.82-1.52],0.4942293658180773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCB,Calcitonin gene-related peptide 2,11656,85,0.77 [0.42-1.39],0.3821347186539638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,13579,100,0.87 [0.73-1.03],0.1149146283248681
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,11368,85,0.89 [0.68-1.18],0.4218123010890665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALY,Neuron-specific vesicular protein calcyon,11332,84,0.64 [0.33-1.25],0.1903172940759216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,13187,100,0.58 [0.38-0.90],0.0154749255983075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,11351,84,1.00 [0.68-1.47],0.9987653223674552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,11674,86,0.83 [0.68-1.01],0.066217281656944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CANT1,Soluble calcium-activated nucleotidase 1,13468,104,0.78 [0.33-1.85],0.5743601286099353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAPG,Macrophage-capping protein,13413,99,1.17 [0.87-1.57],0.2930143345640972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAPN3,Calpain-3,11611,85,1.29 [0.81-2.06],0.2807358034825311
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAPS,Calcyphosin,11656,85,0.84 [0.62-1.15],0.2819964242496532
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CARHSP1,Calcium-regulated heat-stable protein 1,13156,97,0.92 [0.65-1.29],0.6318599686411746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASC3,Protein CASC3,11351,84,0.85 [0.51-1.44],0.5551276689768367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP1,Caspase-1,13156,97,0.87 [0.66-1.15],0.3407797119009528
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP10,Caspase-10,13156,97,0.98 [0.76-1.26],0.8651782793714683
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP2,Caspase-2,13483,101,0.93 [0.71-1.21],0.5856960582560731
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP3,Caspase-3,13658,103,0.89 [0.74-1.08],0.2556339042371292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP4,Caspase-4,11438,86,0.95 [0.84-1.09],0.4738578489084791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP7,Caspase-7,11656,85,0.92 [0.72-1.17],0.4827244844013991
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP8,Caspase-8,13583,99,0.81 [0.60-1.08],0.1470818311860791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP9,Caspase-9,11358,82,1.05 [0.76-1.46],0.7537631592747668
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASQ2,Calsequestrin-2,11332,84,1.03 [0.69-1.54],0.8943631170561276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAT,Catalase,11504,85,1.08 [0.75-1.56],0.6676905347002458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBLIF,Cobalamin binding intrinsic factor,13482,104,1.31 [1.02-1.69],0.0352004798104656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBLN1,Cerebellin-1,11347,80,0.77 [0.58-1.03],0.0767789877214572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBLN4,Cerebellin-4,13620,100,1.48 [0.86-2.53],0.1579099552217373
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBS,Cystathionine beta-synthase,11368,85,1.19 [0.82-1.73],0.3567956723134082
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBX2,Chromobox protein homolog 2,11332,84,0.94 [0.55-1.60],0.8164479386454782
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,13411,102,0.82 [0.64-1.05],0.1236022478915966
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCAR2,Cell cycle and apoptosis regulator protein 2,11656,85,0.77 [0.48-1.22],0.2675838510237501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC134,Coiled-coil domain-containing protein 134,11611,85,0.62 [0.39-0.97],0.0367022148319163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC28A,Coiled-coil domain-containing protein 28A,11351,84,0.68 [0.33-1.38],0.2794358348430501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC50,Coiled-coil domain-containing protein 50,11674,86,0.86 [0.64-1.16],0.318586198139709
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC80,Coiled-coil domain-containing protein 80,13500,104,0.76 [0.44-1.29],0.3046465176878687
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,11368,85,0.88 [0.62-1.26],0.4892174946928791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL11,Eotaxin,13652,101,0.67 [0.43-1.06],0.0854592379561972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL13,C-C motif chemokine 13,13631,101,0.83 [0.64-1.07],0.1555115725408907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL14,C-C motif chemokine 14,13417,99,1.15 [0.74-1.78],0.5486451989386335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL15,C-C motif chemokine 15,13658,103,1.13 [0.77-1.66],0.5315171284697479
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL16,C-C motif chemokine 16,13658,103,0.85 [0.62-1.15],0.2828793123630688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL17,C-C motif chemokine 17,13467,101,0.80 [0.66-0.98],0.0274079048082363
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL18,C-C motif chemokine 18,13265,97,0.94 [0.72-1.22],0.6183378704709728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL19,C-C motif chemokine 19,13626,102,1.02 [0.89-1.16],0.7754612564077742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL2,C-C motif chemokine 2,13390,102,0.94 [0.67-1.31],0.7131743397619066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL20,C-C motif chemokine 20,13652,101,1.06 [0.87-1.28],0.564023042209479
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL21,C-C motif chemokine 21,13555,104,0.46 [0.28-0.75],0.0017591192855147
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL22,C-C motif chemokine 22,13342,100,0.69 [0.48-0.99],0.0450885413827305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL23,C-C motif chemokine 23,13555,104,0.68 [0.44-1.04],0.0770650555637494
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL24,C-C motif chemokine 24,13534,104,0.96 [0.78-1.19],0.7354574287130278
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL25,C-C motif chemokine 25,13652,101,1.01 [0.71-1.44],0.9530456634992136
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL26,C-C motif chemokine 26,13483,101,0.86 [0.69-1.06],0.1642372554868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL27,C-C motif chemokine 27,13500,104,0.76 [0.57-1.00],0.0536337149661514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL28,C-C motif chemokine 28,13443,101,1.00 [0.75-1.34],0.9975248563821012
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL3,C-C motif chemokine 3,13483,101,0.67 [0.44-1.00],0.0501864222996848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL4,C-C motif chemokine 4,13504,101,0.67 [0.48-0.94],0.0214594470097273
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL5,C-C motif chemokine 5,13507,102,0.91 [0.77-1.08],0.2953558266862204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL7,C-C motif chemokine 7,13483,101,0.77 [0.55-1.07],0.1222315139737582
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL8,C-C motif chemokine 8,13604,99,0.99 [0.75-1.32],0.962612382295026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN1,CCN family member 1,13410,101,0.87 [0.70-1.08],0.2202342481443648
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN2,CCN family member 2,13498,104,0.73 [0.54-0.98],0.0362178738798692
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN3,CCN family member 3,13641,103,0.70 [0.40-1.22],0.2097823594497006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN4,CCN family member 4,13620,100,0.84 [0.54-1.30],0.4398550967374919
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN5,CCN family member 5,13496,100,0.90 [0.57-1.42],0.6536910749703175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCND2,G1/S-specific cyclin-D2,11438,86,0.94 [0.55-1.60],0.8074777231364324
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCNE1,G1/S-specific cyclin-E1,11358,82,0.95 [0.75-1.20],0.64826668741048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCS,Copper chaperone for superoxide dismutase,13411,102,0.82 [0.57-1.18],0.2767470396860194
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCT5,T-complex protein 1 subunit epsilon,13187,100,0.75 [0.49-1.15],0.1899121664931695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD101,Immunoglobulin superfamily member 2,11626,86,0.77 [0.48-1.24],0.289174781101415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD109,CD109 antigen,13496,100,0.64 [0.39-1.07],0.0922822470068797
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD14,Monocyte differentiation antigen CD14,13155,97,1.10 [0.71-1.69],0.6750466158991726
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD160,CD160 antigen,13652,101,0.76 [0.51-1.14],0.1819696489047397
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD163,Scavenger receptor cysteine-rich type 1 protein M130,13507,102,0.96 [0.64-1.45],0.8590953948730212
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD164,Sialomucin core protein 24,13496,100,1.04 [0.53-2.04],0.914654801095575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD164L2,CD164 sialomucin-like 2 protein,11351,84,0.59 [0.32-1.09],0.0946366282986182
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD177,CD177 antigen,13476,100,1.15 [0.98-1.34],0.0770130121283627
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD1C,T-cell surface glycoprotein CD1c,13527,102,1.05 [0.49-2.25],0.891017744561049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD2,T-cell surface antigen CD2,11332,84,1.10 [0.67-1.83],0.697451732034059
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD200,OX-2 membrane glycoprotein,13483,101,0.45 [0.22-0.91],0.0259443806173095
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD200R1,Cell surface glycoprotein CD200 receptor 1,13446,101,1.07 [0.64-1.77],0.7996516353635086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD207,C-type lectin domain family 4 member K,13214,100,0.72 [0.45-1.16],0.1776127586655241
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD209,CD209 antigen,13515,101,0.85 [0.54-1.34],0.4819076115009377
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD22,B-cell receptor CD22,13652,101,0.75 [0.48-1.18],0.2112273475877265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD226,CD226 antigen,11358,82,0.78 [0.47-1.30],0.3389727230467141
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD244,Natural killer cell receptor 2B4,13652,101,0.81 [0.42-1.56],0.5312893857624401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD248,Endosialin,11671,86,0.78 [0.46-1.32],0.3554254848752604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD27,CD27 antigen,13527,102,0.75 [0.47-1.20],0.2299712559479291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD274,Programmed cell death 1 ligand 1,13411,102,0.95 [0.56-1.61],0.8536645905320701
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD276,CD276 antigen,13493,104,0.84 [0.53-1.35],0.4826424043080853
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD28,T-cell-specific surface glycoprotein CD28,13187,100,0.65 [0.39-1.11],0.11389873121636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD2AP,CD2-associated protein,13500,104,0.78 [0.59-1.02],0.0738943666414243
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300A,CMRF35-like molecule 8,11422,85,0.60 [0.29-1.24],0.1692819421578358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300C,CMRF35-like molecule 6,13626,102,0.75 [0.44-1.27],0.2870107443700369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300E,CMRF35-like molecule 2,13576,100,0.62 [0.38-1.00],0.0521639210511778
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300LF,CMRF35-like molecule 1,13620,100,0.93 [0.71-1.23],0.627333240865817
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300LG,CMRF35-like molecule 9,13496,100,0.81 [0.50-1.31],0.3971878156831655
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD302,CD302 antigen,13429,102,0.66 [0.35-1.25],0.2030837300733656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD33,Myeloid cell surface antigen CD33,13527,102,0.94 [0.76-1.17],0.6028136068489667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD34,Hematopoietic progenitor cell antigen CD34,13567,101,0.70 [0.34-1.46],0.3411811193849538
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD36,Platelet glycoprotein 4,11358,82,0.68 [0.42-1.12],0.1293013068874684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,13429,102,0.61 [0.34-1.11],0.1073011743892169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD3D,T-cell surface glycoprotein CD3 delta chain,11347,80,0.73 [0.36-1.48],0.3830948090486958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD3E,T-cell surface glycoprotein CD3 epsilon chain,11438,86,1.23 [0.77-1.99],0.3874986946366222
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD3G,T-cell surface glycoprotein CD3 gamma chain,11358,82,0.83 [0.62-1.11],0.2144465135099609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD4,T-cell surface glycoprotein CD4,13459,101,0.56 [0.29-1.08],0.0852293412682208
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD40,Tumor necrosis factor receptor superfamily member 5,13483,101,0.71 [0.49-1.04],0.0794357060692635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD40LG,CD40 ligand,13652,101,0.80 [0.64-1.00],0.0525805582311982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD46,Membrane cofactor protein,13363,98,0.82 [0.43-1.57],0.5507963647475133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD48,CD48 antigen,13534,104,0.74 [0.40-1.35],0.3285871193756249
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD5,T-cell surface glycoprotein CD5,13604,99,0.82 [0.47-1.43],0.4874449433716279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD55,Complement decay-accelerating factor,12985,92,0.72 [0.34-1.54],0.3936929181481321
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD58,Lymphocyte function-associated antigen 3,13465,104,0.63 [0.24-1.68],0.3593932019448351
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD59,CD59 glycoprotein,12973,97,0.37 [0.14-0.99],0.0470089249235269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD5L,CD5 antigen-like,11636,87,0.81 [0.52-1.27],0.3671651376101513
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD6,T-cell differentiation antigen CD6,13625,100,0.94 [0.68-1.31],0.7114310146505356
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD63,CD63 antigen,13390,102,0.88 [0.63-1.23],0.4565722883909738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD69,Early activation antigen CD69,13428,101,0.85 [0.70-1.03],0.0902235665334839
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD7,T-cell antigen CD7,11338,82,0.63 [0.37-1.08],0.0917421674848941
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD70,CD70 antigen,13483,101,1.06 [0.69-1.63],0.7877730617468377
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD72,B-cell differentiation antigen CD72,11422,85,0.70 [0.41-1.18],0.180941980175932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD74,HLA class II histocompatibility antigen gamma chain,13626,102,0.60 [0.35-1.03],0.0637887907607837
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD79B,B-cell antigen receptor complex-associated protein beta chain,13652,101,0.76 [0.49-1.19],0.230737595006459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD80,T-lymphocyte activation antigen CD80,11692,85,0.81 [0.43-1.51],0.5057166928712911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD82,CD82 antigen,11438,86,0.67 [0.36-1.24],0.1998639024683625
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD83,CD83 antigen,13483,101,0.55 [0.31-0.98],0.0417483304963405
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD84,SLAM family member 5,13483,101,0.59 [0.34-1.04],0.0688341445862981
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD86,T-lymphocyte activation antigen CD86,11626,86,0.97 [0.48-1.96],0.938123509382787
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD8A,T-cell surface glycoprotein CD8 alpha chain,13626,102,1.45 [1.03-2.06],0.0357379545277302
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD93,Complement component C1q receptor,12942,92,0.93 [0.51-1.71],0.8147598853931185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD99,CD99 antigen,13496,100,0.62 [0.24-1.59],0.3189768270007296
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD99L2,CD99 antigen-like protein 2,13496,100,0.54 [0.25-1.16],0.1146388451868428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDA,Cytidine deaminase,11671,85,1.08 [0.71-1.65],0.718408696446128
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDAN1,Codanin-1,11656,85,1.63 [0.93-2.86],0.0847198858763179
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC123,Cell division cycle protein 123 homolog,11269,84,1.07 [0.80-1.44],0.6482058497913631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC25A,M-phase inducer phosphatase 1,11269,84,0.82 [0.47-1.42],0.4802841279598308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC26,Anaphase-promoting complex subunit CDC26,11612,86,0.87 [0.64-1.16],0.3377448389647
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC27,Cell division cycle protein 27 homolog,13187,100,0.66 [0.47-0.92],0.0144023921579145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC37,Hsp90 co-chaperone Cdc37,13527,102,0.87 [0.70-1.07],0.1821132940157081
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC42BPB,Serine/threonine-protein kinase MRCK beta,11626,86,0.84 [0.68-1.03],0.0933686683113312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDCP1,CUB domain-containing protein 1,13411,102,0.85 [0.58-1.26],0.4292683582019785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH1,Cadherin-1,12991,94,1.23 [0.82-1.84],0.319112720213419
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH15,Cadherin-15,13597,102,0.69 [0.43-1.11],0.128919446451162
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH17,Cadherin-17,13500,104,0.95 [0.73-1.23],0.7019856308285262
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH2,Cadherin-2,13500,104,1.80 [1.11-2.92],0.0178950333404363
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH22,Cadherin-22,11438,86,0.98 [0.48-1.99],0.9546596078055024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH23,Cadherin-23,11656,85,0.69 [0.30-1.55],0.3640416992722052
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH3,Cadherin-3,13626,102,0.83 [0.50-1.38],0.4726888564487155
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH4,Cadherin-4,11347,80,0.74 [0.44-1.23],0.2433875348277097
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH5,Cadherin-5,13658,103,0.67 [0.37-1.21],0.1819539092846342
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH6,Cadherin-6,13500,104,1.00 [0.63-1.57],0.9905480735377612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDHR1,Cadherin-related family member 1,13156,97,1.08 [0.72-1.62],0.7056747625440773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDHR2,Cadherin-related family member 2,13429,102,1.16 [0.93-1.46],0.182392318788102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDHR5,Cadherin-related family member 5,13500,104,1.07 [0.68-1.66],0.778355134293951
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDK1,Cyclin-dependent kinase 1,11269,84,0.94 [0.54-1.64],0.8244204092159819
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,11674,86,0.92 [0.65-1.31],0.6608280551019894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDKL5,Cyclin-dependent kinase-like 5,11347,80,0.59 [0.35-0.99],0.0450665512815738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDKN1A,Cyclin-dependent kinase inhibitor 1,13429,102,0.86 [0.73-1.02],0.0828483923222726
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,13429,102,0.91 [0.76-1.09],0.3075862630986967
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDNF,Cerebral dopamine neurotrophic factor,13429,102,0.44 [0.25-0.77],0.004547723888547
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,13518,104,0.75 [0.40-1.42],0.3799801884219268
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDSN,Corneodesmosin,13607,100,0.97 [0.64-1.47],0.8862992214577065
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,13505,102,1.06 [0.52-2.16],0.8639472137312044
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,11626,86,0.97 [0.76-1.25],0.8198745461049152
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,11438,86,1.14 [0.88-1.47],0.3290707859262979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,11626,86,1.01 [0.60-1.71],0.9585215233619008
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,11438,86,0.85 [0.52-1.40],0.5250348127470275
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,13483,101,1.13 [0.93-1.38],0.2282938384308239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,13187,100,1.30 [0.94-1.78],0.1089431131840358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,12987,100,0.69 [0.51-0.94],0.018145973644454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,11671,86,0.91 [0.52-1.61],0.751318654771452
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,13267,101,1.01 [0.71-1.44],0.9610259342215796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEBPA,CCAAT/enhancer-binding protein alpha,11358,82,0.70 [0.35-1.41],0.3196690027015107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEBPB,CCAAT/enhancer-binding protein beta,13267,101,0.80 [0.49-1.31],0.3806696134192527
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CELA2A,Chymotrypsin-like elastase family member 2A,11671,86,0.82 [0.58-1.17],0.2681117448218882
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CELA3A,Chymotrypsin-like elastase family member 3A,13636,103,0.83 [0.60-1.15],0.266593734614746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,11422,85,0.57 [0.27-1.21],0.1428095045882773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEMIP2,Cell surface hyaluronidase,11358,82,0.64 [0.30-1.40],0.268271276500756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEND1,Cell cycle exit and neuronal differentiation protein 1,11347,80,0.80 [0.52-1.24],0.3256256642530891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CENPF,Centromere protein F,11438,86,0.90 [0.62-1.33],0.6083362492495054
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CENPJ,Centromere protein J,11438,86,1.07 [0.82-1.39],0.6118077878097264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP112,Centrosomal protein of 112 kDa,11332,84,0.81 [0.48-1.37],0.4262356045986688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP152,Centrosomal protein of 152 kDa,11269,84,0.54 [0.30-0.97],0.0392314258977425
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP164,Centrosomal protein of 164 kDa,13235,101,0.85 [0.61-1.19],0.3414889844080917
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP170,Centrosomal protein of 170 kDa,11368,85,0.76 [0.57-1.01],0.0586144591538491
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP20,Centrosomal protein 20,13187,100,0.88 [0.68-1.12],0.2979066832351256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP290,Centrosomal protein of 290 kDa,11438,86,1.03 [0.71-1.51],0.8690547580439368
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP350,Centrosome-associated protein 350,11269,84,1.21 [0.73-1.99],0.462227078027829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP43,Centrosomal protein 43,13158,99,0.78 [0.59-1.02],0.0666363838065508
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP85,Centrosomal protein of 85 kDa,13187,100,0.69 [0.51-0.94],0.0176124925561619
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CERT,Ceramide transfer protein,13156,97,1.05 [0.78-1.41],0.7534047667428185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CES1,Liver carboxylesterase 1,13516,103,1.04 [0.82-1.31],0.754909261339943
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CES2,Cocaine esterase,13429,102,0.90 [0.64-1.26],0.544475240443954
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CES3,Carboxylesterase 3,13429,102,0.83 [0.62-1.10],0.197644326696788
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CETN2,Centrin-2,13156,97,1.00 [0.76-1.30],0.9732508850872348
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CETN3,Centrin-3,11626,86,0.87 [0.66-1.13],0.2953664007517779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFB,Complement factor B,11475,86,1.73 [0.93-3.21],0.0821275925601896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFC1,Cryptic protein,13187,100,0.94 [0.64-1.37],0.732760027737172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFD,Complement factor D,11702,87,0.54 [0.17-1.70],0.2924001028182328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFH,Complement factor H,11018,79,1.60 [0.64-4.00],0.3107812702685695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFHR2,Complement factor H-related protein 2,11621,87,0.85 [0.60-1.19],0.3315792168488441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFHR4,Complement factor H-related protein 4,11685,87,1.05 [0.79-1.40],0.729017473930248
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFHR5,Complement factor H-related protein 5,11542,85,1.10 [0.66-1.83],0.7014805223340337
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFI,Complement factor I,11702,87,1.00 [0.37-2.74],0.996762170038322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFP,Properdin,11702,87,1.20 [0.57-2.53],0.6326132376703139
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGA,Glycoprotein hormones alpha chain,13496,100,0.81 [0.68-0.98],0.0290977705277123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,11690,85,1.00 [0.65-1.54],0.9986145125223927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGN,Cingulin,11351,84,0.56 [0.29-1.07],0.0808329366660741
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGREF1,Cell growth regulator with EF hand domain protein 1,13500,104,0.72 [0.47-1.09],0.1231346642892993
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,13187,100,0.69 [0.50-0.95],0.0214899528997237
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHAD,Chondroadherin,11422,85,0.70 [0.48-1.02],0.0632579396198704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",11656,85,0.64 [0.35-1.15],0.1377452952361866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHCHD6,MICOS complex subunit MIC25,11611,85,1.05 [0.53-2.09],0.8874387624956794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHEK2,Serine/threonine-protein kinase Chk2,13267,101,1.28 [0.80-2.04],0.3006166119401379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHGA,Chromogranin-A,11671,86,1.21 [0.96-1.51],0.0994804043121827
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHGB,Secretogranin-1,13569,101,0.54 [0.34-0.85],0.0083399657575446
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHI3L1,Chitinase-3-like protein 1,13133,94,0.82 [0.62-1.07],0.1460040247575052
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHIT1,Chitotriosidase-1,13541,100,1.02 [0.90-1.16],0.7217408024397618
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHL1,Neural cell adhesion molecule L1-like protein,13482,102,1.35 [0.80-2.27],0.2618265671148518
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHM,Rab proteins geranylgeranyltransferase component A 1,11351,84,0.66 [0.45-0.95],0.0254066552364754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHMP1A,Charged multivesicular body protein 1a,13411,102,0.94 [0.76-1.18],0.6058993505453927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHMP6,Charged multivesicular body protein 6,11692,85,0.72 [0.50-1.04],0.0788141568846171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHP1,Calcineurin B homologous protein 1,11347,80,0.90 [0.66-1.23],0.5233551743501983
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHRDL1,Chordin-like protein 1,13534,104,0.70 [0.39-1.24],0.2205131809259048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHRDL2,Chordin-like protein 2,13500,104,0.96 [0.72-1.28],0.7848845988391213
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHRM1,Muscarinic acetylcholine receptor M1,11351,84,0.55 [0.28-1.09],0.085408626335193
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CIAPIN1,Anamorsin,13527,102,0.83 [0.63-1.08],0.1672186975392467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CILP,Cartilage intermediate layer protein 1,11671,86,0.93 [0.64-1.37],0.7213502482021973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CINP,Cyclin-dependent kinase 2-interacting protein,11438,86,0.55 [0.30-1.00],0.0488531480492345
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CIRBP,Cold-inducible RNA-binding protein,11626,86,0.92 [0.75-1.14],0.4523106535646023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CIT,Citron Rho-interacting kinase,11351,84,0.85 [0.53-1.36],0.4933596882167554
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CKAP4,Cytoskeleton-associated protein 4,13574,97,0.40 [0.19-0.88],0.0222249889748454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CKB,Creatine kinase B-type,11671,86,0.82 [0.58-1.15],0.2478147379244556
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",13430,101,0.99 [0.77-1.27],0.920270903539813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLASP1,CLIP-associating protein 1,11269,84,0.82 [0.59-1.14],0.2328361707090698
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLC,Galectin-10,13482,104,0.78 [0.59-1.04],0.088939517269448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC10A,C-type lectin domain family 10 member A,13411,102,1.09 [0.67-1.78],0.7331588663133133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC11A,C-type lectin domain family 11 member A,13467,100,0.89 [0.61-1.29],0.5366934159756203
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC12A,C-type lectin domain family 12 member A,11358,82,0.36 [0.12-1.06],0.0639247752022439
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC14A,C-type lectin domain family 14 member A,13496,100,0.64 [0.35-1.15],0.1335997970122776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC1A,C-type lectin domain family 1 member A,13267,101,0.69 [0.39-1.23],0.2076886825345745
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC1B,C-type lectin domain family 1 member B,13626,102,0.82 [0.68-0.98],0.0318682451382847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC2L,C-type lectin domain family 2 member L,11351,84,0.56 [0.31-1.00],0.0509227439392999
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC3B,Tetranectin,11427,85,0.99 [0.38-2.61],0.9891819300171985
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4A,C-type lectin domain family 4 member A,13483,101,0.88 [0.53-1.44],0.6047074603518842
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4C,C-type lectin domain family 4 member C,13483,101,0.67 [0.46-0.98],0.0414398105029933
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4D,C-type lectin domain family 4 member D,13483,101,0.85 [0.64-1.14],0.2912051033094464
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4G,C-type lectin domain family 4 member G,13483,101,1.13 [0.67-1.91],0.6506042307732519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4M,C-type lectin domain family 4 member M,11645,86,0.91 [0.59-1.40],0.6699709743876563
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC5A,C-type lectin domain family 5 member A,13449,101,0.98 [0.52-1.86],0.9488193328558912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC6A,C-type lectin domain family 6 member A,13187,100,0.98 [0.66-1.44],0.9069669258065344
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC7A,C-type lectin domain family 7 member A,13652,101,0.95 [0.71-1.28],0.7529476490367947
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLGN,Calmegin,11351,84,0.88 [0.54-1.44],0.6090923413635196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLIC5,Chloride intracellular channel protein 5,11351,84,0.75 [0.36-1.55],0.429828244165385
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLINT1,Clathrin interactor 1,11269,84,0.94 [0.57-1.52],0.7899653361519652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLIP2,CAP-Gly domain-containing linker protein 2,13483,101,0.89 [0.76-1.03],0.1175928718647277
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLMP,CXADR-like membrane protein,13620,100,0.50 [0.27-0.93],0.0280935510689531
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLNS1A,Methylosome subunit pICln,11351,84,1.00 [0.55-1.82],0.9951975766379592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",13382,102,1.00 [0.84-1.21],0.9718889843056628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLPS,Colipase,13475,100,1.00 [0.77-1.29],0.984684210863224
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSPN,Claspin,13127,97,0.30 [0.15-0.63],0.0012079981772817
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSTN1,Calsyntenin-1,13156,97,1.01 [0.72-1.42],0.9381996417439468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSTN2,Calsyntenin-2,13652,101,0.89 [0.57-1.41],0.6294380940666235
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSTN3,Calsyntenin-3,11656,85,0.94 [0.48-1.85],0.8504394040152692
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLTA,Clathrin light chain A,13267,101,0.88 [0.60-1.30],0.5331349895075439
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLU,Clusterin,11702,87,0.99 [0.54-1.80],0.9707597121788656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLUL1,Clusterin-like protein 1,13484,104,0.87 [0.59-1.27],0.4658387823578027
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CMC1,COX assembly mitochondrial protein homolog,11692,85,0.90 [0.71-1.13],0.3613241578682512
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CMIP,C-Maf-inducing protein,11611,85,0.88 [0.69-1.14],0.3442859400927064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNDP1,Beta-Ala-His dipeptidase,13507,102,1.05 [0.72-1.54],0.8075223779098003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNGB3,Cyclic nucleotide-gated cation channel beta-3,11347,80,1.05 [0.73-1.51],0.7804765985925185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",11344,85,0.95 [0.73-1.23],0.676832101950642
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNPY2,Protein canopy homolog 2,13267,101,0.88 [0.64-1.22],0.4432109640214952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNPY4,Protein canopy homolog 4,13429,102,0.91 [0.72-1.15],0.4221365976323264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNST,Consortin,13500,104,0.85 [0.73-1.00],0.0506808285326244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTF,Ciliary neurotrophic factor,11347,80,1.00 [0.54-1.84],0.988341224319236
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN1,Contactin-1,13658,103,0.81 [0.43-1.52],0.5127420640823825
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN2,Contactin-2,13620,100,0.81 [0.54-1.20],0.2968455850518502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN3,Contactin-3,13496,100,1.09 [0.66-1.80],0.7325926266252347
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN4,Contactin-4,13496,100,1.09 [0.52-2.28],0.816491011270889
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN5,Contactin-5,13530,100,0.66 [0.40-1.09],0.1065040042898572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTNAP2,Contactin-associated protein-like 2,13483,101,0.82 [0.53-1.30],0.4023131557864482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTNAP4,Contactin-associated protein-like 4,11351,84,0.92 [0.73-1.15],0.4489386149685681
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COCH,Cochlin,11692,85,0.80 [0.51-1.27],0.3478938109501019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL15A1,Collagen alpha-1(XV) chain,11671,86,1.14 [0.50-2.58],0.7542513267383621
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL18A1,Collagen alpha-1(XVIII) chain,13540,100,0.51 [0.24-1.09],0.0817574389429965
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL1A1,Collagen alpha-1(I) chain,13658,103,0.69 [0.36-1.35],0.2793188544835339
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL24A1,Collagen alpha-1(XXIV) chain,11626,86,1.13 [0.77-1.63],0.5363531295652506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL28A1,Collagen alpha-1(XXVIII) chain,11351,84,0.82 [0.60-1.11],0.1944434858924677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL2A1,Collagen alpha-1(II) chain,11368,85,0.92 [0.71-1.19],0.509765683637142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL3A1,Collagen alpha-1(III) chain,11671,86,0.74 [0.30-1.82],0.5190096517391805
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL4A1,Collagen alpha-1(IV) chain,13500,104,0.85 [0.55-1.33],0.4785112825282871
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL4A4,Collagen alpha-4(IV) chain,11421,86,0.87 [0.60-1.25],0.4487290534661824
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL5A1,Collagen alpha-1(V) chain,11422,85,0.84 [0.48-1.45],0.5200844169381567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL6A3,Collagen alpha-3(VI) chain,13658,103,0.80 [0.46-1.41],0.4399059541340751
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL9A1,Collagen alpha-1(IX) chain,13483,101,1.28 [0.88-1.85],0.1968356418571559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL9A2,Collagen alpha-2(IX) chain,11438,86,1.00 [0.65-1.55],0.9928035219309737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COLEC12,Collectin-12,13493,104,0.56 [0.27-1.14],0.109110194145825
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMMD1,COMM domain-containing protein 1,11368,85,0.85 [0.60-1.19],0.3336329354278097
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMMD9,COMM domain-containing protein 9,11611,85,0.62 [0.34-1.12],0.1105107068800136
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMP,Cartilage oligomeric matrix protein,13320,97,0.79 [0.46-1.36],0.3968866392085717
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMT,Catechol O-methyltransferase,13117,99,0.86 [0.70-1.06],0.1490991567825255
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COPB2,Coatomer subunit beta',11332,84,0.92 [0.56-1.53],0.7579661718415602
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COPE,Coatomer subunit epsilon,13156,97,0.74 [0.47-1.17],0.1977812119860279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",11368,85,1.30 [0.88-1.92],0.1850463907202386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CORO1A,Coronin-1A,13204,98,0.89 [0.73-1.10],0.2888354001959844
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CORO6,Coronin-6,11347,80,0.78 [0.41-1.46],0.4329751751848467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",13429,102,0.90 [0.70-1.17],0.4327924212541623
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COX6B1,Cytochrome c oxidase subunit 6B1,11692,85,0.77 [0.40-1.50],0.4462708197815235
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPA1,Carboxypeptidase A1,13658,103,0.82 [0.60-1.12],0.2165431336127889
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPA2,Carboxypeptidase A2,13573,102,0.82 [0.61-1.08],0.1622018363560051
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPA4,Carboxypeptidase A4,11183,85,0.90 [0.55-1.47],0.6747356065523105
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPB1,Carboxypeptidase B,13658,103,0.84 [0.61-1.16],0.2824609657226495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPB2,Carboxypeptidase B2,11676,87,2.86 [1.37-5.97],0.0052037933574628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPE,Carboxypeptidase E,13532,99,1.04 [0.66-1.65],0.8677439448665398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPLX2,Complexin-2,11269,84,0.97 [0.48-1.99],0.943276301076154
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPM,Carboxypeptidase M,13567,101,0.80 [0.48-1.32],0.3768867953270349
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",11358,82,0.70 [0.32-1.55],0.3800244538207138
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPPED1,Serine/threonine-protein phosphatase CPPED1,13626,102,0.98 [0.75-1.27],0.8562278233947276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPQ,Carboxypeptidase Q,11651,86,0.88 [0.53-1.47],0.6272597021051267
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPTP,Ceramide-1-phosphate transfer protein,11332,84,1.15 [0.73-1.81],0.5359016688084706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPVL,Probable serine carboxypeptidase CPVL,13601,100,0.95 [0.62-1.46],0.8301412536160844
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPXM1,Probable carboxypeptidase X1,13527,102,0.85 [0.65-1.10],0.2129175199667034
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPXM2,Inactive carboxypeptidase-like protein X2,11692,85,0.52 [0.22-1.25],0.1459194889573695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CR1,Complement receptor type 1,11639,85,1.30 [0.72-2.34],0.3771101191129874
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CR2,Complement receptor type 2,13507,102,1.04 [0.71-1.52],0.8448030902415471
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,13187,100,0.83 [0.66-1.03],0.0877178386657079
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRADD,Death domain-containing protein CRADD,13382,102,0.84 [0.67-1.05],0.1254014163901139
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CREB3,Cyclic AMP-responsive element-binding protein 3,11269,84,0.84 [0.56-1.26],0.4051275037086874
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CREBZF,CREB/ATF bZIP transcription factor,11269,84,0.77 [0.34-1.75],0.5276596978381987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CREG1,Protein CREG1,13300,96,0.79 [0.48-1.33],0.3808712363813178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRELD1,Protein disulfide isomerase CRELD1,11422,85,1.24 [0.71-2.14],0.449180158312773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRELD2,Protein disulfide isomerase CRELD2,13534,104,1.07 [0.77-1.49],0.6861414620208108
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRH,Corticoliberin,13163,100,0.84 [0.68-1.03],0.0933206993401113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRHBP,Corticotropin-releasing factor-binding protein,13493,104,0.96 [0.53-1.76],0.9054706793865628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRHR1,Corticotropin-releasing factor receptor 1,13267,101,1.10 [0.85-1.42],0.4824272629086897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRIM1,Cysteine-rich motor neuron 1 protein,13555,104,0.61 [0.25-1.48],0.2765266290677358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRIP2,Cysteine-rich protein 2,13411,102,1.08 [0.68-1.74],0.7391584487285239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRISP2,Cysteine-rich secretory protein 2,13620,100,1.31 [0.97-1.78],0.0778243037526894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRISP3,Cysteine-rich secretory protein 3,11576,85,1.26 [0.58-2.73],0.5647349330062859
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRKL,Crk-like protein,13506,104,0.89 [0.76-1.04],0.1508157159736667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRLF1,Cytokine receptor-like factor 1,13555,104,1.85 [0.96-3.59],0.0681985654248307
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRNN,Cornulin,13078,97,0.86 [0.65-1.14],0.3066151093150129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRTAC1,Cartilage acidic protein 1,13658,103,0.48 [0.28-0.84],0.0102945366479103
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRTAM,Cytotoxic and regulatory T-cell molecule,13411,102,0.73 [0.51-1.06],0.0967176270307202
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRTAP,Cartilage-associated protein,11351,84,0.77 [0.47-1.26],0.2962513272516994
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRX,Cone-rod homeobox protein,13267,101,0.90 [0.74-1.09],0.2682512314581188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYBB1,Beta-crystallin B1,11692,85,0.78 [0.57-1.08],0.1316914489359776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYBB2,Beta-crystallin B2,11656,85,0.44 [0.23-0.85],0.0146726745010747
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYGD,Gamma-crystallin D,11656,85,0.85 [0.68-1.05],0.1242634513680657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYM,Ketimine reductase mu-crystallin,11347,80,0.65 [0.46-0.93],0.0171569554916484
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYZL1,Quinone oxidoreductase-like protein 1,11368,85,0.93 [0.74-1.16],0.5021850832517786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSDE1,Cold shock domain-containing protein E1,11332,84,0.91 [0.75-1.10],0.3116383029282974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF1,Macrophage colony-stimulating factor 1,13555,104,0.61 [0.31-1.21],0.1597511339666132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF1R,Macrophage colony-stimulating factor 1 receptor,11690,85,1.07 [0.62-1.82],0.8141658921606502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF2,Granulocyte-macrophage colony-stimulating factor,11332,84,1.01 [0.56-1.79],0.9827421281300062
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,13411,102,1.14 [0.87-1.50],0.32458567333123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF2RB,Cytokine receptor common subunit beta,11358,82,0.85 [0.53-1.36],0.5007484953004754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF3,Granulocyte colony-stimulating factor,13235,101,0.72 [0.49-1.04],0.0802316850794918
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF3R,Granulocyte colony-stimulating factor receptor,11358,82,0.61 [0.29-1.27],0.1858343258333341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSH1,Chorionic somatomammotropin hormone 1,11690,85,0.81 [0.40-1.63],0.5490809386074958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSNK1D,Casein kinase I isoform delta,11358,82,0.70 [0.48-1.02],0.0619468577022942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSNK2A1,Casein kinase II subunit alpha,11674,86,0.82 [0.52-1.29],0.3819726309930167
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSPG4,Chondroitin sulfate proteoglycan 4,11671,86,0.73 [0.39-1.34],0.3066155584020851
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSPG5,Chondroitin sulfate proteoglycan 5,11347,80,0.94 [0.59-1.48],0.7740465004362231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSRP3,Cysteine and glycine-rich protein 3,11332,84,1.10 [0.90-1.35],0.3452239848571573
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST1,Cystatin-SN,10108,76,0.85 [0.68-1.08],0.1776655473431697
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST3,Cystatin-C,13488,102,0.77 [0.40-1.50],0.4392915479586893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST5,Cystatin-D,13273,102,0.97 [0.71-1.34],0.8620124649213243
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST6,Cystatin-M,13154,99,0.97 [0.66-1.42],0.870402748594936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST7,Cystatin-F,13504,101,0.89 [0.72-1.10],0.2881323687150773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSTB,Cystatin-B,13298,99,0.65 [0.43-1.01],0.0530342821716673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTAG1A_CTAG1B,Cancer/testis antigen 1,11412,86,0.99 [0.65-1.49],0.9498513245915852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTBS,Di-N-acetylchitobiase,11519,82,0.72 [0.37-1.42],0.3404763052672934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTF1,Cardiotrophin-1,13267,101,0.84 [0.68-1.05],0.1249632519273115
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTHRC1,Collagen triple helix repeat-containing protein 1,11671,86,0.74 [0.34-1.61],0.4502361607668064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTLA4,Cytotoxic T-lymphocyte protein 4,11671,86,0.72 [0.36-1.44],0.3540525506873881
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTNNA1,Catenin alpha-1,11347,80,0.44 [0.19-1.04],0.0615115560983749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTRB1,Chymotrypsinogen B,13496,100,0.87 [0.62-1.23],0.442124148355834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTRC,Chymotrypsin-C,13493,104,0.84 [0.63-1.11],0.2180685545199975
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTRL,Chymotrypsin-like protease CTRL-1,11656,85,0.89 [0.65-1.23],0.4810700837135838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSB,Cathepsin B,13487,100,0.92 [0.66-1.28],0.6029742150827773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSC,Dipeptidyl peptidase 1,13466,104,0.69 [0.45-1.05],0.0821692694641292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSD,Cathepsin D,12535,91,0.79 [0.46-1.35],0.3827486352893313
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSE,Cathepsin E,11422,85,1.08 [0.73-1.60],0.6919151157062811
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSF,Cathepsin F,13527,102,0.71 [0.46-1.09],0.1193026029824594
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSH,Pro-cathepsin H,13228,101,0.83 [0.65-1.06],0.1334659784565799
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSL,Cathepsin L1,13500,104,0.91 [0.43-1.90],0.7982956961039497
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSO,Cathepsin O,13652,101,0.72 [0.40-1.31],0.281158841842494
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSS,Cathepsin S,10650,76,1.13 [0.45-2.85],0.791788404664917
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSV,Cathepsin L2,13587,100,1.00 [0.66-1.50],0.9859346426614034
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSZ,Cathepsin Z,13449,102,0.84 [0.47-1.50],0.5537574536901865
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CUZD1,CUB and zona pellucida-like domain-containing protein 1,11351,84,0.82 [0.44-1.55],0.5443424389962619
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CWC15,Spliceosome-associated protein CWC15 homolog,11562,86,0.89 [0.61-1.28],0.5265007385199607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CX3CL1,Fractalkine,13411,102,0.61 [0.36-1.05],0.0765886209275772
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXADR,Coxsackievirus and adenovirus receptor,13483,101,0.70 [0.49-1.02],0.0603755451603191
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL1,Growth-regulated alpha protein,13453,100,0.89 [0.74-1.08],0.2423442035296429
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL10,C-X-C motif chemokine 10,13555,104,0.84 [0.63-1.11],0.2088431473885539
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL11,C-X-C motif chemokine 11,13626,102,0.82 [0.65-1.04],0.0949275112203612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL12,Stromal cell-derived factor 1,13235,101,0.56 [0.36-0.88],0.0121758111837988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL13,C-X-C motif chemokine 13,13626,102,0.91 [0.68-1.24],0.5626265978437064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL14,C-X-C motif chemokine 14,13235,101,0.91 [0.67-1.23],0.5345941968095134
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL16,C-X-C motif chemokine 16,13628,101,0.68 [0.31-1.45],0.3150652520099649
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL17,C-X-C motif chemokine 17,13652,101,1.08 [0.70-1.67],0.7307115053607325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL3,C-X-C motif chemokine 3,13483,101,0.86 [0.72-1.02],0.0852069379138224
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL5,C-X-C motif chemokine 5,13453,104,0.86 [0.74-1.00],0.0459712050725785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL6,C-X-C motif chemokine 6,13652,101,0.74 [0.58-0.93],0.0092305106841567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL8,Interleukin-8,13386,100,0.80 [0.60-1.06],0.1237480780121632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL9,C-X-C motif chemokine 9,13555,104,0.82 [0.61-1.09],0.1621672171564733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYB5A,Cytochrome b5,11269,84,1.04 [0.79-1.36],0.789468884008745
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYB5R2,NADH-cytochrome b5 reductase 2,11477,86,1.16 [0.81-1.65],0.4262214998066009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",11332,84,0.73 [0.53-1.01],0.0571388844770188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYTH3,Cytohesin-3,11269,84,1.09 [0.84-1.41],0.5061651288561312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYTL1,Cytokine-like protein 1,11671,86,0.92 [0.37-2.29],0.8565968303123992
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAAM1,Disheveled-associated activator of morphogenesis 1,11422,85,0.78 [0.60-1.01],0.0566993218682813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAB2,Disabled homolog 2,13620,100,0.88 [0.75-1.02],0.0936802436347082
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAG1,Dystroglycan,13555,104,0.78 [0.54-1.11],0.1716184744306526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAND5,DAN domain family member 5,11358,82,0.87 [0.58-1.28],0.4727255978009358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAPK2,Death-associated protein kinase 2,11358,82,0.92 [0.61-1.38],0.6741855350112071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,13483,101,0.94 [0.82-1.09],0.427289233506432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DARS1,"Aspartate--tRNA ligase, cytoplasmic",13382,102,0.93 [0.74-1.18],0.5563400803894265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBH,Dopamine beta-hydroxylase,11669,85,1.07 [0.87-1.31],0.5273605017883563
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBI,Acyl-CoA-binding protein,13434,100,0.89 [0.72-1.11],0.3164513699982615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBN1,Drebrin,11358,82,0.65 [0.42-1.00],0.0503282976975117
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBNL,Drebrin-like protein,13555,104,0.85 [0.71-1.03],0.0946784946719971
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",13527,102,0.64 [0.39-1.05],0.0780191941541706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCC,Netrin receptor DCC,11351,84,0.74 [0.26-2.05],0.5572736013562489
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCDC2C,Doublecortin domain-containing protein 2C,11269,84,0.95 [0.68-1.33],0.7530891283101093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCLRE1C,Protein artemis,11269,84,0.47 [0.23-0.95],0.0368784283140722
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCN,Decorin,13267,101,0.36 [0.16-0.81],0.0143722610800152
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTD,Deoxycytidylate deaminase,11422,85,0.90 [0.72-1.12],0.3357693892707838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTN1,Dynactin subunit 1,13620,100,0.81 [0.62-1.06],0.1298153938240568
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTN2,Dynactin subunit 2,13429,102,0.85 [0.70-1.03],0.0903980207260176
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTN6,Dynactin subunit 6,13156,97,0.88 [0.67-1.16],0.3740104253133244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTPP1,dCTP pyrophosphatase 1,13500,104,0.84 [0.48-1.46],0.542335298030873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCUN1D1,DCN1-like protein 1,11347,80,0.70 [0.48-1.01],0.056419321984906
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCUN1D2,DCN1-like protein 2,11269,84,1.06 [0.84-1.35],0.6177302314203186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCXR,L-xylulose reductase,13527,102,1.09 [0.78-1.51],0.6137049163763764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDA1,DET1- and DDB1-associated protein 1,11332,84,0.61 [0.33-1.11],0.1069867417169272
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",13429,102,0.81 [0.54-1.22],0.3218150453376602
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDC,Aromatic-L-amino-acid decarboxylase,13482,104,1.08 [0.76-1.54],0.6629200036125147
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDHD2,Phospholipase DDHD2,11674,86,0.80 [0.59-1.10],0.1667367498251135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDI2,Protein DDI1 homolog 2,11422,85,1.01 [0.78-1.31],0.9335262165571604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDR1,Epithelial discoidin domain-containing receptor 1,13626,102,0.72 [0.32-1.61],0.4256706452968738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDT,D-dopachrome decarboxylase,11671,86,0.93 [0.56-1.53],0.7739748542384854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX1,ATP-dependent RNA helicase DDX1,11626,86,1.31 [0.95-1.82],0.0985714044747468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX25,ATP-dependent RNA helicase DDX25,11351,84,0.35 [0.17-0.72],0.0046110832727402
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX39A,ATP-dependent RNA helicase DDX39A,11358,82,0.74 [0.27-2.06],0.5680917208462501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX4,Probable ATP-dependent RNA helicase DDX4,11358,82,1.07 [0.74-1.53],0.7273507463131055
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX53,Probable ATP-dependent RNA helicase DDX53,11351,84,0.95 [0.52-1.71],0.8531486952274605
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX58,Antiviral innate immune response receptor RIG-I,13187,100,0.91 [0.67-1.25],0.5790917009340213
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",13483,101,0.93 [0.77-1.11],0.4000312838325162
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFA1_DEFA1B,Neutrophil defensin 1,13179,93,1.08 [0.76-1.53],0.666681998159065
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB103A_DEFB103B,Beta-defensin 103,11274,82,1.34 [0.93-1.95],0.1181192588532463
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB104A_DEFB104B,Beta-defensin 104,11347,80,0.83 [0.55-1.28],0.4033557426289424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB116,Beta-defensin 116,11347,80,0.89 [0.66-1.21],0.4597691954056319
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB118,Beta-defensin 118,11347,80,0.89 [0.58-1.35],0.5776982871892908
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB4A_DEFB4B,Beta-defensin 4A,13299,101,0.88 [0.77-1.00],0.0422444978679706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DENND2B,DENN domain-containing protein 2B,11332,84,1.05 [0.72-1.54],0.7843101395184688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DENR,Density-regulated protein,11358,82,0.74 [0.49-1.10],0.1313292550593638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DFFA,DNA fragmentation factor subunit alpha,13652,101,0.91 [0.70-1.18],0.4669405293975232
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DGCR6,Protein DGCR6,11347,80,0.71 [0.40-1.28],0.256622687854902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DGKA,Diacylglycerol kinase alpha,11358,82,0.77 [0.51-1.16],0.2152300501687871
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DGKZ,Diacylglycerol kinase zeta,13235,101,1.01 [0.61-1.65],0.9747598950863584
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DHODH,Dihydroorotate dehydrogenase,11332,84,1.13 [0.76-1.67],0.5444429465213336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DHPS,Deoxyhypusine synthase,11611,85,1.03 [0.64-1.66],0.8991805708366074
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,11656,85,0.70 [0.43-1.15],0.1558097196398679
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DIABLO,"Diablo homolog, mitochondrial",13449,101,0.86 [0.73-1.01],0.0660662354234235
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DIPK1C,Divergent protein kinase domain 1C,11351,84,0.73 [0.42-1.26],0.2560340609773713
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DIPK2B,Divergent protein kinase domain 2B,11422,85,0.75 [0.34-1.65],0.4772891417910148
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKK1,Dickkopf-related protein 1,13626,102,0.79 [0.59-1.05],0.1000444291579776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKK3,Dickkopf-related protein 3,13658,103,0.72 [0.39-1.31],0.2778612051064265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKK4,Dickkopf-related protein 4,13388,102,0.80 [0.54-1.20],0.2798703494480441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKKL1,Dickkopf-like protein 1,13429,102,0.92 [0.76-1.10],0.3554653649134549
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLG4,Disks large homolog 4,11656,85,0.83 [0.61-1.13],0.234340657376756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLGAP5,Disks large-associated protein 5,11674,86,0.71 [0.43-1.20],0.2019452959523266
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLK1,Protein delta homolog 1,13658,103,0.98 [0.70-1.35],0.8822546731349381
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLL1,Delta-like protein 1,13527,102,0.66 [0.35-1.24],0.193836952669348
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLL4,Delta-like protein 4,11368,85,0.88 [0.63-1.23],0.4607695159538781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DMD,Dystrophin,11368,85,0.74 [0.47-1.18],0.2041994272014258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DMP1,Dentin matrix acidic phosphoprotein 1,11368,85,0.97 [0.70-1.34],0.8427764475296781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJA1,DnaJ homolog subfamily A member 1,11269,84,0.99 [0.64-1.53],0.9482739261990656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJA2,DnaJ homolog subfamily A member 2,13601,98,0.81 [0.65-1.00],0.0512064567658211
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJA4,DnaJ homolog subfamily A member 4,11656,85,0.96 [0.72-1.26],0.7540411519486202
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB1,DnaJ homolog subfamily B member 1,13429,102,0.85 [0.69-1.03],0.1044381012737322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB14,DnaJ homolog subfamily B member 14,11626,86,0.84 [0.61-1.17],0.3008251703259126
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB2,DnaJ homolog subfamily B member 2,11422,85,0.90 [0.61-1.31],0.5716426356905766
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB6,DnaJ homolog subfamily B member 6,11305,85,0.83 [0.65-1.07],0.1451223470095769
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB8,DnaJ homolog subfamily B member 8,13267,101,1.09 [0.83-1.45],0.5345886263391433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJC21,DnaJ homolog subfamily C member 21,11656,85,0.99 [0.58-1.69],0.963432196851468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJC6,Putative tyrosine-protein phosphatase auxilin,11368,85,0.83 [0.65-1.07],0.1576708285409002
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJC9,DnaJ homolog subfamily C member 9,11626,86,0.95 [0.73-1.23],0.6906139250352581
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNER,Delta and Notch-like epidermal growth factor-related receptor,13472,104,0.82 [0.41-1.65],0.5752017537477417
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNLZ,DNL-type zinc finger protein,11347,80,1.00 [0.80-1.25],0.9738447336084588
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNM1,Dynamin-1,11626,86,0.96 [0.80-1.15],0.6524381581706071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNM3,Dynamin-3,11674,86,0.70 [0.46-1.07],0.0966595398346891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNMBP,Dynamin-binding protein,13411,102,0.78 [0.58-1.05],0.1082287076058653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNPEP,Aspartyl aminopeptidase,11656,85,0.86 [0.62-1.20],0.3743945876897535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,13527,104,0.96 [0.70-1.33],0.8115189369189006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOC2B,Double C2-like domain-containing protein beta,11351,84,0.56 [0.27-1.17],0.1258630862202856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOCK9,Dedicator of cytokinesis protein 9,11347,80,1.17 [1.01-1.35],0.0362820165592617
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOK1,Docking protein 1,11656,85,0.92 [0.79-1.06],0.2486526326164513
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOK2,Docking protein 2,13500,104,0.87 [0.76-1.01],0.0652602649728882
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPEP1,Dipeptidase 1,13382,102,1.07 [0.75-1.52],0.7093126015164808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPEP2,Dipeptidase 2,13429,102,0.74 [0.40-1.36],0.329892135380843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP10,Inactive dipeptidyl peptidase 10,13483,101,0.68 [0.39-1.19],0.1812482994374887
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP4,Dipeptidyl peptidase 4,13186,96,0.81 [0.44-1.49],0.4975903043625733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP6,Dipeptidyl aminopeptidase-like protein 6,13429,102,0.66 [0.39-1.13],0.1321124525103765
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP7,Dipeptidyl peptidase 2,13384,103,0.92 [0.69-1.24],0.5929341487407981
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPT,Dermatopontin,13658,103,0.48 [0.27-0.85],0.0126475252980055
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPY30,Protein dpy-30 homolog,13580,100,0.90 [0.66-1.22],0.4832159866924496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DRAXIN,Draxin,13411,102,0.90 [0.60-1.37],0.6271810230754424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DRG2,Developmentally-regulated GTP-binding protein 2,13429,102,0.72 [0.52-0.99],0.0439511804875056
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSC2,Desmocollin-2,13348,98,0.99 [0.57-1.71],0.9677152976114232
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSCAM,Down syndrome cell adhesion molecule,11674,86,0.75 [0.42-1.35],0.3367335302209144
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSG2,Desmoglein-2,13496,100,0.93 [0.48-1.80],0.8337886407707706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSG3,Desmoglein-3,13581,100,0.60 [0.35-1.02],0.0588915792904163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSG4,Desmoglein-4,13376,102,0.90 [0.64-1.26],0.5243268872114677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTD1,D-aminoacyl-tRNA deacylase 1,11422,85,0.86 [0.67-1.09],0.1994396373498219
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTNB,Dystrobrevin beta,11597,85,0.64 [0.38-1.07],0.0871279595421982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTX2,Probable E3 ubiquitin-protein ligase DTX2,11351,84,0.78 [0.55-1.12],0.1845280963894416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTX3,Probable E3 ubiquitin-protein ligase DTX3,13429,102,0.46 [0.21-1.00],0.0509033067663789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTYMK,Thymidylate kinase,11692,85,0.73 [0.54-0.99],0.0436987604580223
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUOX2,Dual oxidase 2,13267,101,1.02 [0.80-1.29],0.8775094603128609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUSP13,Dual specificity protein phosphatase 13 isoform A,11611,85,0.99 [0.59-1.65],0.9553125112048434
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUSP29,Dual specificity phosphatase 29,11351,84,0.97 [0.70-1.33],0.8430713103666025
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUSP3,Dual specificity protein phosphatase 3,13156,97,0.95 [0.76-1.18],0.6317236599532683
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",11626,86,0.92 [0.75-1.13],0.4377984727789262
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DXO,Decapping and exoribonuclease protein,11656,85,0.90 [0.57-1.42],0.6562276361908848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,11611,85,0.60 [0.34-1.05],0.0734527037445247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DYNLT1,Dynein light chain Tctex-type 1,11351,84,1.02 [0.79-1.31],0.8880855843009196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DYNLT3,Dynein light chain Tctex-type 3,11611,85,0.98 [0.61-1.56],0.9170457315826562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,13411,102,0.90 [0.75-1.09],0.2724105633101901
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EBI3_IL27,Interleukin-27,13599,100,0.69 [0.38-1.25],0.2226076534229063
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECE1,Endothelin-converting enzyme 1,13156,97,0.77 [0.46-1.29],0.3244537379311965
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",11692,85,1.02 [0.77-1.34],0.8905794790476089
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECHS1,"Enoyl-CoA hydratase, mitochondrial",11368,85,0.95 [0.76-1.17],0.6151573886053113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECI2,Enoyl-CoA delta isomerase 2,11332,84,0.70 [0.48-1.03],0.0689304607215425
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECM1,Extracellular matrix protein 1,11359,86,1.18 [0.66-2.12],0.5801733812304467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECSCR,Endothelial cell-specific chemotaxis regulator,11347,80,0.99 [0.65-1.50],0.9471531729524127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDA2R,Tumor necrosis factor receptor superfamily member 27,13620,100,0.76 [0.43-1.32],0.3304367785333789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDAR,Tumor necrosis factor receptor superfamily member EDAR,13483,101,0.86 [0.71-1.04],0.1179482493512744
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDDM3B,Epididymal secretory protein E3-beta,11611,85,1.12 [0.70-1.80],0.6293471660454155
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,11332,84,0.64 [0.32-1.25],0.1897413856554533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDF1,Endothelial differentiation-related factor 1,11674,86,0.80 [0.57-1.12],0.1889974960471712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,13267,101,1.29 [0.79-2.11],0.3178790432815541
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDN1,Endothelin-1,11368,85,0.69 [0.33-1.43],0.3168622066327291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDNRB,Endothelin receptor type B,11358,82,0.66 [0.37-1.18],0.162742454978051
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EEF1D,Elongation factor 1-delta,11692,85,0.82 [0.65-1.03],0.0867706643519869
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFCAB14,EF-hand calcium-binding domain-containing protein 14,11626,86,0.80 [0.36-1.79],0.584518089803071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFCAB2,Dynein regulatory complex protein 8,11438,86,0.91 [0.50-1.66],0.7602423826188691
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,13477,100,0.66 [0.37-1.19],0.1660753279122812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFHD1,EF-hand domain-containing protein D1,11674,86,0.52 [0.26-1.01],0.0529479799347486
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFNA1,Ephrin-A1,13473,100,0.68 [0.34-1.38],0.2906543312418335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFNA4,Ephrin-A4,13390,102,0.55 [0.28-1.09],0.0863813962488803
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFNB2,Ephrin-B2,11351,84,1.01 [0.72-1.41],0.9647693776756912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGF,Pro-epidermal growth factor,13467,104,0.89 [0.76-1.05],0.1597325233597695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGFL7,Epidermal growth factor-like protein 7,13187,100,0.61 [0.38-0.97],0.036499252861141
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGFLAM,Pikachurin,11626,86,0.78 [0.39-1.57],0.4828810959121459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGFR,Epidermal growth factor receptor,13658,103,1.17 [0.40-3.44],0.7765462103172505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGLN1,Egl nine homolog 1,13483,101,0.84 [0.58-1.21],0.3509999527354027
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EHBP1,EH domain-binding protein 1,11692,85,0.75 [0.56-1.01],0.0549025575342903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EHD3,EH domain-containing protein 3,11368,85,0.93 [0.78-1.11],0.444113444745262
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",11656,85,0.88 [0.59-1.33],0.5485537229097706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",11596,85,0.91 [0.75-1.10],0.3353702785518633
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,11332,84,0.72 [0.51-1.02],0.0680726733688853
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,11368,85,0.73 [0.42-1.27],0.2656669595903146
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4B,Eukaryotic translation initiation factor 4B,13411,102,0.83 [0.62-1.11],0.2048505457676326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4E,Eukaryotic translation initiation factor 4E,11358,82,0.91 [0.72-1.15],0.4225080845221161
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,13500,104,0.94 [0.72-1.22],0.6424169827694592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,13652,101,0.89 [0.75-1.06],0.2006935155033956
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,11674,86,0.85 [0.62-1.18],0.3323670188785303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF5,Eukaryotic translation initiation factor 5,11332,84,0.74 [0.44-1.25],0.264915594231875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF5A,Eukaryotic translation initiation factor 5A-1,13235,101,0.87 [0.47-1.59],0.6413456079235226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELAC1,Zinc phosphodiesterase ELAC protein 1,11674,86,0.85 [0.67-1.08],0.1849222709669323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELAVL4,ELAV-like protein 4,11347,80,1.01 [0.80-1.29],0.9062746670331818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELN,Elastin,11692,85,0.52 [0.28-0.96],0.0382506034514213
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELOA,Elongin-A,13429,102,0.78 [0.53-1.14],0.1923882814181885
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELOB,Elongin-B,11332,84,0.71 [0.39-1.28],0.2553244832171776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENAH,Protein enabled homolog,13235,101,1.02 [0.71-1.47],0.919103447081728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENDOU,Poly(U)-specific endoribonuclease,10814,80,1.37 [0.93-2.04],0.1134281263563234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENG,Endoglin,13658,103,0.79 [0.28-2.22],0.6567528988756507
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENO1,Alpha-enolase,13474,102,0.94 [0.75-1.16],0.5512996097406873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENO2,Gamma-enolase,13626,102,0.81 [0.62-1.06],0.1202231717076061
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENO3,Beta-enolase,11368,85,1.06 [0.74-1.51],0.7629879926651365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENOPH1,Enolase-phosphatase E1,11611,85,0.82 [0.54-1.24],0.3451162031663127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,11332,84,0.98 [0.47-2.06],0.9624738045468264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPEP,Glutamyl aminopeptidase,11332,84,0.77 [0.43-1.37],0.3725983558175141
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,13658,103,0.44 [0.23-0.83],0.0108528334375437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,13555,104,1.03 [0.68-1.56],0.8834767826672468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,11368,85,1.39 [0.79-2.46],0.2543585602291175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,13104,99,1.10 [0.90-1.35],0.3383023459362727
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENSA,Alpha-endosulfine,11611,85,0.69 [0.45-1.07],0.0980609138234019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,13187,100,0.91 [0.60-1.38],0.6507019801070355
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,13267,101,0.78 [0.34-1.80],0.5630396022861247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,13267,101,0.82 [0.44-1.52],0.5267433239455429
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTR1,Endosome-associated-trafficking regulator 1,11368,85,1.06 [0.75-1.51],0.7373530546357612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EP300,Histone acetyltransferase p300,11358,82,0.65 [0.31-1.36],0.2502602504366669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPB41L5,Band 4.1-like protein 5,11351,84,0.97 [0.70-1.35],0.8508276687600653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPCAM,Epithelial cell adhesion molecule,13496,104,0.84 [0.70-1.00],0.0512192084980578
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPGN,Epigen,11611,85,0.85 [0.53-1.39],0.5259462938681831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA1,Ephrin type-A receptor 1,13527,104,0.87 [0.53-1.44],0.5864338023422886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA10,Ephrin type-A receptor 10,13156,97,0.96 [0.71-1.28],0.7587208254398767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA2,Ephrin type-A receptor 2,13012,96,0.46 [0.24-0.90],0.0231264451880724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA4,Ephrin type-A receptor 4,11422,85,0.57 [0.27-1.19],0.1357491193647315
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHB4,Ephrin type-B receptor 4,13658,103,0.59 [0.28-1.28],0.1840358776166719
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHB6,Ephrin type-B receptor 6,13382,102,0.51 [0.29-0.92],0.0255963913095549
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHX2,Bifunctional epoxide hydrolase 2,13267,101,1.00 [0.76-1.33],0.976437323993855
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPN1,Epsin-1,11438,86,0.91 [0.55-1.52],0.7249875288782376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPO,Erythropoietin,13483,101,0.84 [0.66-1.07],0.1576891931691762
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPPK1,Epiplakin,11368,85,0.88 [0.66-1.17],0.3647563427212839
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,13601,100,0.82 [0.45-1.51],0.5325080707979492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBB2,Receptor tyrosine-protein kinase erbB-2,13527,102,0.85 [0.42-1.75],0.6661105373350438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBB3,Receptor tyrosine-protein kinase erbB-3,13439,101,1.32 [0.52-3.35],0.5529028403105928
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBB4,Receptor tyrosine-protein kinase erbB-4,13527,102,1.38 [0.66-2.88],0.3928469727923872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBIN,Erbin,13429,102,0.86 [0.73-1.02],0.0820899483339436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERC2,ERC protein 2,11351,84,0.75 [0.53-1.06],0.1028902592747538
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERCC1,DNA excision repair protein ERCC-1,11269,84,0.83 [0.42-1.66],0.6025715748118351
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EREG,Proepiregulin,13382,102,0.95 [0.76-1.19],0.6727769303989279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERI1,3'-5' exoribonuclease 1,11438,86,0.70 [0.36-1.34],0.2791182576816007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERMAP,Erythroid membrane-associated protein,11358,82,0.59 [0.37-0.94],0.0268162817779841
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,11611,85,0.87 [0.50-1.51],0.6242468134240586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERP29,Endoplasmic reticulum resident protein 29,11422,85,0.91 [0.76-1.09],0.2955062970169092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERP44,Endoplasmic reticulum resident protein 44,13410,101,0.80 [0.40-1.59],0.5217801135945328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,11332,84,0.91 [0.58-1.44],0.6893323471765384
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESAM,Endothelial cell-selective adhesion molecule,13658,103,0.46 [0.26-0.83],0.0100134781094769
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESM1,Endothelial cell-specific molecule 1,13493,104,0.63 [0.37-1.05],0.0782672917943986
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESPL1,Separin,11269,84,0.87 [0.58-1.32],0.5191551102089854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESR1,Estrogen receptor,11358,82,0.84 [0.56-1.26],0.3909317096994615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESYT2,Extended synaptotagmin-2,11656,85,0.79 [0.61-1.03],0.0872638711854083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EVI2B,Protein EVI2B,11269,84,0.99 [0.60-1.64],0.9666907620683732
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EVI5,Ecotropic viral integration site 5 protein homolog,11358,82,0.84 [0.66-1.07],0.1640103323044367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EVPL,Envoplakin,11438,86,0.92 [0.47-1.78],0.7983723232445539
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EXOSC10,Exosome component 10,11332,84,0.63 [0.39-1.01],0.0573485274590389
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EXTL1,Exostosin-like 1,11332,84,0.49 [0.27-0.87],0.0147615354396746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EZR,Ezrin,13626,102,0.62 [0.29-1.32],0.2152556705492408
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F10,Coagulation factor X,11690,85,1.19 [0.59-2.40],0.6334754870411308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F11,Coagulation factor XI,11533,86,1.23 [0.76-2.01],0.3963933158777628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F11R,Junctional adhesion molecule A,13496,100,0.83 [0.61-1.14],0.255251205715046
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F12,Coagulation factor XII,11702,87,1.21 [0.74-1.97],0.4544609364581425
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F13B,Coagulation factor XIII B chain,11636,87,1.45 [0.65-3.23],0.3601757852859258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F2,Prothrombin,11702,87,1.21 [0.30-4.84],0.7839560145270292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F2R,Proteinase-activated receptor 1,13534,104,0.83 [0.62-1.12],0.2179462041294624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F3,Tissue factor,13534,99,0.47 [0.24-0.90],0.023118397104256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F7,Coagulation factor VII,13486,101,0.82 [0.46-1.48],0.5101865844375763
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F9,Coagulation factor IX,13489,102,1.98 [0.76-5.16],0.1626660318331407
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP1,"Fatty acid-binding protein, liver",13493,104,0.88 [0.72-1.06],0.1842036026056237
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP2,"Fatty acid-binding protein, intestinal",13500,104,0.98 [0.78-1.23],0.8543594175673934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP3,"Fatty acid-binding protein, heart",11692,85,0.72 [0.46-1.13],0.1513966124657957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP4,"Fatty acid-binding protein, adipocyte",13658,103,0.64 [0.44-0.93],0.0207695177545095
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP5,Fatty acid-binding protein 5,13590,102,0.76 [0.59-0.98],0.0359087295654378
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP6,Gastrotropin,13250,101,1.05 [0.76-1.45],0.7903913264830267
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP9,Fatty acid-binding protein 9,13483,101,0.92 [0.67-1.26],0.6034275087192308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FADD,FAS-associated death domain protein,13500,104,0.82 [0.66-1.04],0.0975120569413963
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM13A,Protein FAM13A,11626,86,0.81 [0.59-1.10],0.1782387688355974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM171A2,Protein FAM171A2,11674,86,1.00 [0.88-1.13],0.959632213873462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM171B,Protein FAM171B,11611,85,1.29 [0.68-2.45],0.4302981112676582
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM172A,Cotranscriptional regulator FAM172A,11368,85,0.93 [0.67-1.30],0.6670135187766763
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM20A,Pseudokinase FAM20A,11692,85,0.96 [0.47-1.98],0.9134844101841209
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM3B,Protein FAM3B,13429,102,0.58 [0.37-0.89],0.0126896601533462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM3C,Protein FAM3C,13482,104,0.51 [0.28-0.93],0.0288553069025627
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM3D,Protein FAM3D,11626,86,1.14 [0.89-1.46],0.2844680454317801
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAP,Prolyl endopeptidase FAP,13658,103,0.98 [0.51-1.86],0.9409659144563935
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FARSA,Phenylalanine--tRNA ligase alpha subunit,11351,84,0.74 [0.52-1.06],0.100888504072572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAS,Tumor necrosis factor receptor superfamily member 6,13607,100,0.88 [0.49-1.60],0.6794089421601571
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FASLG,Tumor necrosis factor ligand superfamily member 6,13652,101,0.50 [0.32-0.78],0.0020524513731858
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FBLN2,Fibulin-2,11671,86,0.71 [0.36-1.39],0.316795545071338
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FBN2,Fibrillin-2,11351,84,0.82 [0.58-1.15],0.2489331089588949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FBP1,"Fructose-1,6-bisphosphatase 1",13500,104,0.97 [0.76-1.23],0.7949567280757661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,11692,85,0.90 [0.67-1.22],0.5050305494254055
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCAR,Immunoglobulin alpha Fc receptor,13483,101,0.96 [0.66-1.41],0.8521737346411072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,11674,86,0.86 [0.37-2.01],0.7268860933778791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCER2,Low affinity immunoglobulin epsilon Fc receptor,13496,100,0.78 [0.53-1.15],0.2107929832801085
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,13401,99,0.91 [0.70-1.20],0.5195154558935795
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,13187,100,0.95 [0.70-1.30],0.7500506094735854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,13462,101,1.18 [0.82-1.69],0.3668233265074336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCN1,Ficolin-1,11669,85,0.84 [0.61-1.17],0.3091401570216443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCN2,Ficolin-2,13401,101,1.75 [1.09-2.79],0.0197141487252202
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL1,Fc receptor-like protein 1,13500,104,0.79 [0.53-1.18],0.2562743856669019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL2,Fc receptor-like protein 2,13589,101,0.74 [0.50-1.10],0.1406908934210889
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL3,Fc receptor-like protein 3,13235,101,0.70 [0.50-0.98],0.0364928414414359
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL5,Fc receptor-like protein 5,13496,100,0.96 [0.69-1.32],0.7817349637816771
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL6,Fc receptor-like protein 6,13483,101,1.15 [0.88-1.51],0.30521209542808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRLB,Fc receptor-like B,13187,100,1.05 [0.78-1.42],0.7569920929138426
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FDX1,"Adrenodoxin, mitochondrial",11332,84,0.80 [0.54-1.17],0.2440168760940081
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FDX2,"Ferredoxin-2, mitochondrial",11332,84,0.85 [0.57-1.27],0.4344121305089609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FEN1,Flap endonuclease 1,13187,100,0.86 [0.63-1.18],0.3590386159722505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FES,Tyrosine-protein kinase Fes/Fps,13187,100,0.97 [0.66-1.42],0.8808608408032991
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FETUB,Fetuin-B,13489,102,0.73 [0.48-1.12],0.1511471805866497
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGA,Fibrinogen alpha chain,11421,85,1.31 [0.67-2.56],0.4287582719948491
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",11674,86,0.81 [0.62-1.05],0.1117200343623209
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF12,Fibroblast growth factor 12,11358,82,0.63 [0.32-1.25],0.1842994610494389
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF16,Fibroblast growth factor 16,11358,82,1.01 [0.65-1.55],0.9801508785178672
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF19,Fibroblast growth factor 19,13555,104,1.07 [0.85-1.34],0.5637358641476996
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF2,Fibroblast growth factor 2,13483,101,0.87 [0.66-1.14],0.3062603059929993
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF20,Fibroblast growth factor 20,11358,82,0.77 [0.44-1.35],0.3632454663255088
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF21,Fibroblast growth factor 21,13599,100,1.00 [0.86-1.16],0.988223414244554
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF23,Fibroblast growth factor 23,13601,100,0.54 [0.37-0.81],0.0023077885638669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF3,Fibroblast growth factor 3,11358,82,1.38 [0.82-2.30],0.2234794326980343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF5,Fibroblast growth factor 5,13235,101,0.58 [0.33-1.01],0.0550328522314259
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF6,Fibroblast growth factor 6,11358,82,1.39 [1.06-1.83],0.0173701130553388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF7,Fibroblast growth factor 7,11269,84,0.77 [0.55-1.07],0.1182621780146765
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF9,Fibroblast growth factor 9,11246,84,1.03 [0.61-1.73],0.9158904453397226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFBP1,Fibroblast growth factor-binding protein 1,13527,102,0.95 [0.54-1.66],0.857826863870115
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFBP2,Fibroblast growth factor-binding protein 2,11671,86,0.98 [0.65-1.47],0.920478296479341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFBP3,Fibroblast growth factor-binding protein 3,11656,85,0.68 [0.39-1.20],0.1829361108377342
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFR2,Fibroblast growth factor receptor 2,13527,102,1.18 [0.51-2.73],0.702986635039219
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFR4,Fibroblast growth factor receptor 4,11422,85,1.05 [0.72-1.53],0.8069968142496577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGL1,Fibrinogen-like protein 1,11690,85,0.87 [0.63-1.21],0.4211766829654338
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGR,Tyrosine-protein kinase Fgr,13156,97,1.04 [0.77-1.41],0.7738969858243507
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FH,"Fumarate hydratase, mitochondrial",11347,80,0.95 [0.73-1.24],0.7135751639113066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FHIP2A,FHF complex subunit HOOK interacting protein 2A,11332,84,1.19 [0.83-1.70],0.3427361800656545
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FHIT,Bis(5'-adenosyl)-triphosphatase,13156,97,0.86 [0.68-1.08],0.1975147968036784
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FIS1,Mitochondrial fission 1 protein,13476,101,0.82 [0.65-1.03],0.0939686366395555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,11674,86,0.91 [0.74-1.12],0.3746209757051028
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,13541,100,0.91 [0.78-1.07],0.2703782455839877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,13411,102,0.78 [0.53-1.14],0.1982257298811072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,13411,102,0.92 [0.77-1.10],0.3698913011334194
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,13127,97,0.86 [0.56-1.30],0.4712993555426854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBPL,FK506-binding protein-like,11626,86,0.97 [0.68-1.37],0.8480519452318003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLI1,Friend leukemia integration 1 transcription factor,13187,100,0.88 [0.74-1.04],0.1442391470465667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,13411,102,0.48 [0.26-0.91],0.0231715437614957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT1,Vascular endothelial growth factor receptor 1,13401,102,0.44 [0.18-1.07],0.0711494044223056
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT3,Receptor-type tyrosine-protein kinase FLT3,13187,100,0.60 [0.32-1.13],0.1130543529281635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT3LG,Fms-related tyrosine kinase 3 ligand,13652,101,0.91 [0.53-1.57],0.7297085510315804
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT4,Vascular endothelial growth factor receptor 3,13527,102,1.56 [0.92-2.66],0.1004171965975219
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FMNL1,Formin-like protein 1,13156,97,0.97 [0.72-1.30],0.822138345931902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FMR1,Synaptic functional regulator FMR1,13187,100,0.81 [0.49-1.35],0.4226007682326211
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FN1,Fibronectin,11702,87,2.32 [1.11-4.85],0.0249491274145932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FNDC1,Fibronectin type III domain-containing protein 1,11656,85,0.82 [0.52-1.28],0.3756605478050028
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,11611,85,0.95 [0.53-1.70],0.8568084332293362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLH1,Glutamate carboxypeptidase 2,11358,82,0.95 [0.78-1.16],0.6244996814156345
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLR1,Folate receptor alpha,13457,102,0.73 [0.38-1.41],0.3514340189092904
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLR2,Folate receptor beta,13626,102,0.76 [0.42-1.40],0.3843693419176583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLR3,Folate receptor gamma,13483,102,0.98 [0.89-1.07],0.6146861274860056
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOS,Proto-oncogene c-Fos,11246,84,0.84 [0.46-1.53],0.5693471647460846
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOSB,Protein fosB,13156,97,1.19 [0.82-1.73],0.3602809699867493
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOXJ3,Forkhead box protein J3,11358,82,0.69 [0.41-1.18],0.1783576974160185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOXO1,Forkhead box protein O1,13483,101,0.94 [0.77-1.16],0.5774420999419114
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOXO3,Forkhead box protein O3,13187,100,0.85 [0.70-1.03],0.1029251148893445
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FRMD4B,FERM domain-containing protein 4B,11332,84,0.71 [0.51-0.98],0.0387649896241037
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FRMD7,FERM domain-containing protein 7,11351,84,0.72 [0.38-1.35],0.303798428126515
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FRZB,Secreted frizzled-related protein 3,13366,102,0.92 [0.49-1.72],0.7942936069242517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FSHB,Follitropin subunit beta,11368,85,0.78 [0.58-1.04],0.0933371113410482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FST,Follistatin,13534,104,1.00 [0.72-1.39],0.996148632576046
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FSTL1,Follistatin-related protein 1,11368,85,0.57 [0.23-1.44],0.2360778393568227
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FSTL3,Follistatin-related protein 3,13472,104,0.49 [0.27-0.92],0.0263122615381308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FTCD,Formimidoyltransferase-cyclodeaminase,11642,85,0.98 [0.76-1.27],0.8906939504945343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUCA1,Tissue alpha-L-fucosidase,13572,103,0.92 [0.75-1.13],0.4319910614059412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUOM,Fucose mutarotase,11422,85,1.08 [0.78-1.51],0.6457540014502801
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FURIN,Furin,13527,102,0.68 [0.40-1.14],0.1419588886390578
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUS,RNA-binding protein FUS,13168,100,0.87 [0.55-1.37],0.5397776701118232
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",11416,86,0.87 [0.61-1.23],0.4268921075114723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,13626,102,1.09 [0.74-1.62],0.6495659104889886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUT8,"Alpha-(1,6)-fucosyltransferase",13411,102,0.95 [0.71-1.29],0.7558692079191963
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FXN,"Frataxin, mitochondrial",13620,100,0.86 [0.68-1.09],0.2134065434327889
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FXYD5,FXYD domain-containing ion transport regulator 5,13235,101,0.95 [0.72-1.25],0.702687881057444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FYB1,FYN-binding protein 1,13475,100,0.92 [0.76-1.12],0.4221986151222635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FZD10,Frizzled-10,11351,84,0.65 [0.41-1.04],0.0739522348536883
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FZD8,Frizzled-8,11347,80,0.82 [0.47-1.42],0.4682402978571041
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GABARAP,Gamma-aminobutyric acid receptor-associated protein,11611,85,0.53 [0.32-0.88],0.0134331059271283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,11438,86,1.12 [0.86-1.47],0.4026319947762335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,11347,80,0.60 [0.38-0.94],0.0267773891971627
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAD1,Glutamate decarboxylase 1,11269,84,0.74 [0.33-1.67],0.4732782850676137
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAD2,Glutamate decarboxylase 2,11358,82,1.07 [0.71-1.60],0.7587402900246847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,11438,86,1.18 [0.85-1.63],0.3244808794830158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,11368,85,0.96 [0.65-1.42],0.8300645738584231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAGE2A,G antigen 2A,11269,84,0.97 [0.69-1.37],0.8584957950448501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAL,Galanin peptides,13555,104,1.08 [0.82-1.42],0.5723274082344294
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,13429,102,0.59 [0.32-1.11],0.0999616615062314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,13620,100,0.43 [0.21-0.86],0.0165410281765615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,13235,101,0.85 [0.56-1.31],0.4651867120537328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,11692,85,0.71 [0.32-1.55],0.3893596161475227
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT7,N-acetylgalactosaminyltransferase 7,13429,102,0.59 [0.26-1.33],0.2021108506486695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAMT,Guanidinoacetate N-methyltransferase,11332,84,1.09 [0.65-1.82],0.7397789381979901
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,11170,84,1.00 [0.54-1.83],0.990345324295714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GART,Trifunctional purine biosynthetic protein adenosine-3,11674,86,0.65 [0.27-1.55],0.3297764377696563
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAS2,Growth arrest-specific protein 2,11438,86,0.90 [0.59-1.38],0.6349757311517721
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAS6,Growth arrest-specific protein 6,13558,100,0.85 [0.43-1.68],0.6364635350581418
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GASK1A,Golgi-associated kinase 1A,11332,84,0.86 [0.52-1.40],0.5392645665939837
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAST,Gastrin,11656,85,1.09 [0.93-1.28],0.2913988734942081
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,11269,84,0.94 [0.42-2.07],0.8745622990132367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",11368,85,1.00 [0.76-1.30],0.9713426997364716
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBA,Lysosomal acid glucosylceramidase,11351,84,1.07 [0.74-1.55],0.7093566432835301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP1,Guanylate-binding protein 1,11633,85,1.05 [0.76-1.45],0.7570677894009552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP2,Guanylate-binding protein 2,13235,101,0.85 [0.63-1.15],0.3004015938960304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP4,Guanylate-binding protein 4,13156,97,1.00 [0.70-1.45],0.9804336519907384
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP6,Guanylate-binding protein 6,11332,84,0.66 [0.37-1.18],0.1591245675752432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GC,Vitamin D-binding protein,11702,87,1.32 [0.62-2.83],0.472463097095792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCC1,GRIP and coiled-coil domain-containing protein 1,11656,85,0.89 [0.74-1.08],0.2266124713652297
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCG,Pro-glucagon,13187,100,0.88 [0.76-1.02],0.0862272178877172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,11132,84,0.93 [0.61-1.44],0.7560944113685991
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCLM,Glutamate--cysteine ligase regulatory subunit,11332,84,0.86 [0.53-1.40],0.549559683265062
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",13429,102,1.20 [0.73-1.99],0.465994046210756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GDF15,Growth/differentiation factor 15,13658,103,1.00 [0.63-1.57],0.985081997702102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GDF2,Growth/differentiation factor 2,13500,104,0.76 [0.46-1.24],0.2714774248313609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GDNF,Glial cell line-derived neurotrophic factor,13156,97,0.58 [0.35-0.96],0.0322934289993839
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GET3,ATPase GET3,11692,85,0.79 [0.52-1.18],0.2476428472734291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFAP,Glial fibrillary acidic protein,13171,100,0.74 [0.49-1.12],0.1514700249216207
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFER,FAD-linked sulfhydryl oxidase ALR,13187,100,0.86 [0.64-1.14],0.2874439199622816
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,13187,100,0.99 [0.86-1.14],0.9220445877989614
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRA1,GDNF family receptor alpha-1,13599,100,0.41 [0.21-0.80],0.0090843304680894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRA2,GDNF family receptor alpha-2,13429,102,0.56 [0.25-1.24],0.1543019825806018
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRA3,GDNF family receptor alpha-3,13369,101,0.75 [0.40-1.42],0.3808254328208541
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRAL,GDNF family receptor alpha-like,11305,81,0.96 [0.67-1.36],0.8130517387281906
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGA1,ADP-ribosylation factor-binding protein GGA1,13156,97,1.10 [0.88-1.38],0.3905161561410794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGACT,Gamma-glutamylaminecyclotransferase,11692,85,0.82 [0.61-1.10],0.1912048327004437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGCT,Gamma-glutamylcyclotransferase,11671,85,0.86 [0.56-1.33],0.5026937056365381
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGH,Gamma-glutamyl hydrolase,13215,96,0.95 [0.56-1.61],0.838232836649066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGT1,Glutathione hydrolase 1 proenzyme,13473,100,1.13 [0.78-1.63],0.5240540830904662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGT5,Glutathione hydrolase 5 proenzyme,13411,102,0.84 [0.39-1.82],0.6626989951935334
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GH1,Somatotropin,13482,104,0.99 [0.90-1.09],0.85970262586281
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GH2,Growth hormone variant,13187,100,1.01 [0.92-1.12],0.8018545662216573
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GHR,Growth hormone receptor,11422,85,0.74 [0.36-1.50],0.402575222843255
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GHRHR,Growth hormone-releasing hormone receptor,13156,97,0.97 [0.71-1.33],0.848870279934588
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GHRL,Appetite-regulating hormone,13500,104,1.11 [0.88-1.40],0.376726715110158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GID8,Glucose-induced degradation protein 8 homolog,11674,86,0.96 [0.52-1.80],0.9105126037522984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIGYF2,GRB10-interacting GYF protein 2,11674,86,0.79 [0.60-1.04],0.0897109936184475
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIMAP7,GTPase IMAP family member 7,11422,85,0.99 [0.52-1.88],0.9684374445777914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIMAP8,GTPase IMAP family member 8,11269,84,0.63 [0.39-1.02],0.0619222206351343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIP,Gastric inhibitory polypeptide,11368,85,0.90 [0.56-1.45],0.6732343046049767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIPC2,PDZ domain-containing protein GIPC2,11656,85,0.64 [0.30-1.35],0.2379529547957763
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIPC3,PDZ domain-containing protein GIPC3,11626,86,0.94 [0.77-1.16],0.5765674472679616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIPR,Gastric inhibitory polypeptide receptor,11358,82,0.56 [0.31-0.99],0.0468255475940898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIT1,ARF GTPase-activating protein GIT1,11358,82,0.90 [0.72-1.13],0.3749181408581298
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GJA8,Gap junction alpha-8 protein,11269,84,0.94 [0.65-1.35],0.7325950456249086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GKN1,Gastrokine-1,12899,96,1.27 [0.67-2.40],0.4614076146592557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLA,Alpha-galactosidase A,11393,85,1.08 [0.61-1.90],0.7886748378984263
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLB1,Beta-galactosidase,13411,102,0.91 [0.59-1.40],0.6750427236867524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLI2,Zinc finger protein GLI2,11358,82,0.57 [0.27-1.20],0.1385144671527267
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLO1,Lactoylglutathione lyase,13267,101,0.90 [0.67-1.21],0.4811935459176077
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLOD4,Glyoxalase domain-containing protein 4,13455,101,0.76 [0.47-1.21],0.2473762195617584
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLP1R,Glucagon-like peptide 1 receptor,11347,80,0.50 [0.25-1.02],0.0569434937824456
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLRX,Glutaredoxin-1,13423,104,0.99 [0.74-1.34],0.9636859481173432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",11422,85,0.90 [0.71-1.14],0.3815523079460404
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,13156,97,1.05 [0.74-1.48],0.7989771680754642
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLYR1,Putative oxidoreductase GLYR1,11611,85,0.84 [0.58-1.22],0.3616386080840016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GM2A,Ganglioside GM2 activator,11407,86,0.64 [0.33-1.22],0.1740444499680551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GMFG,Glia maturation factor gamma,11692,85,0.84 [0.63-1.12],0.235181847018935
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GMPR,GMP reductase 1,13652,101,0.81 [0.59-1.13],0.2146322694857194
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GMPR2,GMP reductase 2,11422,85,0.85 [0.62-1.16],0.3055038004095937
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNAS,Neuroendocrine secretory protein 55,11674,86,0.95 [0.75-1.19],0.640848163503807
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,13187,100,0.89 [0.67-1.17],0.4042239301700402
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,11351,84,0.85 [0.54-1.34],0.4948797485098756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNLY,Granulysin,13496,100,1.30 [0.92-1.85],0.1401107969846383
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNPDA1,Glucosamine-6-phosphate isomerase 1,11368,85,0.57 [0.26-1.24],0.1553646318673759
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNPDA2,Glucosamine-6-phosphate isomerase 2,11422,85,0.77 [0.43-1.38],0.3778758923201636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOLGA3,Golgin subfamily A member 3,11674,86,0.85 [0.65-1.13],0.2655433400553882
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOLM2,Protein GOLM2,13626,102,0.60 [0.27-1.33],0.2099187859517232
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,13483,101,0.92 [0.77-1.09],0.3164293584311727
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GORASP2,Golgi reassembly-stacking protein 2,11626,86,0.98 [0.63-1.51],0.9109768564188792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOT1,"Aspartate aminotransferase, cytoplasmic",11671,86,1.18 [0.72-1.92],0.5206872710236503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP1BA,Platelet glycoprotein Ib alpha chain,13406,99,0.92 [0.53-1.60],0.7611273555169684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP1BB,Platelet glycoprotein Ib beta chain,11332,84,0.88 [0.64-1.21],0.4284099430017318
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,13092,98,1.03 [0.83-1.27],0.7941284635424595
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP5,Platelet glycoprotein V,11422,85,0.80 [0.46-1.39],0.429911245198172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP6,Platelet glycoprotein VI,13475,100,0.93 [0.76-1.13],0.4392557081022088
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPA33,Cell surface A33 antigen,13429,102,0.90 [0.79-1.03],0.1281503350984404
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPC1,Glypican-1,13620,100,0.40 [0.22-0.72],0.0025305545422421
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPC5,Glypican-5,13411,102,0.72 [0.53-0.99],0.0426187247473047
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPD1,Glycerol-3-phosphate dehydrogenase,11611,85,0.69 [0.45-1.07],0.0978360981409029
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPHA2,Glycoprotein hormone alpha-2,11626,86,0.81 [0.50-1.32],0.3993706516180791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPI,Glucose-6-phosphate isomerase,11690,85,0.77 [0.49-1.21],0.2507098748694039
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,11626,86,0.94 [0.71-1.25],0.6840497419761811
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPKOW,G-patch domain and KOW motifs-containing protein,13156,97,0.83 [0.41-1.66],0.5947809200913741
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPNMB,Transmembrane glycoprotein NMB,13139,99,0.94 [0.50-1.77],0.845634962520913
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR101,Probable G-protein coupled receptor 101,11347,80,0.96 [0.68-1.36],0.8313172127982635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR158,Probable G-protein coupled receptor 158,11674,86,0.38 [0.18-0.80],0.0106691333522277
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR15L,Protein GPR15L,11626,86,0.98 [0.70-1.36],0.8885689074567653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR37,Prosaposin receptor GPR37,13267,101,0.75 [0.57-0.98],0.0363890477755806
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPRC5C,G-protein coupled receptor family C group 5 member C,11611,85,0.95 [0.65-1.39],0.7993933936899434
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRAP2,GRB2-related adapter protein 2,13500,104,0.91 [0.80-1.04],0.1639262091874222
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,11692,85,0.75 [0.55-1.03],0.0761595175737905
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRIK2,"Glutamate receptor ionotropic, kainate 2",11674,86,0.51 [0.27-0.97],0.0399714514599821
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",11347,80,0.54 [0.31-0.95],0.0321496474776617
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRK5,G protein-coupled receptor kinase 5,13267,101,0.91 [0.63-1.31],0.6222931876024447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRN,Progranulin,13433,100,0.87 [0.42-1.83],0.7198663230799465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRP,Gastrin-releasing peptide,11368,85,0.78 [0.53-1.15],0.2176758892185791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRPEL1,"GrpE protein homolog 1, mitochondrial",13429,102,1.05 [0.79-1.39],0.7579808338616838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRSF1,G-rich sequence factor 1,11209,83,0.83 [0.63-1.11],0.2103651384992038
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSAP,Gamma-secretase-activating protein,13187,100,1.12 [0.95-1.32],0.1803338470546009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSN,Gelsolin,11646,85,1.32 [0.41-4.19],0.6434146424978849
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSR,"Glutathione reductase, mitochondrial",11616,85,0.76 [0.29-2.04],0.5912903518134458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTA1,Glutathione S-transferase A1,13482,104,0.97 [0.78-1.19],0.7602609863240043
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTA3,Glutathione S-transferase A3,13187,100,1.04 [0.83-1.32],0.7132883242925898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTM4,Glutathione S-transferase Mu 4,11332,84,1.08 [0.82-1.42],0.5866227203591594
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTP1,Glutathione S-transferase P,13074,96,0.90 [0.69-1.18],0.4620683154907934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTT2B,Glutathione S-transferase theta-2B,11656,85,1.02 [0.93-1.11],0.7079159462207284
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,11438,86,1.05 [0.80-1.36],0.7367895485066535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GTPBP2,GTP-binding protein 2,11351,84,0.87 [0.66-1.13],0.2903843373090831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUCA2A,Guanylin,13432,100,0.71 [0.41-1.23],0.2220237210368443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUCY2C,Heat-stable enterotoxin receptor,11438,86,0.86 [0.65-1.13],0.2805936876484984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUK1,Guanylate kinase,11332,84,1.13 [0.74-1.74],0.5656272135585153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUSB,Beta-glucuronidase,13543,100,1.04 [0.77-1.42],0.7853252205364596
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GYS1,"Glycogen [starch] synthase, muscle",13267,101,0.88 [0.72-1.06],0.1825275546417586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GZMA,Granzyme A,13652,101,0.76 [0.45-1.27],0.2933234354635587
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GZMB,Granzyme B,13483,101,0.77 [0.57-1.04],0.0889973692364398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GZMH,Granzyme H,13267,101,1.06 [0.84-1.33],0.614357468538127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",H2AP,Huntingtin-interacting protein M,11269,84,0.84 [0.51-1.39],0.5015968823724022
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",11332,84,0.86 [0.60-1.25],0.4407137786903314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",13583,99,0.94 [0.74-1.19],0.5905618204747013
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAO1,Hydroxyacid oxidase 1,13620,100,1.08 [0.95-1.23],0.2316673788776548
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HARS1,"Histidine--tRNA ligase, cytoplasmic",13496,100,0.87 [0.70-1.09],0.2351408285803828
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAVCR1,Hepatitis A virus cellular receptor 1,13604,99,0.97 [0.71-1.32],0.8257316931378575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAVCR2,Hepatitis A virus cellular receptor 2,13496,100,0.75 [0.44-1.28],0.2915288036440859
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HBEGF,Proheparin-binding EGF-like growth factor,13583,99,0.78 [0.61-1.00],0.0458853492059674
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HBQ1,Hemoglobin subunit theta-1,13620,100,1.10 [0.84-1.45],0.485453922680705
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HBZ,Hemoglobin subunit zeta,11692,85,1.05 [0.87-1.27],0.6361500064695309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HCG22,Protein PBMUCL2,11332,84,0.90 [0.59-1.39],0.6455911006079607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HCLS1,Hematopoietic lineage cell-specific protein,13652,101,0.79 [0.58-1.06],0.1198580745900665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDAC8,Histone deacetylase 8,11358,82,0.96 [0.68-1.35],0.8119533282141116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDAC9,Histone deacetylase 9,11347,80,0.68 [0.43-1.07],0.0927042572394178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDDC2,5'-deoxynucleotidase HDDC2,11626,86,0.96 [0.60-1.53],0.8617414107238107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDGF,Hepatoma-derived growth factor,13604,100,0.86 [0.71-1.04],0.1151450524730368
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDGFL2,Hepatoma-derived growth factor-related protein 2,11656,85,0.87 [0.62-1.22],0.4140866921814174
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEBP1,Heme-binding protein 1,13267,101,1.07 [0.80-1.42],0.6548279827966014
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEG1,Protein HEG homolog 1,11422,85,0.92 [0.41-2.06],0.8467170369238093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEPACAM2,HEPACAM family member 2,11656,85,0.62 [0.38-1.03],0.0637768475400139
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEPH,Hephaestin,11692,85,0.81 [0.36-1.81],0.600848284442214
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEXIM1,Protein HEXIM1,13483,101,0.84 [0.67-1.04],0.1069707425962662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HGF,Hepatocyte growth factor,13652,101,0.66 [0.39-1.13],0.1313484442561031
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HGFAC,Hepatocyte growth factor activator,11579,85,0.68 [0.34-1.34],0.2610980030214705
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,13187,100,0.85 [0.67-1.08],0.188009111585831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HHEX,Hematopoietically-expressed homeobox protein HHEX,11656,85,0.79 [0.60-1.04],0.097640692169906
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HIF1A,Hypoxia-inducible factor 1-alpha,11358,82,1.09 [0.83-1.41],0.5430851919010787
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HIP1,Huntingtin-interacting protein 1,11332,84,0.74 [0.37-1.46],0.3797836921017175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HIP1R,Huntingtin-interacting protein 1-related protein,11640,85,0.63 [0.35-1.14],0.1275360292847058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HJV,Hemojuvelin,11674,86,0.69 [0.41-1.14],0.1460944644675698
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HK2,Hexokinase-2,13267,101,1.22 [0.67-2.22],0.5170391917304253
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",11674,86,0.38 [0.21-0.70],0.0019199058401891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",13441,101,1.10 [0.68-1.78],0.7075153419645561
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",13483,101,0.65 [0.33-1.27],0.2087581140843376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMBS,Porphobilinogen deaminase,13620,100,1.36 [0.93-1.98],0.1133398676917711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMCN2,Hemicentin-2,11399,85,1.37 [0.94-1.99],0.0992802019004549
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",11368,85,0.85 [0.55-1.31],0.4591478798473679
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",11332,84,0.79 [0.47-1.32],0.3686378187661093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMMR,Hyaluronan mediated motility receptor,11255,84,0.83 [0.51-1.35],0.445231503910107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMOX1,Heme oxygenase 1,13350,101,1.01 [0.69-1.49],0.9547167296750892
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMOX2,Heme oxygenase 2,13156,97,0.92 [0.62-1.39],0.7032341481251118
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNF1A,Hepatocyte nuclear factor 1-alpha,11351,84,0.96 [0.71-1.30],0.7824624671739692
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNMT,Histamine N-methyltransferase,13339,102,0.88 [0.59-1.31],0.5310942774698153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,13223,101,0.83 [0.65-1.06],0.1333817830171609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,11674,86,0.71 [0.44-1.15],0.1665256225507226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HPCAL1,Hippocalcin-like protein 1,13652,101,0.93 [0.74-1.17],0.5237266679684347
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HPGDS,Hematopoietic prostaglandin D synthase,13187,100,0.79 [0.48-1.29],0.3403777197137445
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HPSE,Heparanase,11504,86,0.91 [0.74-1.14],0.4220090339006387
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HRAS,GTPase Hras,11422,85,0.97 [0.77-1.21],0.757714804967257
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,11368,85,0.52 [0.26-1.03],0.060580409369524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HRG,Histidine-rich glycoprotein,11636,87,0.96 [0.51-1.81],0.8894018611711869
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS1BP3,HCLS1-binding protein 3,11368,85,0.92 [0.73-1.16],0.4628540064087973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,13429,102,0.99 [0.62-1.55],0.9484096550943578
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,13620,100,0.52 [0.31-0.88],0.0156291885493181
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,11358,82,0.67 [0.32-1.41],0.2971574853544997
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSBP1,Heat shock factor-binding protein 1,11368,85,0.91 [0.73-1.13],0.375926089858845
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,13483,101,1.04 [0.66-1.65],0.850484843569814
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,11656,85,1.03 [0.74-1.43],0.8694936148585631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSD17B3,Testosterone 17-beta-dehydrogenase 3,11332,84,0.67 [0.40-1.10],0.1116680376375015
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,11368,85,1.08 [0.70-1.66],0.7357024690229355
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSP90B1,Endoplasmin,13096,97,1.03 [0.81-1.32],0.7954476198881957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPA1A,Heat shock 70 kDa protein 1A,13527,104,0.82 [0.64-1.05],0.1138434518350567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPA2,Heat shock-related 70 kDa protein 2,11611,85,1.02 [0.55-1.90],0.9414546149856574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPB1,Heat shock protein beta-1,13267,100,0.77 [0.61-0.98],0.0316938978424527
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPB6,Heat shock protein beta-6,13620,100,0.61 [0.36-1.04],0.0670712502619735
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,13347,99,0.79 [0.37-1.69],0.5449740573324016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HTR1A,5-hydroxytryptamine receptor 1A,11347,80,0.69 [0.47-1.01],0.0542894653522179
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HTR1B,5-hydroxytryptamine receptor 1B,11347,80,0.61 [0.34-1.12],0.1087675098026671
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HTRA2,"Serine protease HTRA2, mitochondrial",13527,102,0.89 [0.67-1.18],0.416762937015609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HYAL1,Hyaluronidase-1,13370,102,1.11 [0.52-2.36],0.78829793948181
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HYOU1,Hypoxia up-regulated protein 1,13658,103,0.94 [0.41-2.13],0.8791916994712017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICA1,Islet cell autoantigen 1,13235,101,0.88 [0.70-1.11],0.2732864889191631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM1,Intercellular adhesion molecule 1,13407,98,1.23 [0.65-2.31],0.5257002067282481
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM2,Intercellular adhesion molecule 2,13658,103,0.90 [0.51-1.59],0.7214893711553475
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM3,Intercellular adhesion molecule 3,13658,103,1.02 [0.50-2.06],0.9617738556793958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM4,Intercellular adhesion molecule 4,13483,101,0.90 [0.65-1.25],0.520648761530367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM5,Intercellular adhesion molecule 5,13500,104,0.65 [0.45-0.96],0.0281810444001982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICOSLG,ICOS ligand,13429,102,0.90 [0.36-2.25],0.8259838066929799
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ID4,DNA-binding protein inhibitor ID-4,11438,86,0.87 [0.53-1.42],0.5679070413526346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDI2,Isopentenyl-diphosphate delta-isomerase 2,13156,97,1.08 [0.74-1.58],0.6901289017554704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDO1,"Indoleamine 2,3-dioxygenase 1",11368,85,0.75 [0.53-1.06],0.1000131154322144
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDS,Iduronate 2-sulfatase,13652,101,0.89 [0.12-6.63],0.9098689141724796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDUA,Alpha-L-iduronidase,13620,100,0.81 [0.55-1.17],0.2560700117557501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,11353,83,0.90 [0.51-1.59],0.7259166020252852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,11438,86,0.78 [0.51-1.20],0.2626728532927467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,11438,86,1.13 [0.65-1.94],0.6694659634869323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNAR1,Interferon alpha/beta receptor 1,11626,86,0.81 [0.36-1.84],0.6206995273750452
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNG,Interferon gamma,13235,101,0.93 [0.81-1.08],0.3650462990176158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNGR1,Interferon gamma receptor 1,13555,104,0.49 [0.20-1.19],0.1150625131641455
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNGR2,Interferon gamma receptor 2,13411,102,0.93 [0.66-1.30],0.6575107535166897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNL1,Interferon lambda-1,13156,97,1.12 [0.75-1.66],0.5840151983292798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNL2,Interferon lambda-2,11347,80,0.57 [0.35-0.95],0.0300904983873143
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNLR1,Interferon lambda receptor 1,13483,101,0.86 [0.52-1.41],0.5491946213156338
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNW1,Interferon omega-1,11332,84,0.78 [0.40-1.50],0.4539300326516616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFT20,Intraflagellar transport protein 20 homolog,11351,84,0.66 [0.39-1.12],0.1208258461723732
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGBP1,Immunoglobulin-binding protein 1,11674,86,0.79 [0.56-1.11],0.1793444636453035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,11347,80,0.64 [0.35-1.16],0.1426099219885604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,11671,86,1.13 [0.50-2.54],0.7733136092980447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGF1R,Insulin-like growth factor 1 receptor,13429,102,0.40 [0.21-0.76],0.0046993644293941
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,11332,84,0.68 [0.39-1.18],0.1733888745717982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGF2R,Cation-independent mannose-6-phosphate receptor,13496,100,0.72 [0.34-1.55],0.4060357022015924
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP1,Insulin-like growth factor-binding protein 1,13633,102,1.00 [0.87-1.17],0.9562654775887472
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP2,Insulin-like growth factor-binding protein 2,13630,103,0.87 [0.66-1.14],0.3152027332868947
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP3,Insulin-like growth factor-binding protein 3,13507,102,1.60 [0.80-3.21],0.1844544640276547
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP4,Insulin-like growth factor-binding protein 4,13307,100,0.69 [0.43-1.13],0.1436029540818094
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP6,Insulin-like growth factor-binding protein 6,13400,99,0.83 [0.42-1.64],0.5896434230629484
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP7,Insulin-like growth factor-binding protein 7,13658,103,0.70 [0.37-1.31],0.2614649751423195
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBPL1,Insulin-like growth factor-binding protein-like 1,13500,104,0.65 [0.38-1.13],0.1259026523289247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFL4,Insulin growth factor-like family member 4,11358,82,1.11 [0.89-1.39],0.3624275272822183
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGHMBP2,DNA-binding protein SMUBP-2,11332,84,0.66 [0.42-1.02],0.0597478904727604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGLC2,Immunoglobulin lambda constant 2,11683,87,0.85 [0.32-2.22],0.7321478761224207
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGLON5,IgLON family member 5,11269,84,0.86 [0.65-1.14],0.303042912919588
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF21,Immunoglobulin superfamily member 21,11368,85,0.89 [0.51-1.56],0.6909311909098513
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF3,Immunoglobulin superfamily member 3,13429,102,0.69 [0.38-1.24],0.2143324216492459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF8,Immunoglobulin superfamily member 8,13500,104,0.92 [0.51-1.64],0.7717811254394129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF9,Protein turtle homolog A,11692,85,1.04 [0.80-1.35],0.7518704478049942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IKBKG,NF-kappa-B essential modulator,13483,101,0.85 [0.70-1.03],0.1074330458983135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IKZF2,Zinc finger protein Helios,13187,100,1.03 [0.86-1.22],0.7797244636129893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL10,Interleukin-10,13235,101,0.89 [0.71-1.13],0.3504392448156972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL10RA,Interleukin-10 receptor subunit alpha,13235,101,0.81 [0.57-1.16],0.2517687611062154
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL10RB,Interleukin-10 receptor subunit beta,13555,104,0.72 [0.38-1.36],0.3089419879805427
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL11,Interleukin-11,13235,101,0.84 [0.62-1.15],0.2884961689233543
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12A_IL12B,Interleukin-12,13429,102,0.70 [0.55-0.89],0.003577670933392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12B,Interleukin-12 subunit beta,13652,101,0.62 [0.45-0.87],0.0057597269498003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12RB1,Interleukin-12 receptor subunit beta-1,13235,101,0.78 [0.49-1.26],0.3197863677365559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12RB2,Interleukin-12 receptor subunit beta-2,11358,82,0.49 [0.27-0.87],0.0142279134873952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL13,Interleukin-13,13235,101,0.87 [0.58-1.30],0.4889144775352978
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL13RA1,Interleukin-13 receptor subunit alpha-1,13315,102,0.85 [0.36-1.98],0.6979250695941301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL13RA2,Interleukin-13 receptor subunit alpha-2,11347,80,0.65 [0.31-1.35],0.2486126274465947
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL15,Interleukin-15,13483,101,1.13 [0.66-1.92],0.6585408226444881
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL15RA,Interleukin-15 receptor subunit alpha,13235,101,0.83 [0.50-1.38],0.4729580480038761
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL16,Pro-interleukin-16,13652,101,0.77 [0.49-1.19],0.2330069713407135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17A,Interleukin-17A,13220,101,1.00 [0.66-1.53],0.9894856868149916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17C,Interleukin-17C,13235,101,1.04 [0.80-1.35],0.7602872456947283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17D,Interleukin-17D,13235,101,0.63 [0.34-1.19],0.1532822632957083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17F,Interleukin-17F,13235,101,1.10 [0.91-1.34],0.3268998704905519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17RA,Interleukin-17 receptor A,13496,100,1.05 [0.71-1.56],0.8118109126566067
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17RB,Interleukin-17 receptor B,13304,98,0.95 [0.68-1.33],0.7618200316058283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18,Interleukin-18,13444,104,0.86 [0.59-1.25],0.4269249935300956
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18BP,Interleukin-18-binding protein,13507,102,1.19 [0.66-2.12],0.5613410739089886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18R1,Interleukin-18 receptor 1,13652,101,1.23 [0.73-2.07],0.4440695967875347
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18RAP,Interleukin-18 receptor accessory protein,13325,101,0.91 [0.82-1.01],0.0853028356702982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL19,Interleukin-19,13162,102,0.89 [0.68-1.18],0.4302965421632523
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1A,Interleukin-1 alpha,13235,101,1.10 [0.81-1.49],0.5424070178447058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1B,Interleukin-1 beta,13173,101,0.69 [0.48-0.98],0.0396375933285564
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1R1,Interleukin-1 receptor type 1,13473,100,1.13 [0.50-2.58],0.77085354437458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1R2,Interleukin-1 receptor type 2,13472,103,0.94 [0.38-2.33],0.8925511567204852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RAP,Interleukin-1 receptor accessory protein,13496,100,1.35 [0.91-2.02],0.1395758238100684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RL1,Interleukin-1 receptor-like 1,13607,100,1.23 [0.84-1.81],0.2867798344681706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RL2,Interleukin-1 receptor-like 2,13235,101,0.92 [0.61-1.41],0.715166269125816
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RN,Interleukin-1 receptor antagonist protein,13455,101,0.78 [0.54-1.11],0.1631057019227414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2,Interleukin-2,13235,101,0.75 [0.43-1.32],0.3220104611558
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL20,Interleukin-20,13235,101,0.86 [0.58-1.27],0.4538019725432346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL20RA,Interleukin-20 receptor subunit alpha,13235,101,1.32 [1.00-1.74],0.0519938343627316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL20RB,Interleukin-20 receptor subunit beta,11358,82,1.30 [0.84-2.03],0.2419485473022905
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL21R,Interleukin-21 receptor,11358,82,0.82 [0.52-1.29],0.3822177488802102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL22,Interleukin-22,11611,85,1.20 [0.90-1.60],0.2027733739825414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL22RA1,Interleukin-22 receptor subunit alpha-1,13235,101,0.81 [0.52-1.25],0.3367922768784829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL24,Interleukin-24,13235,101,0.98 [0.67-1.43],0.9181492579011648
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL25,Interleukin-25,11228,83,1.20 [0.65-2.20],0.5594663679307503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2RA,Interleukin-2 receptor subunit alpha,13390,97,1.24 [0.79-1.96],0.3494112779644448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2RB,Interleukin-2 receptor subunit beta,13235,101,0.87 [0.53-1.43],0.5758304772370972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2RG,Cytokine receptor common subunit gamma,11611,85,0.73 [0.39-1.38],0.3385600558527832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL3,Interleukin-3,11269,84,0.86 [0.63-1.17],0.3284452043771831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL31,Interleukin-31,11358,82,0.64 [0.40-1.03],0.0663635855890223
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL31RA,Interleukin-31 receptor subunit alpha,11317,82,0.90 [0.54-1.52],0.7040106798545571
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL32,Interleukin-32,13483,101,0.91 [0.60-1.41],0.6848182162689387
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL33,Interleukin-33,13235,101,0.79 [0.51-1.24],0.3077570539003746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL34,Interleukin-34,13137,97,0.85 [0.52-1.39],0.5163250212366971
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL36A,Interleukin-36 alpha,11358,82,1.09 [0.79-1.52],0.5896172424750525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL36G,Interleukin-36 gamma,11316,82,1.34 [1.07-1.68],0.0104932692395179
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL3RA,Interleukin-3 receptor subunit alpha,13235,101,0.72 [0.40-1.27],0.2557223429478962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL4,Interleukin-4,13235,101,0.92 [0.77-1.09],0.3441803235836926
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL4R,Interleukin-4 receptor subunit alpha,13483,101,0.83 [0.49-1.38],0.4669771984849431
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL5,Interleukin-5,13235,101,0.96 [0.85-1.09],0.5522363357891003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL5RA,Interleukin-5 receptor subunit alpha,13483,101,0.71 [0.51-0.99],0.0439950447256297
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL6,Interleukin-6,13429,102,0.86 [0.66-1.13],0.2873130935031944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL6R,Interleukin-6 receptor subunit alpha,13378,98,0.97 [0.57-1.64],0.906526087345299
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL6ST,Interleukin-6 receptor subunit beta,13500,104,0.80 [0.29-2.15],0.6529860291309153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL7,Interleukin-7,13483,101,0.85 [0.65-1.12],0.2526849038258448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL7R,Interleukin-7 receptor subunit alpha,13496,100,0.77 [0.56-1.07],0.1251631737369527
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL9,Interleukin-9,11438,86,0.89 [0.59-1.32],0.5553733552792142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,13141,97,0.91 [0.67-1.26],0.5795718609847786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMMT,MICOS complex subunit MIC60,11611,85,0.52 [0.30-0.90],0.0201545246088355
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMPA1,Inositol monophosphatase 1,13411,102,0.81 [0.60-1.09],0.1603159526704648
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMPACT,Protein IMPACT,11656,85,0.84 [0.58-1.21],0.3446897023010467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMPG1,Interphotoreceptor matrix proteoglycan 1,11347,80,0.56 [0.24-1.28],0.1702241265911455
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ING1,Inhibitor of growth protein 1,13127,97,1.06 [0.72-1.56],0.7620121619309661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INHBB,Inhibin beta B chain,11422,85,1.05 [0.69-1.58],0.8300207371444176
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INHBC,Inhibin beta C chain,13496,100,1.00 [0.66-1.49],0.9842252182269892
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPP1,Inositol polyphosphate 1-phosphatase,13429,102,0.80 [0.58-1.11],0.1880256443626304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",11368,85,0.79 [0.54-1.16],0.22942369993164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",11674,86,0.95 [0.58-1.55],0.8477678188414342
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",13429,102,0.86 [0.72-1.03],0.1013166493825896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSL3,Insulin-like 3,11656,85,1.10 [0.76-1.58],0.6146902125021011
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSL4,Early placenta insulin-like peptide,11611,85,0.94 [0.62-1.41],0.7536771937539914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSL5,Insulin-like peptide INSL5,11626,86,1.19 [0.97-1.46],0.0954882611748222
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSR,Insulin receptor,11358,82,0.62 [0.17-2.24],0.4658534547717182
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IPCEF1,Interactor protein for cytohesin exchange factors 1,13390,102,0.91 [0.75-1.11],0.36122446250076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IQGAP2,Ras GTPase-activating-like protein IQGAP2,13429,102,0.84 [0.61-1.17],0.3047371587843698
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",13267,101,0.86 [0.70-1.07],0.1808466238889492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IRAK1,Interleukin-1 receptor-associated kinase 1,13235,101,0.82 [0.63-1.07],0.1443410191230461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IRAK4,Interleukin-1 receptor-associated kinase 4,13483,101,0.92 [0.78-1.08],0.3184202168654806
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,12965,96,0.75 [0.46-1.23],0.2555980182486985
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ISM1,Isthmin-1,13483,101,0.67 [0.43-1.04],0.0732339590343847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ISM2,Isthmin-2,11671,86,0.91 [0.56-1.49],0.7179863191864657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IST1,IST1 homolog,11549,84,0.88 [0.72-1.08],0.2342161594285887
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA11,Integrin alpha-11,13483,101,0.62 [0.37-1.03],0.0644355960248446
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA2,Integrin alpha-2,11422,85,0.80 [0.43-1.49],0.4785390072411115
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA5,Integrin alpha-5,13496,100,0.80 [0.39-1.66],0.5495260125465108
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA6,Integrin alpha-6,13483,101,0.68 [0.48-0.98],0.0365022268711814
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAL,Integrin alpha-L,11358,82,0.90 [0.56-1.45],0.6732005126218221
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAM,Integrin alpha-M,13496,100,0.85 [0.49-1.49],0.5795527770584685
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAV,Integrin alpha-V,13620,100,0.48 [0.17-1.37],0.1698155896101155
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAX,Integrin alpha-X,11438,86,0.98 [0.67-1.44],0.9319980713489984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB1,Integrin beta-1,13437,99,0.99 [0.44-2.26],0.9875158778066596
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB1BP1,Integrin beta-1-binding protein 1,13187,100,0.73 [0.47-1.13],0.1560754848650399
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB1BP2,Integrin beta-1-binding protein 2,13267,101,0.91 [0.78-1.06],0.2222051560267439
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB2,Integrin beta-2,13400,100,0.66 [0.35-1.24],0.1987972758660125
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB5,Integrin beta-5,13527,102,0.62 [0.37-1.02],0.0581267390938016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB6,Integrin beta-6,13235,101,0.68 [0.37-1.23],0.1970091367435604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB7,Integrin beta-7,13620,100,1.17 [0.81-1.70],0.3971155047403539
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGBL1,Integrin beta-like protein 1,11671,86,0.80 [0.43-1.49],0.4823770466760934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,11702,87,0.76 [0.26-2.23],0.6130573668257617
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,13507,102,1.29 [0.80-2.06],0.2943888692521216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,11702,87,0.75 [0.34-1.63],0.4696046104035775
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,11611,85,1.01 [0.65-1.57],0.9594599622207548
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITM2A,Integral membrane protein 2A,13483,101,1.13 [0.84-1.52],0.4268287716795261
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITPA,Inosine triphosphate pyrophosphatase,11332,84,0.84 [0.61-1.15],0.2810306677907026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",11368,85,0.91 [0.67-1.23],0.5317732838776132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",11347,80,0.81 [0.50-1.33],0.4123935016170954
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",13156,97,0.82 [0.56-1.20],0.3135150302801246
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IZUMO1,Izumo sperm-egg fusion protein 1,11269,84,0.76 [0.46-1.27],0.3003623161283995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JAM2,Junctional adhesion molecule B,13626,102,0.36 [0.17-0.73],0.004817412661572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JAM3,Junctional adhesion molecule C,11422,85,0.72 [0.46-1.12],0.1406101015869926
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JCHAIN,Immunoglobulin J chain,13235,101,0.97 [0.72-1.30],0.8342689837080326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,11269,84,0.99 [0.67-1.46],0.9646060827900316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JPT2,Jupiter microtubule associated homolog 2,11626,86,0.95 [0.76-1.20],0.687474217827027
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JUN,Transcription factor AP-1,13235,101,0.95 [0.67-1.33],0.7590618316518497
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,13429,102,0.92 [0.63-1.34],0.6530545747766314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KAZN,Kazrin,11626,86,0.91 [0.75-1.11],0.3542118851737502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCNC4,Potassium voltage-gated channel subfamily C member 4,11347,80,0.59 [0.35-0.99],0.0450210641010056
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCNH2,Potassium voltage-gated channel subfamily H member 2,11351,84,0.81 [0.58-1.14],0.2254331930265405
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCNIP4,Kv channel-interacting protein 4,13156,97,1.07 [0.78-1.48],0.6627808373407839
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCTD5,BTB/POZ domain-containing protein KCTD5,11436,85,0.81 [0.49-1.35],0.4181842018292926
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KDM3A,Lysine-specific demethylase 3A,11358,82,0.86 [0.65-1.12],0.2598077704815727
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KDR,Vascular endothelial growth factor receptor 2,13527,102,1.24 [0.62-2.46],0.5397247761960291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KEL,Kell blood group glycoprotein,13156,97,0.59 [0.35-0.97],0.0369237405871101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KHDC3L,KH domain-containing protein 3,11269,84,0.62 [0.40-0.96],0.0311983257112927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KHK,Ketohexokinase,11368,85,0.90 [0.65-1.23],0.5058118905630564
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA0319,Dyslexia-associated protein KIAA0319,11656,85,0.43 [0.21-0.91],0.0269706927831669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA1549,UPF0606 protein KIAA1549,11438,86,1.12 [0.85-1.48],0.4214831036914489
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA1549L,UPF0606 protein KIAA1549L,11438,86,0.49 [0.23-1.09],0.0797351193032419
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA2013,Uncharacterized protein KIAA2013,11611,85,1.08 [0.79-1.49],0.6168156978405113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIF1C,Kinesin-like protein KIF1C,11332,84,0.57 [0.27-1.18],0.1300921351700066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIF20B,Kinesin-like protein KIF20B,11347,80,1.08 [0.84-1.39],0.533356687535185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIF22,Kinesin-like protein KIF22,11332,84,0.86 [0.73-1.02],0.0914566776172102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIFBP,KIF-binding protein,13429,102,0.88 [0.72-1.08],0.2320616951926797
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,11611,85,0.83 [0.65-1.06],0.1283476986577585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,13187,100,0.92 [0.72-1.16],0.4716970191472737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,11626,86,1.01 [0.90-1.14],0.811431901913982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,13187,100,0.91 [0.78-1.06],0.2278320419431794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,11269,84,0.96 [0.75-1.24],0.7797591583631123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIRREL1,Kin of IRRE-like protein 1,11347,80,0.63 [0.37-1.07],0.0852704121427237
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIRREL2,Kin of IRRE-like protein 2,13156,97,0.55 [0.35-0.87],0.0103955821637345
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIT,Mast/stem cell growth factor receptor Kit,13489,102,1.88 [1.04-3.38],0.0364347534793014
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KITLG,Kit ligand,13500,104,0.77 [0.48-1.23],0.2792406113404584
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLB,Beta-klotho,13156,97,0.75 [0.59-0.96],0.0235223080942151
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLF4,Krueppel-like factor 4,11347,80,0.58 [0.33-1.04],0.0696218249580487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLHL41,Kelch-like protein 41,11674,86,0.93 [0.60-1.44],0.7362513931150568
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK1,Kallikrein-1,13352,100,0.95 [0.82-1.10],0.5082711608857347
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK10,Kallikrein-10,13489,102,0.61 [0.39-0.96],0.0332125946886053
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK11,Kallikrein-11,13389,102,0.53 [0.28-1.00],0.0516765897101121
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK12,Kallikrein-12,13187,100,0.88 [0.78-1.00],0.0470316347870206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK13,Kallikrein-13,13195,100,0.90 [0.59-1.36],0.6108432131613037
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK14,Kallikrein-14,13620,100,0.76 [0.52-1.12],0.1696134654399007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK15,Kallikrein-15,11595,85,0.73 [0.48-1.10],0.1275252012615739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK3,Prostate-specific antigen,11671,86,1.21 [0.87-1.68],0.2659584326479655
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK4,Kallikrein-4,13620,100,1.22 [0.93-1.60],0.1508875932053976
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK6,Kallikrein-6,13516,102,0.56 [0.31-1.00],0.0519341353987188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK7,Kallikrein-7,11092,85,0.97 [0.57-1.66],0.9218104715440016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK8,Kallikrein-8,13031,98,0.72 [0.43-1.21],0.2174856238061145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLKB1,Plasma kallikrein,11476,86,1.48 [0.67-3.25],0.3292197157071801
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRB1,Killer cell lectin-like receptor subfamily B member 1,13652,101,0.94 [0.58-1.53],0.8011104738592313
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,11347,80,0.82 [0.55-1.25],0.3580367635538146
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRD1,Natural killer cells antigen CD94,13652,101,0.84 [0.57-1.24],0.3850319138935894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRF1,Killer cell lectin-like receptor subfamily F member 1,11358,82,0.90 [0.53-1.53],0.7046133215539754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRK1,NKG2-D type II integral membrane protein,11656,85,0.84 [0.53-1.32],0.4448766929574713
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT14,"Keratin, type I cytoskeletal 14",12725,91,1.02 [0.54-1.94],0.9534001836189148
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT17,"Keratin, type I cytoskeletal 17",11332,84,1.02 [0.60-1.73],0.9330157929890902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT18,"Keratin, type I cytoskeletal 18",13429,102,1.03 [0.82-1.30],0.785505693857368
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT19,"Keratin, type I cytoskeletal 19",13467,101,0.73 [0.55-0.99],0.0399144729664391
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT5,"Keratin, type II cytoskeletal 5",13156,97,0.90 [0.61-1.33],0.602813583598595
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT6C,"Keratin, type II cytoskeletal 6C",11332,84,1.04 [0.64-1.69],0.8721298254798829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT8,"Keratin, type II cytoskeletal 8",11347,80,0.85 [0.54-1.33],0.4672345611584934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KYAT1,Kynurenine--oxoglutarate transaminase 1,13470,102,0.94 [0.69-1.28],0.6846414847787591
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KYNU,Kynureninase,13652,101,0.88 [0.59-1.31],0.519444299360607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",L1CAM,Neural cell adhesion molecule L1,13527,102,1.04 [0.56-1.93],0.9000267967146838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,11692,85,0.95 [0.76-1.20],0.6727866277460645
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LACRT,Extracellular glycoprotein lacritin,11595,85,1.16 [0.81-1.65],0.4219092831507305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LACTB2,Endoribonuclease LACTB2,13500,104,0.86 [0.66-1.12],0.2612266982819218
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAG3,Lymphocyte activation gene 3 protein,13429,102,0.90 [0.58-1.39],0.6256263798170439
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,13493,104,0.62 [0.37-1.06],0.0790912112611808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,13411,102,1.00 [0.85-1.18],0.9812268956572684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMA1,Laminin subunit alpha-1,11332,84,0.66 [0.39-1.10],0.1107332399226623
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMA4,Laminin subunit alpha-4,13555,104,0.51 [0.30-0.89],0.017178010795206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMB1,Laminin subunit beta-1,11368,85,0.68 [0.34-1.34],0.2605571366179988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMP1,Lysosome-associated membrane glycoprotein 1,11363,86,1.24 [0.70-2.19],0.461360441910001
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMP2,Lysosome-associated membrane glycoprotein 2,13086,101,0.39 [0.15-0.98],0.0462610836205808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMP3,Lysosome-associated membrane glycoprotein 3,13625,100,1.21 [0.85-1.72],0.2983644817661004
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMTOR5,Ragulator complex protein LAMTOR5,11611,85,0.95 [0.57-1.58],0.8512878061555271
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAP3,Cytosol aminopeptidase,13235,101,0.92 [0.64-1.32],0.6587134601033218
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LARP1,La-related protein 1,11611,85,1.03 [0.76-1.40],0.8446249579296207
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAT,Linker for activation of T-cells family member 1,13652,101,0.83 [0.67-1.03],0.0907089940319211
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAT2,Linker for activation of T-cells family member 2,13429,102,0.90 [0.78-1.04],0.1416715568227436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LATS1,Serine/threonine-protein kinase LATS1,11358,82,0.97 [0.75-1.25],0.8043304389442361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAYN,Layilin,13382,102,0.52 [0.29-0.91],0.0232115348278652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LBP,Lipopolysaccharide-binding protein,13507,102,1.15 [0.86-1.54],0.3491354294574612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LBR,Delta(14)-sterol reductase LBR,13626,102,0.88 [0.67-1.15],0.3502857836538773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCAT,Phosphatidylcholine-sterol acyltransferase,11690,85,0.79 [0.31-2.00],0.6154731233110995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCN15,Lipocalin-15,11674,86,0.92 [0.66-1.31],0.6572380035645469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCN2,Neutrophil gelatinase-associated lipocalin,13029,94,1.10 [0.67-1.83],0.6985404049333529
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCP1,Plastin-2,11671,86,0.81 [0.52-1.26],0.3505820429562583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LDLR,Low-density lipoprotein receptor,13533,100,0.82 [0.58-1.16],0.2633552821517078
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LDLRAP1,Low density lipoprotein receptor adapter protein 1,11674,86,0.85 [0.69-1.06],0.1453587099089585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LECT2,Leukocyte cell-derived chemotaxin-2,11692,85,0.70 [0.50-0.98],0.0354925773916962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEFTY2,Left-right determination factor 2,13599,100,0.71 [0.51-0.99],0.0409059592302586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEG1,Protein LEG1 homolog,11024,82,1.16 [0.86-1.56],0.3384119217126952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LELP1,Late cornified envelope-like proline-rich protein 1,11347,80,0.83 [0.60-1.16],0.2818949262429802
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEO1,RNA polymerase-associated protein LEO1,11674,86,0.69 [0.30-1.58],0.3856044440485854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEP,Leptin,13500,104,0.84 [0.65-1.09],0.1992442139390526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEPR,Leptin receptor,13500,104,0.80 [0.45-1.42],0.4411001555440175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LETM1,Mitochondrial proton/calcium exchanger protein,11674,86,0.71 [0.46-1.08],0.1114422370827929
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS1,Galectin-1,13500,104,0.80 [0.47-1.37],0.4221709967738665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS3,Galectin-3,13528,100,0.66 [0.37-1.19],0.1635849138960822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS3BP,Galectin-3-binding protein,11702,87,0.89 [0.44-1.77],0.7340399034341739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS4,Galectin-4,13493,104,0.80 [0.56-1.14],0.2144877388031735
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS7_LGALS7B,Galectin-7,13485,99,0.69 [0.43-1.10],0.1190936936548884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS8,Galectin-8,13626,102,0.81 [0.60-1.09],0.1663293874987158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS9,Galectin-9,13483,101,0.56 [0.32-0.99],0.0473278353875123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGMN,Legumain,13555,104,0.70 [0.42-1.14],0.1495325624819206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LHB,Lutropin subunit beta,13187,100,0.78 [0.61-1.00],0.046652327954517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,13506,104,1.12 [0.84-1.48],0.4452608726387573
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LIF,Leukemia inhibitory factor,13156,97,0.86 [0.59-1.25],0.4262234608627955
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LIFR,Leukemia inhibitory factor receptor,13483,101,0.97 [0.47-1.99],0.9294355679273628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,13496,100,1.08 [0.67-1.75],0.7493766402561555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,11671,86,1.17 [0.95-1.44],0.1497582766905822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,11332,84,0.97 [0.64-1.46],0.8751336468790509
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,13482,104,0.57 [0.33-0.99],0.0470054065111469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,11692,85,0.88 [0.67-1.16],0.3747992278968038
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,13658,103,1.07 [0.57-2.02],0.8293359133145897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,13579,100,1.39 [0.83-2.33],0.2129665131668692
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,13235,101,0.72 [0.47-1.12],0.1436977771220551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,13658,103,0.86 [0.68-1.09],0.218892196042439
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LIPF,Gastric triacylglycerol lipase,11368,85,1.21 [0.86-1.70],0.2717729432730392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMNB1,Lamin-B1,11601,86,1.12 [0.82-1.55],0.4758636127457016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMNB2,Lamin-B2,11656,85,0.87 [0.40-1.90],0.7299631779464002
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMOD1,Leiomodin-1,11674,86,0.62 [0.31-1.22],0.1684584093167816
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMOD2,Leiomodin-2,11347,80,0.61 [0.40-0.92],0.0174558988889364
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LONP1,"Lon protease homolog, mitochondrial",11368,85,0.96 [0.75-1.22],0.7212371298371019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPA,Apolipoprotein(a),11400,84,0.98 [0.87-1.10],0.7070002801253614
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPCAT2,Lysophosphatidylcholine acyltransferase 2,13429,102,0.99 [0.65-1.52],0.9747022961648398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPL,Lipoprotein lipase,13500,104,1.01 [0.70-1.47],0.9592859663038308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPO,Lactoperoxidase,13087,102,1.12 [0.84-1.51],0.4451605012660464
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPP,Lipoma-preferred partner,11332,84,0.92 [0.67-1.25],0.5924443679353557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,11332,84,0.83 [0.60-1.15],0.2700860496461255
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,11351,84,0.48 [0.26-0.89],0.0193497026604037
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRG1,Leucine-rich alpha-2-glycoprotein,11702,87,1.42 [0.66-3.04],0.3663459643477305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,13583,99,0.72 [0.43-1.22],0.2216879023226432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,11315,81,0.60 [0.25-1.41],0.2381149769855662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP1,Prolow-density lipoprotein receptor-related protein 1,13429,102,0.89 [0.46-1.75],0.744902544282364
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP11,Low-density lipoprotein receptor-related protein 11,13500,104,0.77 [0.46-1.28],0.3088587984196799
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP2,Low-density lipoprotein receptor-related protein 2,11351,84,0.68 [0.36-1.27],0.2261183371457368
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP2BP,LRP2-binding protein,11351,84,0.91 [0.69-1.20],0.5117473586761438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,13626,102,0.94 [0.69-1.30],0.7225686484370997
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC25,Leucine-rich repeat-containing protein 25,13429,102,0.80 [0.50-1.29],0.3622167569379936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC37A2,Leucine-rich repeat-containing protein 37A2,11626,86,0.98 [0.60-1.60],0.9428432527885076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC38,Leucine-rich repeat-containing protein 38,11351,84,0.97 [0.63-1.49],0.900864565077714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC59,Leucine-rich repeat-containing protein 59,11692,85,0.59 [0.36-0.99],0.0438011155684022
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,11611,85,0.60 [0.37-0.97],0.0385452513671318
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRN1,Leucine-rich repeat neuronal protein 1,13235,101,0.94 [0.59-1.50],0.7991545340654476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,11351,84,0.44 [0.24-0.84],0.0121331978952771
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,11674,86,0.88 [0.40-1.92],0.7434671071255068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LSM1,U6 snRNA-associated Sm-like protein LSm1,13187,100,0.87 [0.62-1.23],0.4277851238038406
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LSM8,U6 snRNA-associated Sm-like protein LSm8,11438,86,0.95 [0.75-1.20],0.664013483812534
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LSP1,Lymphocyte-specific protein 1,13483,101,0.98 [0.64-1.51],0.9402612706992468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTA,Lymphotoxin-alpha,13483,101,0.84 [0.54-1.31],0.4421966983718025
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTA4H,Leukotriene A-4 hydrolase,13620,100,0.93 [0.69-1.27],0.6689943102282987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTB,Lymphotoxin-beta,11611,85,0.73 [0.38-1.42],0.3576814127238432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTBP2,Latent-transforming growth factor beta-binding protein 2,13658,103,0.56 [0.31-1.00],0.0500314786587377
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTBP3,Latent-transforming growth factor beta-binding protein 3,13187,100,0.73 [0.50-1.07],0.1082878294545368
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTBR,Tumor necrosis factor receptor superfamily member 3,13414,101,0.78 [0.39-1.57],0.4901098627481841
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTO1,Protein LTO1 homolog,13235,101,0.96 [0.62-1.48],0.8556640924438108
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LUZP2,Leucine zipper protein 2,11611,85,0.84 [0.51-1.38],0.4942645806499216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LXN,Latexin,13346,102,1.03 [0.80-1.32],0.8303645340008086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY6D,Lymphocyte antigen 6D,13407,101,0.80 [0.48-1.34],0.3993859940957341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY75,Lymphocyte antigen 75,13483,101,0.68 [0.44-1.05],0.082019668472401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY9,T-lymphocyte surface antigen Ly-9,13372,101,0.79 [0.41-1.50],0.4710893218944068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY96,Lymphocyte antigen 96,13411,102,0.56 [0.32-0.96],0.035543704434995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYAR,Cell growth-regulating nucleolar protein,13187,100,0.89 [0.62-1.29],0.5331295689903868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYN,Tyrosine-protein kinase Lyn,13429,102,0.85 [0.69-1.04],0.1154179890331475
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPD1,Ly6/PLAUR domain-containing protein 1,13156,97,0.89 [0.65-1.22],0.4774828248108524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPD3,Ly6/PLAUR domain-containing protein 3,13424,102,1.42 [0.88-2.29],0.1550269626638816
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPD8,Ly6/PLAUR domain-containing protein 8,13187,100,0.91 [0.64-1.30],0.6118902575682396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPLA2,Acyl-protein thioesterase 2,11347,80,1.01 [0.83-1.23],0.9299076027596052
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,11351,84,0.85 [0.68-1.07],0.1741310734730053
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,11702,87,0.63 [0.22-1.82],0.3970060916488643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYZL2,Lysozyme-like protein 2,11269,84,1.11 [0.64-1.91],0.7073748308947366
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LZTFL1,Leucine zipper transcription factor-like protein 1,11422,85,0.83 [0.62-1.12],0.2332812338994095
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",M6PR,Cation-dependent mannose-6-phosphate receptor,11368,85,0.97 [0.59-1.60],0.9094357835224616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,13365,102,0.73 [0.48-1.13],0.1594142010572748
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAEA,E3 ubiquitin-protein transferase MAEA,13187,100,0.65 [0.39-1.06],0.0837372871959441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAG,Myelin-associated glycoprotein,11351,84,0.59 [0.39-0.91],0.0165339767951309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAGEA3,Melanoma-associated antigen 3,11438,86,1.16 [0.91-1.47],0.2389960909738653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAGED1,Melanoma-associated antigen D1,13187,100,0.89 [0.61-1.30],0.5407907178183742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAMDC2,MAM domain-containing protein 2,11692,85,0.65 [0.34-1.23],0.1870040301036851
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAMDC4,Apical endosomal glycoprotein,11611,85,1.12 [0.77-1.63],0.5391229843539479
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",11368,85,0.76 [0.34-1.71],0.5086273175913616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAN2B2,Epididymis-specific alpha-mannosidase,11692,85,0.82 [0.58-1.16],0.2526546673452033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",11269,84,0.89 [0.58-1.35],0.5736155885220204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANF,Mesencephalic astrocyte-derived neurotrophic factor,13555,104,0.91 [0.79-1.04],0.1559329596293157
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANSC1,MANSC domain-containing protein 1,13527,102,0.89 [0.47-1.68],0.7110541660076231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANSC4,MANSC domain-containing protein 4,11332,84,0.83 [0.58-1.18],0.2959407384832461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,11347,80,0.75 [0.38-1.48],0.4023752808952838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,11332,84,0.92 [0.65-1.31],0.6399388122898764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP2,Microtubule-associated protein 2,11656,85,0.72 [0.44-1.19],0.2012855869116695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,11626,86,0.87 [0.63-1.20],0.3848642182552658
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,13483,101,0.91 [0.77-1.08],0.2939729589180665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,13187,100,0.79 [0.65-0.96],0.0195370512528954
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,13382,102,0.90 [0.77-1.05],0.1795550488796259
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPK13,Mitogen-activated protein kinase 13,11269,84,0.92 [0.56-1.51],0.7491322346760343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPK9,Mitogen-activated protein kinase 9,13483,101,0.74 [0.50-1.11],0.141871336701967
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPKAPK2,MAP kinase-activated protein kinase 2,11438,86,0.94 [0.71-1.25],0.6819739098023241
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPRE3,Microtubule-associated protein RP/EB family member 3,11269,84,0.85 [0.70-1.02],0.0850847419291021
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPT,Microtubule-associated protein tau,13156,97,1.14 [0.80-1.62],0.4664136228501625
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MARCO,Macrophage receptor MARCO,13500,104,0.72 [0.38-1.37],0.3152020444088638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MARS1,"Methionine--tRNA ligase, cytoplasmic",11393,85,0.87 [0.68-1.12],0.2810684905447848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MASP1,Mannan-binding lectin serine protease 1,13382,102,0.95 [0.46-1.97],0.8869376719008428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MATN2,Matrilin-2,13518,104,0.86 [0.48-1.53],0.6092275692289175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MATN3,Matrilin-3,13390,102,1.19 [0.67-2.12],0.5438289151214488
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAVS,Mitochondrial antiviral-signaling protein,13187,100,0.83 [0.68-1.01],0.0649394360538521
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAX,Protein max,13156,97,0.87 [0.73-1.04],0.1154512716095297
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MB,Myoglobin,13658,103,0.93 [0.64-1.34],0.690073428426812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MBL2,Mannose-binding protein C,11530,86,0.97 [0.80-1.18],0.7888905872948644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCAM,Cell surface glycoprotein MUC18,13507,102,0.91 [0.54-1.54],0.7370139281371804
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",11674,86,0.82 [0.49-1.38],0.4545583670953603
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCEMP1,Mast cell-expressed membrane protein 1,11358,82,0.83 [0.65-1.06],0.1348723212980102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCFD2,Multiple coagulation factor deficiency protein 2,13452,104,0.85 [0.57-1.27],0.4304885869973438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCTS1,Malignant T-cell-amplified sequence 1,11626,86,1.20 [0.57-2.52],0.6328925571418913
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,13411,102,0.79 [0.62-1.01],0.0585903074231589
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDH1,"Malate dehydrogenase, cytoplasmic",11616,85,0.79 [0.47-1.33],0.3744590591734696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDK,Midkine,13486,102,0.83 [0.58-1.18],0.2966588608664206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDM1,Nuclear protein MDM1,11351,84,0.35 [0.17-0.70],0.0033949972769871
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",11368,85,0.95 [0.76-1.20],0.6741407597912336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MED18,Mediator of RNA polymerase II transcription subunit 18,13187,100,0.87 [0.69-1.10],0.2514126233892848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MED21,Mediator of RNA polymerase II transcription subunit 21,11332,84,0.89 [0.56-1.41],0.6167649606063995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEGF10,Multiple epidermal growth factor-like domains protein 10,13493,104,0.66 [0.43-1.03],0.0644801192304615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEGF11,Multiple epidermal growth factor-like domains protein 11,11332,84,0.40 [0.18-0.90],0.0268542773459478
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEGF9,Multiple epidermal growth factor-like domains protein 9,13607,100,0.81 [0.36-1.83],0.6069290040827847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MELTF,Melanotransferrin,11692,85,0.40 [0.21-0.79],0.0077829246236163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MENT,Protein MENT,11422,85,1.06 [0.40-2.81],0.9146129075527374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEP1A,Meprin A subunit alpha,11626,86,0.97 [0.72-1.32],0.8680452686486626
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEP1B,Meprin A subunit beta,13500,104,1.01 [0.87-1.17],0.9262102277798192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEPE,Matrix extracellular phosphoglycoprotein,13493,104,0.64 [0.34-1.18],0.1502441737318318
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MERTK,Tyrosine-protein kinase Mer,13652,101,0.74 [0.38-1.46],0.3865185803952894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MESD,LRP chaperone MESD,13496,100,0.94 [0.81-1.09],0.3979640731968894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MET,Hepatocyte growth factor receptor,13528,102,1.05 [0.44-2.52],0.9098133125040158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",METAP1,Methionine aminopeptidase 1,13156,97,1.24 [0.73-2.11],0.4331165869163835
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",13483,101,0.92 [0.74-1.14],0.4343407591836118
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",METAP2,Methionine aminopeptidase 2,13599,100,0.82 [0.61-1.09],0.1746730774361808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP3,Microfibril-associated glycoprotein 3,13267,101,1.31 [1.00-1.72],0.054223356072357
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP3L,Microfibrillar-associated protein 3-like,11351,84,0.84 [0.58-1.22],0.3632880907521227
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP4,Microfibril-associated glycoprotein 4,11422,85,0.76 [0.39-1.48],0.4160628551761122
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP5,Microfibrillar-associated protein 5,13658,103,0.70 [0.46-1.06],0.090272745171009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFGE8,Lactadherin,13496,100,0.72 [0.47-1.11],0.1391985355235113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MGLL,Monoglyceride lipase,13534,104,0.91 [0.75-1.10],0.3235802908413233
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MGMT,Methylated-DNA--protein-cysteine methyltransferase,13483,101,0.98 [0.85-1.13],0.7861076280305022
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MIA,Melanoma-derived growth regulatory protein,13527,102,0.99 [0.61-1.62],0.9805610697482938
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MICALL2,MICAL-like protein 2,11351,84,0.76 [0.54-1.07],0.1116992055447969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,13483,101,1.07 [0.94-1.22],0.2894129640282129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MIF,Macrophage migration inhibitory factor,13475,100,0.88 [0.69-1.14],0.3386550238970933
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MILR1,Allergin-1,13235,101,0.72 [0.50-1.04],0.0812623780369442
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,11611,85,0.81 [0.67-0.98],0.028640797781601
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MINK1,Misshapen-like kinase 1,11656,85,0.85 [0.69-1.06],0.1564712238677917
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MITD1,MIT domain-containing protein 1,13411,102,0.89 [0.75-1.06],0.1987961306900759
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MKI67,Proliferation marker protein Ki-67,11358,82,0.62 [0.32-1.21],0.1599883786103546
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MLLT1,Protein ENL,11269,84,1.16 [0.90-1.49],0.2567506468185959
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MLN,Promotilin,13483,101,0.95 [0.78-1.16],0.6453744316669268
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MME,Neprilysin,13429,102,1.04 [0.83-1.29],0.746282286784758
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP1,Interstitial collagenase,12980,95,0.91 [0.76-1.11],0.3603712048854952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP10,Stromelysin-2,13482,104,0.87 [0.65-1.17],0.3512193403644353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP12,Macrophage metalloelastase,13518,99,0.88 [0.61-1.27],0.499701258831456
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP13,Collagenase 3,13156,97,0.77 [0.44-1.34],0.3508400329734215
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP15,Matrix metalloproteinase-15,11692,85,1.15 [0.82-1.60],0.4214509583454336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP3,Stromelysin-1,13496,100,0.88 [0.60-1.31],0.5304804450205616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP7,Matrilysin,13241,101,0.90 [0.63-1.30],0.5874317653637187
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP8,Neutrophil collagenase,13606,102,0.96 [0.76-1.22],0.7679675293975603
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP9,Matrix metalloproteinase-9,13475,100,1.00 [0.75-1.33],0.9990944431862492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",11332,84,0.93 [0.60-1.43],0.7293648606008415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MN1,Transcriptional activator MN1,11351,84,0.61 [0.39-0.98],0.0400506097147159
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MNAT1,CDK-activating kinase assembly factor MAT1,11438,86,1.14 [0.74-1.75],0.5609248098000744
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MNDA,Myeloid cell nuclear differentiation antigen,13482,104,1.00 [0.85-1.19],0.9700024529633042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MOCS2,Molybdopterin synthase catalytic subunit,11422,85,0.79 [0.57-1.08],0.1409328824155658
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MOG,Myelin-oligodendrocyte glycoprotein,13620,100,0.52 [0.30-0.91],0.0224693278093301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORC3,MORC family CW-type zinc finger protein 3,11656,85,0.98 [0.47-2.03],0.9569643782385112
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORF4L1,Mortality factor 4-like protein 1,11438,86,0.72 [0.40-1.29],0.268022219342835
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORF4L2,Mortality factor 4-like protein 2,11269,84,0.87 [0.48-1.57],0.6379632918047397
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORN4,MORN repeat-containing protein 4,11269,84,0.83 [0.61-1.13],0.2370821002949803
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPHOSPH8,M-phase phosphoprotein 8,13267,101,0.86 [0.67-1.10],0.2199227224376415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPI,Mannose-6-phosphate isomerase,13429,102,0.94 [0.76-1.15],0.529192768204301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,13534,104,0.86 [0.70-1.06],0.147371974076914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPO,Myeloperoxidase,13496,100,1.10 [0.76-1.58],0.6229730220518463
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPRIP,Myosin phosphatase Rho-interacting protein,11589,85,0.63 [0.39-1.00],0.0521364986505167
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRC1,Macrophage mannose receptor 1,11690,85,0.66 [0.31-1.42],0.2900674529321183
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRI1,Methylthioribose-1-phosphate isomerase,11351,84,0.95 [0.70-1.28],0.7402965291643807
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL24,"39S ribosomal protein L24, mitochondrial",11332,84,1.09 [0.68-1.75],0.7093325526318502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL28,"39S ribosomal protein L28, mitochondrial",11674,86,0.89 [0.47-1.67],0.7104320230366155
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL46,"39S ribosomal protein L46, mitochondrial",13156,97,0.83 [0.42-1.65],0.5974670008158103
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL52,"39S ribosomal protein L52, mitochondrial",11255,84,1.25 [0.58-2.71],0.5709129704119469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",11674,86,0.60 [0.41-0.89],0.0116461121052688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPS16,"28S ribosomal protein S16, mitochondrial",11358,82,1.78 [1.12-2.83],0.0154544233108495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSLN,Mesothelin,13415,102,0.93 [0.65-1.34],0.7061396605015051
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSLNL,Mesothelin-like protein,11351,84,0.59 [0.32-1.10],0.0965285024166228
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSMB,Beta-microseminoprotein,13446,102,1.07 [0.83-1.39],0.5962974296489667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSR1,Macrophage scavenger receptor types I and II,13626,102,0.82 [0.57-1.19],0.2950581127091652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSRA,Mitochondrial peptide methionine sulfoxide reductase,13527,102,0.84 [0.66-1.06],0.1397700972523936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MST1,Hepatocyte growth factor-like protein,11510,84,0.96 [0.70-1.31],0.7859105507283461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSTN,Growth/differentiation factor 8,13267,101,0.94 [0.66-1.33],0.7127017134190669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTDH,Protein LYRIC,11358,82,0.91 [0.72-1.16],0.442019206518769
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",11656,85,0.63 [0.25-1.55],0.3131075214504718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,11438,86,0.87 [0.72-1.05],0.1572638189234319
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTIF3,"Translation initiation factor IF-3, mitochondrial",11626,86,0.95 [0.75-1.20],0.672278596124003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTPN,Myotrophin,13267,101,1.15 [0.72-1.85],0.5623985941568139
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTR,Methionine synthase,11332,84,0.84 [0.57-1.22],0.3487411228081983
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTSS1,Protein MTSS 1,11626,86,0.83 [0.69-1.00],0.0494166445049861
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTSS2,Protein MTSS 2,11611,85,0.94 [0.76-1.16],0.582093599957644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTUS1,Microtubule-associated tumor suppressor 1,11438,86,0.87 [0.60-1.28],0.4862672039526172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUC13,Mucin-13,13156,97,0.71 [0.49-1.04],0.0783931940709167
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUC16,Mucin-16,13429,102,1.11 [1.00-1.23],0.0462304895760739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUC2,Mucin-2,11671,86,0.99 [0.79-1.24],0.9417753080907888
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUCL3,Mucin-like protein 3,11269,84,0.90 [0.55-1.48],0.670549360419465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MVK,Mevalonate kinase,13235,101,0.93 [0.73-1.17],0.5331415520925877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MXRA8,Matrix remodeling-associated protein 8,11422,85,0.57 [0.30-1.08],0.0868760632417436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYBPC1,"Myosin-binding protein C, slow-type",11692,85,0.97 [0.69-1.36],0.859780003589208
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYBPC2,"Myosin-binding protein C, fast-type",11368,85,0.94 [0.72-1.23],0.6521781255021865
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,11674,86,0.84 [0.61-1.15],0.2774505069209903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYDGF,Myeloid-derived growth factor,11692,85,0.93 [0.76-1.14],0.4708105130419487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYH4,Myosin-4,11332,84,0.77 [0.45-1.31],0.3300752161561366
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYH7B,Myosin-7B,11269,84,0.89 [0.54-1.47],0.6425646527738897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYH9,Myosin-9,11671,86,0.90 [0.75-1.08],0.2683531218664945
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",11332,84,0.84 [0.47-1.47],0.535418092881037
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL3,Myosin light chain 3,11368,85,1.01 [0.75-1.37],0.9283905153440928
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL4,Myosin light chain 4,11368,85,0.96 [0.65-1.43],0.8560367726093814
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL6B,Myosin light chain 6B,11351,84,0.77 [0.58-1.03],0.0764582006182507
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",11351,84,0.67 [0.36-1.25],0.2064817635850873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYO6,Unconventional myosin-VI,11674,86,0.49 [0.24-0.97],0.0419735062793832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYO9B,Unconventional myosin-IXb,13235,101,0.74 [0.55-1.00],0.0504586044609998
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOC,Myocilin,13496,100,0.60 [0.41-0.88],0.0085992443452849
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOM1,Myomesin-1,11347,80,1.14 [0.75-1.73],0.5398935101215058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOM2,Myomesin-2,11332,84,0.80 [0.49-1.31],0.3804319916842766
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOM3,Myomesin-3,11422,85,1.09 [0.87-1.36],0.4669319322591524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MZB1,Marginal zone B- and B1-cell-specific protein,13539,104,1.06 [0.75-1.51],0.7399241352856958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MZT1,Mitotic-spindle organizing protein 1,13187,100,0.73 [0.50-1.07],0.1050462306968389
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAA10,N-alpha-acetyltransferase 10,11332,84,0.80 [0.53-1.20],0.2734038422209947
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAA80,N-alpha-acetyltransferase 80,11351,84,0.88 [0.74-1.05],0.1601630906160732
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAAA,N-acylethanolamine-hydrolyzing acid amidase,13349,102,0.74 [0.54-1.00],0.0537331375033413
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NACC1,Nucleus accumbens-associated protein 1,11611,85,0.75 [0.49-1.13],0.1634380930530268
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NADK,NAD kinase,13500,104,1.00 [0.74-1.37],0.9829666659341852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAGA,Alpha-N-acetylgalactosaminidase,11338,82,0.83 [0.56-1.24],0.3645705009072404
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAGK,N-acetyl-D-glucosamine kinase,11344,85,0.93 [0.64-1.34],0.681774512602894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,11422,85,1.25 [0.47-3.37],0.6534557897912453
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAMPT,Nicotinamide phosphoribosyltransferase,13187,100,0.84 [0.58-1.22],0.3614706451255849
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAP1L4,Nucleosome assembly protein 1-like 4,11612,86,0.96 [0.59-1.55],0.8553254038532434
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAPRT,Nicotinate phosphoribosyltransferase,11656,85,0.79 [0.41-1.55],0.4965029055133785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NARS1,"Asparagine--tRNA ligase, cytoplasmic",11674,86,0.86 [0.56-1.31],0.4758612077545069
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NBL1,Neuroblastoma suppressor of tumorigenicity 1,13527,102,0.49 [0.25-0.96],0.0374918313481929
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NBN,Nibrin,13235,101,0.74 [0.49-1.11],0.143939883331332
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCAM1,Neural cell adhesion molecule 1,13507,102,0.93 [0.50-1.76],0.8348375103949457
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCAM2,Neural cell adhesion molecule 2,13496,100,1.17 [0.61-2.24],0.6452904162668025
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCAN,Neurocan core protein,13626,102,0.73 [0.46-1.16],0.1800332446133407
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCF2,Neutrophil cytosol factor 2,13467,101,0.99 [0.81-1.22],0.9319988019715552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCK2,Cytoplasmic protein NCK2,13555,104,0.90 [0.76-1.06],0.2129152214762417
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCLN,Nicalin,13235,101,0.89 [0.62-1.27],0.5074069928468168
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCR1,Natural cytotoxicity triggering receptor 1,13463,101,0.67 [0.41-1.10],0.1172102306817328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,11626,86,0.81 [0.42-1.54],0.5153074725462745
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCS1,Neuronal calcium sensor 1,13620,100,0.39 [0.21-0.72],0.0029047963331319
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDRG1,Protein NDRG1,13156,97,0.74 [0.53-1.04],0.0804183657958794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,11611,85,0.89 [0.61-1.28],0.518592535971498
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,11335,82,0.79 [0.43-1.44],0.4343674759757359
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,11626,86,0.90 [0.71-1.13],0.3504456404505266
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",13187,100,0.82 [0.63-1.06],0.1262923633658802
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEB,Nebulin,11332,84,0.52 [0.26-1.05],0.0679748532838958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECAP2,Adaptin ear-binding coat-associated protein 2,11332,84,0.92 [0.66-1.27],0.6053801310210386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECTIN1,Nectin-1,11358,82,0.99 [0.51-1.92],0.9792942166467482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECTIN2,Nectin-2,13482,104,0.60 [0.31-1.14],0.1154912153722987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECTIN4,Nectin-4,13527,102,0.77 [0.40-1.46],0.4200109527483252
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,11358,82,0.92 [0.59-1.41],0.689226809767109
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEDD9,Enhancer of filamentation 1,11358,82,0.62 [0.30-1.28],0.1982270674007696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEFL,Neurofilament light polypeptide,13112,97,0.86 [0.54-1.36],0.5137365352731267
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEK7,Serine/threonine-protein kinase Nek7,11438,86,0.85 [0.62-1.17],0.325517670080927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NELL1,Protein kinase C-binding protein NELL1,13527,102,0.97 [0.63-1.49],0.8792911984419354
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NELL2,Protein kinase C-binding protein NELL2,13555,104,0.41 [0.22-0.76],0.0049268040034199
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NENF,Neudesin,11611,85,0.99 [0.82-1.19],0.8930129850323388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEO1,Neogenin,11674,86,0.62 [0.23-1.64],0.3348757940158734
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEXN,Nexilin,11690,85,0.98 [0.72-1.33],0.9031190347149431
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFASC,Neurofascin,13652,101,0.98 [0.50-1.89],0.9421878801197472
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFAT5,Nuclear factor of activated T-cells 5,11358,82,0.79 [0.60-1.04],0.0881073520047901
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",13483,101,0.85 [0.71-1.03],0.0899891750063537
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",13235,101,0.83 [0.60-1.15],0.2627127416399399
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFE2,Transcription factor NF-E2 45 kDa subunit,11368,85,0.84 [0.63-1.12],0.2314730421802416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFIC,Nuclear factor 1 C-type,11674,86,0.73 [0.40-1.36],0.3217092864596723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFKB1,Nuclear factor NF-kappa-B p105 subunit,11332,84,0.87 [0.65-1.16],0.3360593809110089
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFKB2,Nuclear factor NF-kappa-B p100 subunit,11438,86,0.66 [0.39-1.13],0.1298770826786691
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFKBIE,NF-kappa-B inhibitor epsilon,13187,100,0.57 [0.38-0.85],0.0060311780984524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",11626,86,0.96 [0.79-1.17],0.6975630367227822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFX1,Transcriptional repressor NF-X1,11332,84,1.00 [0.73-1.38],0.9802130144098864
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFYA,Nuclear transcription factor Y subunit alpha,11332,84,1.32 [0.85-2.05],0.2168476572828957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NGF,Beta-nerve growth factor,13411,102,0.45 [0.11-1.85],0.2690073540299704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NGFR,Tumor necrosis factor receptor superfamily member 16,11692,85,0.44 [0.20-0.99],0.047558241402293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NGRN,Neugrin,11656,85,0.81 [0.30-2.15],0.66903935225551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NHLRC3,NHL repeat-containing protein 3,11132,84,0.75 [0.39-1.45],0.4001520257660128
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NID1,Nidogen-1,13468,102,1.13 [0.73-1.76],0.5808467214527169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NID2,Nidogen-2,13496,100,1.09 [0.86-1.38],0.4817174282881532
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NINJ1,Ninjurin-1,13187,100,0.86 [0.61-1.21],0.3802268120220722
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NIT1,Deaminated glutathione amidase,11368,85,0.86 [0.57-1.30],0.473415381873876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NIT2,Omega-amidase NIT2,11656,84,0.87 [0.67-1.14],0.3062028584687287
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NLGN1,Neuroligin-1,11351,84,1.02 [0.76-1.38],0.8777184208829856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NLGN2,Neuroligin-2,11347,80,0.92 [0.58-1.47],0.7383874163433315
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NME1,Nucleoside diphosphate kinase A,11358,82,1.04 [0.39-2.78],0.9303236203217043
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NME3,Nucleoside diphosphate kinase 3,13518,104,0.45 [0.20-0.99],0.046205646764723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMI,N-myc-interactor,11569,85,0.95 [0.71-1.26],0.7043213165611939
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,13411,102,0.98 [0.77-1.24],0.8567895480698084
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMRK2,Nicotinamide riboside kinase 2,11269,84,0.54 [0.27-1.07],0.0780729076860791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,11674,86,0.91 [0.66-1.27],0.577003962325733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOMO1,Nodal modulator 1,13496,100,1.01 [0.49-2.10],0.9799452655841526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOP56,Nucleolar protein 56,11332,84,0.97 [0.80-1.18],0.7486509473075771
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOS1,"Nitric oxide synthase, brain",13156,97,0.94 [0.65-1.35],0.7360616811829236
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOS2,"Nitric oxide synthase, inducible",11332,84,0.90 [0.52-1.55],0.7008698330172269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOS3,"Nitric oxide synthase, endothelial",13156,97,0.84 [0.58-1.22],0.3694071806955794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOTCH1,Neurogenic locus notch homolog protein 1,13658,103,0.42 [0.13-1.29],0.1279076451660779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOTCH2,Neurogenic locus notch homolog protein 2,11671,86,0.99 [0.39-2.48],0.9758222360537272
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOTCH3,Neurogenic locus notch homolog protein 3,13658,103,0.59 [0.36-0.98],0.0401847386462079
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPC2,NPC intracellular cholesterol transporter 2,11483,86,0.52 [0.26-1.04],0.0630007241439386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPDC1,Neural proliferation differentiation and control protein 1,13500,104,0.65 [0.35-1.23],0.1860424172670265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPHS1,Nephrin,11358,82,0.64 [0.33-1.25],0.1940510598600264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPHS2,Podocin,11358,82,0.85 [0.67-1.07],0.1658205819125808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPL,N-acetylneuraminate lyase,11692,85,0.87 [0.53-1.42],0.585224068148855
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPPB,Natriuretic peptides B,13267,101,1.01 [0.88-1.16],0.8870627599183171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPPC,C-type natriuretic peptide,13483,101,0.73 [0.47-1.14],0.1639585815237367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPR1,Atrial natriuretic peptide receptor 1,11332,84,0.72 [0.40-1.31],0.2818857094493713
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTN,Neuroplastin,13187,100,0.90 [0.71-1.14],0.3703510711313824
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTX1,Neuronal pentraxin-1,13496,100,0.70 [0.44-1.11],0.1330906511383508
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTX2,Neuronal pentraxin-2,11671,86,1.14 [0.61-2.12],0.6739188038788597
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTXR,Neuronal pentraxin receptor,13500,104,0.94 [0.56-1.58],0.8040172195699445
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPY,Pro-neuropeptide Y,13620,100,0.84 [0.65-1.08],0.1813620241252006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRCAM,Neuronal cell adhesion molecule,13500,104,0.64 [0.33-1.21],0.1693158486002447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRGN,Neurogranin,11690,85,0.91 [0.72-1.14],0.400575400167742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRN1,Neuritin,11674,86,0.55 [0.26-1.16],0.1147647667740643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRP1,Neuropilin-1,13536,102,1.91 [1.04-3.50],0.0374550230216675
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRP2,Neuropilin-2,13496,100,0.80 [0.43-1.48],0.4765532408268624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRTN,Neurturin,13235,101,1.23 [0.89-1.69],0.2021943660720101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRXN3,Neurexin-3,11351,84,0.75 [0.38-1.48],0.4006880598283449
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NSFL1C,NSFL1 cofactor p47,13626,102,0.81 [0.62-1.05],0.1113610331122203
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",11692,85,0.82 [0.62-1.07],0.1454635917387171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5C1A,Cytosolic 5'-nucleotidase 1A,11656,85,0.57 [0.27-1.20],0.1354767632673547
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5C3A,Cytosolic 5'-nucleotidase 3A,13465,101,0.87 [0.72-1.06],0.1711606606987197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5E,5'-nucleotidase,13527,102,1.15 [0.86-1.54],0.3585981033400376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTF3,Neurotrophin-3,13483,101,0.57 [0.34-0.96],0.0352561985470169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTF4,Neurotrophin-4,13187,100,0.91 [0.56-1.48],0.7018409544143702
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTRK2,BDNF/NT-3 growth factors receptor,13500,104,0.56 [0.28-1.09],0.0894472553444969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTRK3,NT-3 growth factor receptor,13626,102,0.64 [0.29-1.43],0.2782209571768032
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTproBNP,N-terminal prohormone of brain natriuretic peptide,13500,104,0.98 [0.81-1.19],0.8259126735241458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUB1,NEDD8 ultimate buster 1,13483,101,0.90 [0.72-1.11],0.3213476168584714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,11611,85,0.87 [0.69-1.10],0.2315961938078738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUCB2,Nucleobindin-2,13595,100,0.63 [0.39-1.03],0.0653522324963236
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDC,Nuclear migration protein nudC,13652,101,0.89 [0.68-1.16],0.3951881157127831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,11368,85,1.14 [0.56-2.32],0.7120821008584852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,11332,84,0.58 [0.34-0.98],0.0413788567784187
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT16,U8 snoRNA-decapping enzyme,11607,85,0.88 [0.69-1.11],0.2738782834222152
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],13429,102,1.00 [0.74-1.35],0.9799190425031328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT5,ADP-sugar pyrophosphatase,13496,100,0.88 [0.62-1.23],0.450417880165751
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUMB,Protein numb homolog,11358,82,0.87 [0.68-1.12],0.2883158464684987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUP50,Nuclear pore complex protein Nup50,11332,84,1.09 [0.60-1.97],0.7713753540845598
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NXPE4,NXPE family member 4,11332,84,0.95 [0.52-1.74],0.8647717664008072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NXPH1,Neurexophilin-1,13156,97,0.84 [0.51-1.40],0.5141287898890725
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NXPH3,Neurexophilin-3,11358,82,0.58 [0.29-1.15],0.1157862243011658
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OBP2B,Odorant-binding protein 2b,13367,102,1.07 [0.82-1.39],0.617870675310164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OCLN,Occludin,11674,86,0.62 [0.37-1.03],0.0658096556623227
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ODAM,Odontogenic ameloblast-associated protein,13137,97,0.68 [0.46-1.02],0.0603558061980332
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OFD1,Oral-facial-digital syndrome 1 protein,11438,86,0.91 [0.65-1.27],0.5655393844450325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGA,Protein O-GlcNAcase,11626,86,0.92 [0.69-1.23],0.5787067468341116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGFR,Opioid growth factor receptor,13429,102,0.68 [0.40-1.18],0.1719956897365831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGN,Mimecan,13496,100,0.81 [0.51-1.28],0.3650691953662422
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,11438,86,0.76 [0.51-1.12],0.1670654844412346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OLFM4,Olfactomedin-4,10996,83,0.95 [0.80-1.13],0.592142186092456
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OLR1,Oxidized low-density lipoprotein receptor 1,13355,100,1.15 [0.87-1.52],0.3248429820948376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OMD,Osteomodulin,13555,104,0.78 [0.54-1.12],0.184577884621282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OMG,Oligodendrocyte-myelin glycoprotein,13429,102,0.82 [0.62-1.09],0.1673554882074354
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OMP,Olfactory marker protein,11347,80,1.08 [0.72-1.60],0.7167058202207399
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OPHN1,Oligophrenin-1,11656,85,0.91 [0.75-1.11],0.3506811500982369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OPLAH,5-oxoprolinase,11368,85,0.81 [0.59-1.11],0.1955908822997341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OPTC,Opticin,13429,102,0.70 [0.46-1.07],0.1035864010849622
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ORM1,Alpha-1-acid glycoprotein 1,11662,86,1.21 [0.44-3.36],0.7148961847988233
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSBPL2,Oxysterol-binding protein-related protein 2,11656,85,1.21 [0.80-1.83],0.359708147438611
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSCAR,Osteoclast-associated immunoglobulin-like receptor,13518,104,1.06 [0.63-1.79],0.8359903070649014
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSM,Oncostatin-M,13409,98,0.95 [0.75-1.22],0.6975020691318072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSMR,Oncostatin-M-specific receptor subunit beta,13536,102,1.30 [0.57-2.97],0.5307361090360936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSTN,Osteocrin,11351,84,0.58 [0.31-1.10],0.0956233581080818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OTOA,Otoancorin,11347,80,0.69 [0.41-1.15],0.1513731439401383
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OTUD6B,Deubiquitinase OTUD6B,11626,86,0.84 [0.59-1.19],0.3272760236934561
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OTUD7B,OTU domain-containing protein 7B,11674,86,0.76 [0.55-1.06],0.1085203835744655
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",11368,85,1.13 [0.84-1.51],0.4306982469598657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OXT,Oxytocin-neurophysin 1,13626,102,0.95 [0.83-1.08],0.4391535993543392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",P4HB,Protein disulfide-isomerase,13420,102,0.87 [0.55-1.38],0.5564706469625007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PACS2,Phosphofurin acidic cluster sorting protein 2,11332,84,0.76 [0.53-1.08],0.1284799032800859
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PADI2,Protein-arginine deiminase type-2,13235,101,0.72 [0.49-1.07],0.1005433586995071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PADI4,Protein-arginine deiminase type-4,13137,97,1.03 [0.81-1.31],0.7996998271190303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAEP,Glycodelin,13411,102,1.04 [0.93-1.17],0.4854500936792179
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,11674,86,0.86 [0.69-1.06],0.1609077885665194
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",11438,86,0.77 [0.50-1.20],0.2557088957447544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,13267,101,0.90 [0.65-1.24],0.5221641775443369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAGR1,PAXIP1-associated glutamate-rich protein 1,11368,85,0.76 [0.46-1.27],0.2972932349936314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,11246,84,0.99 [0.66-1.47],0.9485158512632867
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAK4,Serine/threonine-protein kinase PAK 4,13156,97,1.02 [0.76-1.37],0.8817593921046398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALLD,Palladin,11358,82,0.60 [0.31-1.15],0.1227081487753459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALM,Paralemmin-1,11569,85,0.84 [0.41-1.73],0.6429389376104091
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALM2,Paralemmin-2,11656,85,0.61 [0.33-1.11],0.1059138579367643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALM3,Paralemmin-3,11332,84,0.82 [0.58-1.17],0.2806772839274326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAM,Peptidyl-glycine alpha-amidating monooxygenase,13581,103,0.60 [0.34-1.05],0.0749261974425617
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAMR1,Inactive serine protease PAMR1,13496,100,1.02 [0.54-1.92],0.947746834303178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAPPA,Pappalysin-1,13235,101,0.89 [0.61-1.30],0.5481510491197805
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PARD3,Partitioning defective 3 homolog,11438,86,0.82 [0.60-1.12],0.2083631561422918
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PARK7,Parkinson disease protein 7,13496,100,0.88 [0.64-1.22],0.4493056911188217
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PARP1,Poly [ADP-ribose] polymerase 1,13483,101,0.79 [0.53-1.16],0.2315862090159811
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAXX,Protein PAXX,11422,85,0.69 [0.44-1.08],0.1035666659660705
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PBK,Lymphokine-activated killer T-cell-originated protein kinase,11269,84,0.96 [0.49-1.90],0.9166637325449238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PBLD,Phenazine biosynthesis-like domain-containing protein,13156,97,0.99 [0.69-1.42],0.9492449807815252
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,11626,86,0.76 [0.37-1.57],0.4633248410191847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCARE,Photoreceptor cilium actin regulator,11347,80,0.75 [0.54-1.05],0.0934379472441428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,11393,85,0.91 [0.57-1.46],0.6958771045422727
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCBP2,Poly(rC)-binding protein 2,11674,86,0.78 [0.58-1.04],0.0945505536767586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH1,Protocadherin-1,13610,100,0.54 [0.22-1.36],0.1894014061615412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH12,Protocadherin-12,11674,86,0.52 [0.23-1.19],0.1205093155727689
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH17,Protocadherin-17,13500,104,0.84 [0.50-1.41],0.5034797486141812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH7,Protocadherin-7,11626,86,0.65 [0.32-1.31],0.2312602826933951
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH9,Protocadherin-9,11626,86,0.91 [0.49-1.67],0.7576735868946054
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDHB15,Protocadherin beta-15,11611,85,0.89 [0.53-1.51],0.6679707347087517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCNA,Proliferating cell nuclear antigen,11269,84,0.83 [0.56-1.22],0.3489072628410616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCSK7,Proprotein convertase subtilisin/kexin type 7,11611,85,1.02 [0.65-1.61],0.9247000564858066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCSK9,Proprotein convertase subtilisin/kexin type 9,13658,103,0.80 [0.51-1.25],0.3219324525910902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCYT2,Ethanolamine-phosphate cytidylyltransferase,11626,86,0.89 [0.68-1.16],0.3854117317813612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDAP1,28 kDa heat- and acid-stable phosphoprotein,11692,85,0.93 [0.75-1.14],0.4674116799652086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD1,Programmed cell death protein 1,13603,100,0.68 [0.43-1.08],0.1005148509660097
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD1LG2,Programmed cell death 1 ligand 2,13429,102,1.09 [0.62-1.92],0.7558621653600719
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD5,Programmed cell death protein 5,13626,102,0.82 [0.61-1.11],0.2042012673090353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD6,Programmed cell death protein 6,13500,104,0.98 [0.77-1.26],0.899616838098652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCL2,Phosducin-like protein 2,11269,84,1.00 [0.68-1.46],0.9944888120400348
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",11269,84,0.79 [0.50-1.24],0.2995302503351454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",11332,84,0.88 [0.60-1.28],0.4922590593008006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",11422,85,0.91 [0.75-1.10],0.3342259721933593
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFA,Platelet-derived growth factor subunit A,13658,103,0.86 [0.68-1.09],0.207689864651595
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFB,Platelet-derived growth factor subunit B,13555,104,0.87 [0.71-1.05],0.1449644766999746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFC,Platelet-derived growth factor C,13187,100,0.87 [0.47-1.60],0.6586434473976468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFRA,Platelet-derived growth factor receptor alpha,13500,104,0.77 [0.42-1.43],0.4153970098901061
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFRB,Platelet-derived growth factor receptor beta,13658,103,0.81 [0.50-1.31],0.3793359545502379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA2,Protein disulfide-isomerase A2,11269,84,0.91 [0.52-1.58],0.7421939788440386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA3,Protein disulfide-isomerase A3,11422,85,0.88 [0.38-2.04],0.7642992998028639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA4,Protein disulfide-isomerase A4,11671,86,0.98 [0.70-1.37],0.9029061273147436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA5,Protein disulfide-isomerase A5,11269,84,0.71 [0.48-1.06],0.0937380457766925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDLIM5,PDZ and LIM domain protein 5,11674,86,0.91 [0.77-1.08],0.2978957558419632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDLIM7,PDZ and LIM domain protein 7,13555,104,0.90 [0.79-1.03],0.1378606196989421
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",13187,100,0.91 [0.64-1.31],0.6234083865063024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDRG1,p53 and DNA damage-regulated protein 1,11351,84,0.75 [0.48-1.19],0.2239164850615467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,11269,84,0.52 [0.28-0.97],0.0400738975664469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDZD2,PDZ domain-containing protein 2,11332,84,0.80 [0.55-1.17],0.256657140336565
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,11358,82,0.81 [0.47-1.37],0.4287143974201539
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PEAR1,Platelet endothelial aggregation receptor 1,13658,103,0.47 [0.23-0.98],0.0441921860249466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PEBP1,Phosphatidylethanolamine-binding protein 1,13496,100,0.85 [0.63-1.14],0.2738175313157172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PECAM1,Platelet endothelial cell adhesion molecule,13496,100,0.64 [0.35-1.17],0.1462858212738667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PECR,Peroxisomal trans-2-enoyl-CoA reductase,11368,85,0.79 [0.36-1.71],0.5506718063316197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PENK,Proenkephalin-A,11422,85,0.69 [0.33-1.46],0.3353578089109301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PEPD,Xaa-Pro dipeptidase,11690,85,1.05 [0.46-2.37],0.9134943306107934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PER3,Period circadian protein homolog 3,11358,82,0.94 [0.78-1.13],0.513935194455887
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PF4,Platelet factor 4,11613,84,0.89 [0.72-1.10],0.2788216383384494
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFDN2,Prefoldin subunit 2,13156,97,1.19 [0.89-1.60],0.2405063553375581
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFDN4,Prefoldin subunit 4,11269,84,0.81 [0.53-1.24],0.3385830826657396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFDN6,Prefoldin subunit 6,11351,84,0.86 [0.61-1.23],0.4191978546683952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",13410,101,0.82 [0.65-1.03],0.0845220182849112
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGA4,Pepsin A-4,11690,85,1.70 [1.23-2.35],0.0011712112941631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",11692,85,0.77 [0.52-1.13],0.1745585880019608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGF,Placenta growth factor,13652,101,0.64 [0.30-1.39],0.2637841098589557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGLYRP1,Peptidoglycan recognition protein 1,13579,100,1.20 [0.81-1.79],0.3687727457339468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,11545,86,1.33 [0.69-2.56],0.4021326545040919
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGLYRP4,Peptidoglycan recognition protein 4,11332,84,0.99 [0.71-1.37],0.9293918379116328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGM2,Phosphoglucomutase-2,11351,84,0.66 [0.41-1.06],0.0844308290145276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGR,Progesterone receptor,11358,82,0.98 [0.80-1.19],0.8081841552756167
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHACTR2,Phosphatase and actin regulator 2,11674,86,0.87 [0.73-1.04],0.1204250740278042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHLDB1,Pleckstrin homology-like domain family B member 1,11626,86,1.05 [0.72-1.54],0.7831312150237293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHLDB2,Pleckstrin homology-like domain family B member 2,11269,84,0.94 [0.74-1.20],0.6315922832131243
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,13411,102,0.79 [0.44-1.43],0.432809738489218
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,11422,85,0.83 [0.51-1.37],0.468882237729476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PI16,Peptidase inhibitor 16,11690,85,0.76 [0.33-1.77],0.5254037556981312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PI3,Elafin,13306,98,0.97 [0.68-1.38],0.8647201408261881
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",11674,86,0.75 [0.57-0.98],0.0368785410619232
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIGR,Polymeric immunoglobulin receptor,13328,100,1.34 [0.81-2.22],0.2517500498176661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,13483,101,1.04 [0.79-1.38],0.7797223244685416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,13496,100,0.43 [0.21-0.91],0.0272738780242995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,11358,82,0.81 [0.54-1.22],0.3059538577678362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PILRA,Paired immunoglobulin-like type 2 receptor alpha,13496,100,0.72 [0.48-1.09],0.1221622154036714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PILRB,Paired immunoglobulin-like type 2 receptor beta,13500,104,0.78 [0.58-1.03],0.0833645985322504
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,11422,85,0.96 [0.70-1.31],0.783631129856135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PITHD1,PITH domain-containing protein 1,11246,84,1.05 [0.83-1.33],0.6666635543877311
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKD1,Polycystin-1,11692,85,0.68 [0.31-1.49],0.3318863929302447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKD2,Polycystin-2,11332,84,0.68 [0.46-1.01],0.0591984576691333
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKLR,Pyruvate kinase PKLR,13506,104,1.09 [0.85-1.40],0.4880367308029951
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKN3,Serine/threonine-protein kinase N3,11438,86,0.75 [0.56-1.01],0.0578716998309239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G10,Group 10 secretory phospholipase A2,13411,102,0.95 [0.71-1.27],0.7299231401754344
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G15,Phospholipase A2 group XV,13527,102,0.71 [0.36-1.43],0.3391679574180304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G1B,Phospholipase A2,13632,103,0.92 [0.60-1.41],0.7001095413195579
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G2A,"Phospholipase A2, membrane associated",13455,101,0.82 [0.59-1.15],0.2484740932126323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G4A,Cytosolic phospholipase A2,13555,104,0.90 [0.74-1.10],0.3046893626906258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G7,Platelet-activating factor acetylhydrolase,13496,100,1.41 [0.78-2.56],0.2595075886690259
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLAT,Tissue-type plasminogen activator,13607,100,0.89 [0.62-1.27],0.5150502835446361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLAU,Urokinase-type plasminogen activator,13496,100,0.79 [0.42-1.45],0.4426362618268999
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLAUR,Urokinase plasminogen activator surface receptor,13402,101,0.85 [0.42-1.71],0.6398596312603968
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLB1,"Phospholipase B1, membrane-associated",11656,85,0.96 [0.69-1.35],0.8216635226992298
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",11358,82,0.90 [0.56-1.44],0.6544036211456092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",11656,85,0.81 [0.66-1.00],0.054358444099051
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLEKHO1,Pleckstrin homology domain-containing family O member 1,11656,85,0.87 [0.64-1.18],0.363966730305962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLG,Plasminogen,11381,83,1.79 [0.89-3.62],0.1038279599235666
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLIN1,Perilipin-1,13156,97,0.86 [0.50-1.48],0.5754004368604928
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLIN3,Perilipin-3,13500,104,0.74 [0.49-1.12],0.1518817483686363
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLPBP,Pyridoxal phosphate homeostasis protein,13500,104,0.86 [0.67-1.11],0.2522949044540282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLSCR3,Phospholipid scramblase 3,11644,85,0.81 [0.57-1.14],0.2327949511826842
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLTP,Phospholipid transfer protein,13601,103,1.12 [0.67-1.87],0.6703567569822864
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXDC1,Plexin domain-containing protein 1,13187,100,0.58 [0.31-1.08],0.0851445093254303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXDC2,Plexin domain-containing protein 2,11656,85,0.75 [0.34-1.66],0.4767833856215148
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXNA4,Plexin-A4,13483,101,0.85 [0.69-1.05],0.1235787351605476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXNB2,Plexin-B2,13593,100,0.60 [0.27-1.30],0.192129324412873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXNB3,Plexin-B3,13458,104,0.85 [0.58-1.23],0.3794356288240643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,13443,104,0.98 [0.89-1.08],0.6787353221438893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMCH,Pro-MCH,11332,84,0.65 [0.43-0.97],0.0340050148023481
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMM2,Phosphomannomutase 2,11332,84,0.85 [0.59-1.21],0.3567456802289593
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMS1,PMS1 protein homolog 1,11351,84,0.54 [0.33-0.87],0.0114616407214987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMVK,Phosphomevalonate kinase,13135,97,0.92 [0.79-1.07],0.2796278041863937
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNLIP,Pancreatic triacylglycerol lipase,11690,85,0.85 [0.60-1.22],0.3863453987008854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNLIPRP1,Inactive pancreatic lipase-related protein 1,11656,85,0.85 [0.65-1.13],0.2657787590606834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNLIPRP2,Pancreatic lipase-related protein 2,13493,104,0.97 [0.92-1.03],0.2912204293148918
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNMA1,Paraneoplastic antigen Ma1,11368,85,0.75 [0.51-1.12],0.1584462773054862
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNMA2,Paraneoplastic antigen Ma2,11347,80,0.75 [0.45-1.27],0.2886395413228622
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",13235,101,1.02 [0.89-1.17],0.7386869678602608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PODXL,Podocalyxin,13429,102,0.54 [0.17-1.68],0.2897556285845484
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PODXL2,Podocalyxin-like protein 2,13527,102,0.75 [0.39-1.43],0.378321334179555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POF1B,Protein POF1B,11358,82,1.04 [0.66-1.64],0.8764187384360167
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POLR2A,DNA-directed RNA polymerase II subunit RPB1,11358,82,0.57 [0.26-1.24],0.1546553468738426
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",13429,102,0.69 [0.37-1.26],0.2264155591169617
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POMC,Pro-opiomelanocortin,11368,85,1.07 [0.78-1.46],0.6686272844660588
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PON1,Serum paraoxonase/arylesterase 1,11690,85,0.63 [0.31-1.29],0.2067443993881058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PON2,Serum paraoxonase/arylesterase 2,13267,101,0.82 [0.49-1.38],0.4518892848683241
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PON3,Serum paraoxonase/lactonase 3,13555,104,0.70 [0.48-1.01],0.0534746733517585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POSTN,Periostin,11671,86,1.67 [1.00-2.78],0.0503598075026438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPBP,Platelet basic protein,11608,84,0.90 [0.71-1.15],0.394334186554704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPCDC,Phosphopantothenoylcysteine decarboxylase,13626,102,0.80 [0.56-1.16],0.2459053822451628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPIB,Peptidyl-prolyl cis-trans isomerase B,13483,100,0.89 [0.74-1.07],0.2224118664869046
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPIE,Peptidyl-prolyl cis-trans isomerase E,11438,86,1.10 [0.82-1.47],0.5422821022756534
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",11671,86,1.03 [0.74-1.43],0.8667656978929721
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPL,Periplakin,11358,82,0.67 [0.34-1.33],0.2530604009237437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPM1A,Protein phosphatase 1A,13187,100,0.84 [0.46-1.53],0.5630169586592664
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPM1B,Protein phosphatase 1B,11358,82,1.00 [0.73-1.37],0.9964459368199028
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPM1F,Protein phosphatase 1F,11692,85,0.85 [0.57-1.26],0.4219213257225417
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPME1,Protein phosphatase methylesterase 1,13429,102,0.78 [0.59-1.03],0.084789827613227
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,11611,85,0.80 [0.62-1.04],0.0997865658260179
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,13527,102,0.88 [0.73-1.06],0.1793534632134465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,11438,86,0.75 [0.53-1.06],0.1058212682087426
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,11674,86,0.78 [0.59-1.03],0.0755655574533275
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,11674,86,0.45 [0.23-0.87],0.017825290354339
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R2,Protein phosphatase inhibitor 2,13500,104,0.87 [0.70-1.09],0.2279128440773506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R9B,Neurabin-2,13652,101,0.87 [0.72-1.05],0.1519769823349057
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,11626,86,0.94 [0.79-1.12],0.5071709385447172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP3R1,Calcineurin subunit B type 1,13411,102,0.74 [0.48-1.12],0.1546763973667374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPT1,Palmitoyl-protein thioesterase 1,11351,84,0.76 [0.53-1.09],0.1325764006393934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPY,Pancreatic prohormone,13472,102,0.86 [0.72-1.02],0.0908128117798625
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PQBP1,Polyglutamine-binding protein 1,13187,100,0.97 [0.70-1.35],0.8606528141876908
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRAME,Melanoma antigen preferentially expressed in tumors,11269,84,0.64 [0.28-1.49],0.3020556666332756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRAP1,Proline-rich acidic protein 1,11671,86,0.67 [0.42-1.08],0.1000862968135004
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRC1,Protein regulator of cytokinesis 1,11611,85,1.23 [0.93-1.64],0.1523704577843286
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRCP,Lysosomal Pro-X carboxypeptidase,13568,103,0.69 [0.39-1.22],0.2033030027012516
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX1,Peroxiredoxin-1,13130,101,0.89 [0.72-1.09],0.2534507551243836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX2,Peroxiredoxin-2,11489,83,1.18 [0.86-1.62],0.2943374226828175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",13235,101,0.89 [0.70-1.14],0.3646911992343609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX5,"Peroxiredoxin-5, mitochondrial",13652,101,0.83 [0.66-1.04],0.1089023707621272
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX6,Peroxiredoxin-6,13620,100,0.88 [0.65-1.18],0.3952898996529654
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PREB,Prolactin regulatory element-binding protein,13235,101,0.90 [0.49-1.66],0.7437852953655291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRELP,Prolargin,13493,104,0.55 [0.34-0.90],0.0165260540242636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRG2,Bone marrow proteoglycan,11671,86,0.77 [0.51-1.15],0.1990992558084409
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRG3,Proteoglycan 3,11671,86,0.82 [0.55-1.22],0.3279157992747546
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,13235,101,0.82 [0.59-1.16],0.2604041915736608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,11351,84,0.42 [0.19-0.91],0.0273971626075843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,13500,104,0.87 [0.71-1.07],0.179595027155785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,11637,84,0.78 [0.61-1.00],0.0476365377356389
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKCQ,Protein kinase C theta type,13235,101,0.89 [0.59-1.36],0.6015200567557282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKD2,Serine/threonine-protein kinase D2,11332,84,0.90 [0.56-1.43],0.6450134546674414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKG1,cGMP-dependent protein kinase 1,11422,85,0.91 [0.77-1.07],0.2620986795623594
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,13187,100,0.94 [0.72-1.24],0.6697561545613544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRL,Prolactin,13626,102,0.98 [0.78-1.23],0.874213688292532
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRND,Prion-like protein doppel,11656,85,0.85 [0.57-1.27],0.4259553933344325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROC,Vitamin K-dependent protein C,13489,102,1.21 [0.61-2.43],0.5840560484266812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROCR,Endothelial protein C receptor,11332,84,0.52 [0.25-1.11],0.0921377068332184
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROK1,Prokineticin-1,13483,101,1.04 [0.82-1.32],0.7465232795488574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROS1,Vitamin K-dependent protein S,11702,87,1.56 [0.73-3.33],0.2520058495452781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRR4,Proline-rich protein 4,11352,85,0.94 [0.70-1.27],0.7020854230636057
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRR5,Proline-rich protein 5,11358,82,0.89 [0.56-1.42],0.6348740384509963
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRRT3,Proline-rich transmembrane protein 3,11368,85,0.67 [0.38-1.18],0.1669741936947323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS2,Trypsin-2,13507,102,0.92 [0.64-1.32],0.6488978484951129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS22,Brain-specific serine protease 4,11358,82,0.58 [0.28-1.19],0.1356341661572273
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS27,Serine protease 27,13449,101,0.96 [0.63-1.48],0.8579558046747134
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS53,Serine protease 53,11656,85,0.66 [0.38-1.15],0.1414582072708438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS8,Prostasin,13434,101,0.87 [0.55-1.37],0.5382829167829677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,13156,97,0.95 [0.81-1.11],0.481459127126248
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRTG,Protogenin,13620,100,0.60 [0.29-1.22],0.1588945724508678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRTN3,Myeloblastin,13138,98,0.92 [0.62-1.38],0.6970437213315548
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRUNE2,Protein prune homolog 2,11438,86,0.92 [0.44-1.91],0.8161593968435414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSAP,Prosaposin,11564,86,0.57 [0.26-1.23],0.1541209662729459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSAPL1,Proactivator polypeptide-like 1,11626,86,1.10 [0.73-1.66],0.6481721402221654
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSCA,Prostate stem cell antigen,11626,86,1.01 [0.93-1.10],0.7496909711180977
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSG1,Pregnancy-specific beta-1-glycoprotein 1,13411,102,0.96 [0.83-1.11],0.5678715380354733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSIP1,PC4 and SFRS1-interacting protein,13483,101,0.79 [0.57-1.08],0.1431284666651465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMA1,Proteasome subunit alpha type-1,13187,100,0.78 [0.52-1.18],0.2365076570770253
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMC3,26S proteasome regulatory subunit 6A,11269,84,0.98 [0.49-1.95],0.946064503964082
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMD1,26S proteasome non-ATPase regulatory subunit 1,11674,86,0.96 [0.63-1.45],0.8426727454229154
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMD5,26S proteasome non-ATPase regulatory subunit 5,11351,84,0.61 [0.37-1.01],0.0552129164494652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMD9,26S proteasome non-ATPase regulatory subunit 9,13429,102,0.90 [0.66-1.24],0.530347709830289
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSME1,Proteasome activator complex subunit 1,13393,102,0.89 [0.56-1.42],0.6308293888773411
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSME2,Proteasome activator complex subunit 2,13346,102,0.96 [0.60-1.53],0.8694069441936793
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMG3,Proteasome assembly chaperone 3,13483,101,0.95 [0.68-1.32],0.7527514718433874
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMG4,Proteasome assembly chaperone 4,11358,82,0.89 [0.61-1.29],0.5321278137051465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSPN,Persephin,13483,101,1.02 [0.85-1.21],0.8640682529299117
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSRC1,Proline/serine-rich coiled-coil protein 1,13187,100,0.96 [0.70-1.31],0.7845986878964604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,10988,82,0.87 [0.72-1.05],0.1380644291663011
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",13156,97,0.58 [0.32-1.05],0.0729070796329066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTGDS,Prostaglandin-H2 D-isomerase,13357,98,0.70 [0.36-1.39],0.3101374938690472
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTGES2,Prostaglandin E synthase 2,11271,82,0.89 [0.60-1.32],0.5659578358089221
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTGR1,Prostaglandin reductase 1,11692,85,1.04 [0.80-1.35],0.76298242128644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTH,Parathyroid hormone,11351,84,0.74 [0.56-0.98],0.0369381218205254
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,13483,101,1.01 [0.63-1.60],0.9821965614364896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTK7,Inactive tyrosine-protein kinase 7,13156,97,0.88 [0.54-1.42],0.5944717212874586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTN,Pleiotrophin,13267,101,0.75 [0.52-1.07],0.1103026527363471
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTP4A3,Protein tyrosine phosphatase type IVA 3,11358,82,0.98 [0.65-1.46],0.9114976144397684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,13411,102,0.86 [0.68-1.08],0.1851534012539068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,13534,104,0.92 [0.76-1.10],0.349103412048772
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,11332,82,0.76 [0.42-1.37],0.361072894935007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRB,Receptor-type tyrosine-protein phosphatase beta,11692,85,1.18 [0.59-2.36],0.6499691848261953
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRC,Receptor-type tyrosine-protein phosphatase C,11671,86,0.68 [0.27-1.68],0.4009826252898193
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRF,Receptor-type tyrosine-protein phosphatase F,13658,103,0.87 [0.48-1.59],0.6543732734950255
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRH,Receptor-type tyrosine-protein phosphatase H,11626,86,1.01 [0.66-1.56],0.9469462931226296
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,11626,86,1.88 [0.99-3.58],0.0540548587877952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRM,Receptor-type tyrosine-protein phosphatase mu,13457,101,0.60 [0.29-1.25],0.1730622056181371
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,13359,102,0.50 [0.28-0.89],0.018905608180068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRR,Receptor-type tyrosine-protein phosphatase R,11656,85,0.68 [0.37-1.25],0.2196447011498128
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRS,Receptor-type tyrosine-protein phosphatase S,13658,103,0.94 [0.46-1.92],0.8748236283548378
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,11692,85,0.64 [0.34-1.21],0.1698845475520846
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,11422,85,0.80 [0.57-1.13],0.2029005465935242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTS,6-pyruvoyl tetrahydrobiopterin synthase,13101,97,0.97 [0.69-1.36],0.869723521804023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTTG1,Securin,11438,86,0.88 [0.52-1.48],0.6183354962233226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTX3,Pentraxin-related protein PTX3,13483,101,1.02 [0.72-1.45],0.891108567003734
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PVALB,Parvalbumin alpha,13564,99,0.86 [0.74-1.00],0.0427201830845069
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PVR,Poliovirus receptor,13626,102,0.91 [0.56-1.46],0.687747266283365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PXDNL,Peroxidasin-like protein,11611,85,0.76 [0.49-1.19],0.2291930484428931
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PXN,Paxillin,13156,97,0.74 [0.51-1.07],0.1113548575938357
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PYDC1,Pyrin domain-containing protein 1,11368,85,0.87 [0.52-1.47],0.6129432633150136
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PYY,Peptide YY,11332,84,0.78 [0.61-1.00],0.047683592914838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PZP,Pregnancy zone protein,11702,87,0.77 [0.56-1.07],0.1151357410993865
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",QDPR,Dihydropteridine reductase,13442,103,0.96 [0.64-1.42],0.8241232654182643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",QPCT,Glutaminyl-peptide cyclotransferase,13498,100,0.72 [0.39-1.34],0.3001153189045467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",QSOX1,Sulfhydryl oxidase 1,11453,86,0.79 [0.43-1.45],0.4422800686536785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB10,Ras-related protein Rab-10,11692,85,0.71 [0.47-1.06],0.0909910072480724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB11FIP3,Rab11 family-interacting protein 3,11692,85,0.87 [0.72-1.05],0.1466428766214742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB27B,Ras-related protein Rab-27B,11692,85,0.82 [0.65-1.04],0.0967951414182789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB2B,Ras-related protein Rab-2B,11611,85,0.77 [0.54-1.08],0.1319642448885429
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB33A,Ras-related protein Rab-33A,11332,84,0.92 [0.67-1.26],0.5964816608978413
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB37,Ras-related protein Rab-37,13235,101,0.96 [0.78-1.19],0.7296978494382641
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB39B,Ras-related protein Rab-39B,11332,84,1.04 [0.84-1.29],0.7172477356491649
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,11347,80,0.89 [0.60-1.32],0.5615242371523733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB44,Ras-related protein Rab-44,11611,85,1.00 [0.62-1.59],0.9888806914926372
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB6A,Ras-related protein Rab-6A,13483,101,0.77 [0.53-1.12],0.1753423395664328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB6B,Ras-related protein Rab-6B,13156,97,1.01 [0.70-1.45],0.9472458529408504
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RABEP1,Rab GTPase-binding effector protein 1,11422,85,0.80 [0.61-1.05],0.1080659122674291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RABEPK,Rab9 effector protein with kelch motifs,13187,100,0.95 [0.70-1.27],0.7173769324137178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RABGAP1L,Rab GTPase-activating protein 1-like,13235,101,0.95 [0.71-1.28],0.7470245586393629
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAC3,Ras-related C3 botulinum toxin substrate 3,11351,84,0.81 [0.56-1.18],0.271635102245599
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAD23B,UV excision repair protein RAD23 homolog B,13187,100,0.85 [0.57-1.24],0.3942526856610387
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAD51,DNA repair protein RAD51 homolog 1,11438,86,0.79 [0.51-1.23],0.2951248457644911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RALB,Ras-related protein Ral-B,11358,82,1.35 [0.68-2.68],0.3892561859710106
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RALY,RNA-binding protein Raly,11611,85,0.75 [0.46-1.22],0.2512803048150912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RANBP1,Ran-specific GTPase-activating protein,11368,85,0.80 [0.54-1.19],0.2731957651290829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RANBP2,E3 SUMO-protein ligase RanBP2,11347,80,0.57 [0.29-1.13],0.1052417171772293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RANGAP1,Ran GTPase-activating protein 1,13187,100,0.74 [0.49-1.11],0.1458236955375103
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAP1A,Ras-related protein Rap-1A,11358,82,0.82 [0.57-1.18],0.2772990250764535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAPGEF2,Rap guanine nucleotide exchange factor 2,11438,86,0.74 [0.48-1.12],0.1566505138729123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RARRES1,Retinoic acid receptor responder protein 1,13187,100,0.66 [0.35-1.22],0.1830148456931372
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RARRES2,Retinoic acid receptor responder protein 2,13536,102,0.82 [0.56-1.21],0.3142106214693271
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RASA1,Ras GTPase-activating protein 1,13156,97,0.91 [0.53-1.57],0.7345238760397597
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,11269,84,1.01 [0.62-1.64],0.9801930113245044
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RASSF2,Ras association domain-containing protein 2,13187,100,0.89 [0.63-1.25],0.501826970985691
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBFOX3,RNA binding protein fox-1 homolog 3,11674,86,0.67 [0.36-1.25],0.2113105187976103
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBKS,Ribokinase,13172,101,1.16 [0.83-1.63],0.3934343492789893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBM17,Splicing factor 45,11674,86,0.78 [0.59-1.03],0.0832378523055722
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBM19,Probable RNA-binding protein 19,11332,84,1.16 [0.79-1.70],0.4528243763630047
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBM25,RNA-binding protein 25,11269,84,0.91 [0.57-1.45],0.6941453284426433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP1,Retinol-binding protein 1,11351,84,0.78 [0.53-1.14],0.192229069383836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP2,Retinol-binding protein 2,13429,102,0.98 [0.78-1.24],0.8689349535720926
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP5,Retinol-binding protein 5,13429,102,0.82 [0.58-1.15],0.2390226240501612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP7,Retinoid-binding protein 7,11626,86,0.94 [0.66-1.32],0.7134073461295554
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBPMS,RNA-binding protein with multiple splicing,11358,82,0.79 [0.53-1.18],0.2481513829646895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBPMS2,RNA-binding protein with multiple splicing 2,11368,85,0.88 [0.72-1.08],0.2285476738554228
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RCC1,Regulator of chromosome condensation,11611,85,0.91 [0.59-1.41],0.6826320761037459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RCOR1,REST corepressor 1,13267,101,0.76 [0.46-1.24],0.2703434886505964
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,11368,85,0.54 [0.19-1.53],0.2473660976817279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REEP4,Receptor expression-enhancing protein 4,11674,86,0.72 [0.50-1.04],0.0817739912778251
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG1A,Lithostathine-1-alpha,13391,100,1.09 [0.75-1.58],0.6516213342256401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG1B,Lithostathine-1-beta,13658,103,0.99 [0.72-1.36],0.9665560298519766
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG3A,Regenerating islet-derived protein 3-alpha,13658,103,0.90 [0.67-1.22],0.5133868525973884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG3G,Regenerating islet-derived protein 3-gamma,11611,85,0.94 [0.55-1.58],0.8086895537053503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG4,Regenerating islet-derived protein 4,13518,104,0.69 [0.47-1.03],0.0674181008508365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RELB,Transcription factor RelB,11358,82,0.84 [0.54-1.33],0.4615317778271802
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RELT,Tumor necrosis factor receptor superfamily member 19L,13496,100,0.58 [0.28-1.20],0.143653745866924
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REN,Renin,13500,104,1.12 [0.86-1.45],0.4137112785348226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REPS1,RalBP1-associated Eps domain-containing protein 1,11358,82,0.73 [0.40-1.32],0.2969311847589428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REST,RE1-silencing transcription factor,11269,84,0.47 [0.24-0.94],0.0313732966310916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,13429,102,0.92 [0.60-1.40],0.6814215954939881
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RETN,Resistin,13438,99,0.84 [0.54-1.32],0.4471538060369614
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REXO2,"Oligoribonuclease, mitochondrial",11332,84,0.71 [0.42-1.20],0.2026795611014541
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RFC4,Replication factor C subunit 4,11611,85,0.77 [0.28-2.12],0.6074155155441896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGCC,Regulator of cell cycle RGCC,11674,86,0.85 [0.65-1.12],0.2539617659886263
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,11438,86,0.91 [0.65-1.27],0.5594672356520094
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGMA,Repulsive guidance molecule A,13626,102,0.51 [0.29-0.90],0.0194974310063457
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGMB,RGM domain family member B,13626,102,0.48 [0.24-0.99],0.0463632255483017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGS10,Regulator of G-protein signaling 10,11674,86,0.81 [0.56-1.15],0.2356597926226488
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGS8,Regulator of G-protein signaling 8,13235,101,0.98 [0.74-1.29],0.8632324570665347
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RHOC,Rho-related GTP-binding protein RhoC,13313,101,0.91 [0.79-1.05],0.2074177916977358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RICTOR,Rapamycin-insensitive companion of mTOR,11358,82,0.94 [0.60-1.48],0.7834125719639836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,11422,85,0.92 [0.59-1.43],0.710295070635659
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RILP,Rab-interacting lysosomal protein,13583,99,0.92 [0.69-1.23],0.5834306218031033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RILPL2,RILP-like protein 2,11692,85,0.89 [0.73-1.10],0.2917743908106353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,11332,84,0.69 [0.45-1.04],0.0741119524887214
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RLN1,Prorelaxin H1,11674,86,0.86 [0.65-1.13],0.269326217212688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RLN2,Prorelaxin H2,11405,84,1.00 [0.89-1.13],0.9563427554227412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE1,Ribonuclease pancreatic,11690,85,1.21 [0.49-2.99],0.6772115364983985
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE10,Inactive ribonuclease-like protein 10,11368,85,0.96 [0.62-1.49],0.8632962128787289
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE3,Eosinophil cationic protein,13431,101,1.01 [0.86-1.18],0.9238789135044296
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE4,Ribonuclease 4,11295,85,0.53 [0.23-1.22],0.1342998540392034
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE6,Ribonuclease K6,11598,85,0.49 [0.20-1.18],0.1106607120544391
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASEH2A,Ribonuclease H2 subunit A,11674,86,0.77 [0.48-1.23],0.2669610741454543
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASET2,Ribonuclease T2,13590,103,0.75 [0.37-1.50],0.4112016270633274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF149,E3 ubiquitin-protein ligase RNF149,11368,85,1.20 [0.59-2.42],0.6148839705002216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF168,E3 ubiquitin-protein ligase RNF168,11358,82,0.74 [0.42-1.32],0.3076099457391616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF31,E3 ubiquitin-protein ligase RNF31,11358,82,0.98 [0.56-1.73],0.9527121879799256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF4,E3 ubiquitin-protein ligase RNF4,11438,86,0.78 [0.55-1.11],0.1725821067013333
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF41,E3 ubiquitin-protein ligase NRDP1,13187,100,0.83 [0.63-1.09],0.1812299013923083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF43,E3 ubiquitin-protein ligase RNF43,11438,86,0.77 [0.50-1.20],0.2471403998399939
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF5,E3 ubiquitin-protein ligase RNF5,11368,85,0.82 [0.62-1.07],0.1472447094178075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROBO1,Roundabout homolog 1,13518,104,0.57 [0.27-1.22],0.1490535419946666
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROBO2,Roundabout homolog 2,13626,102,0.88 [0.41-1.88],0.7423006315450409
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROBO4,Roundabout homolog 4,11368,85,0.50 [0.20-1.24],0.1330668453623852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,13500,104,0.98 [0.56-1.72],0.9413173424377188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RP2,Protein XRP2,13429,102,0.71 [0.45-1.10],0.1246683096377594
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPA2,Replication protein A 32 kDa subunit,11358,82,1.31 [0.73-2.36],0.362008641133366
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPE,Ribulose-phosphate 3-epimerase,11438,86,0.85 [0.63-1.16],0.3006046641060866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPGR,X-linked retinitis pigmentosa GTPase regulator,11351,84,0.50 [0.27-0.91],0.0230516467076836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPL14,60S ribosomal protein L14,11368,85,0.84 [0.49-1.42],0.514569584715812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPS10,40S ribosomal protein S10,11332,84,0.70 [0.39-1.26],0.2291010863519618
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRAS,Ras-related protein R-Ras,11351,84,0.95 [0.80-1.11],0.5043049061605227
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRM2,Ribonucleoside-diphosphate reductase subunit M2,13187,100,0.78 [0.51-1.18],0.2416351624683597
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,13187,100,0.91 [0.70-1.18],0.4617945766605912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRP15,RRP15-like protein,11347,80,0.93 [0.74-1.18],0.5418957871617724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RSPO1,R-spondin-1,13411,102,0.75 [0.46-1.23],0.2554547649790162
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RSPO3,R-spondin-3,13620,100,0.49 [0.25-0.94],0.0330779516682834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTBDN,Retbindin,13429,102,0.40 [0.22-0.74],0.0036359655504697
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTKN2,Rhotekin-2,11332,84,0.62 [0.37-1.05],0.0739314431220318
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",11674,86,0.90 [0.72-1.14],0.3874812255189169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTN4R,Reticulon-4 receptor,13620,100,0.76 [0.44-1.30],0.3176828159629745
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RUVBL1,RuvB-like 1,13187,100,1.07 [0.91-1.25],0.4270291992657665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RWDD1,RWD domain-containing protein 1,13626,102,0.79 [0.60-1.04],0.0885031454296438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RYR1,Ryanodine receptor 1,11332,84,0.61 [0.29-1.27],0.1875076734477514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A11,Protein S100-A11,13386,103,0.94 [0.64-1.39],0.7713166469096192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A12,Protein S100-A12,13313,102,0.99 [0.79-1.25],0.9613022021538712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A13,Protein S100-A13,11358,82,0.92 [0.49-1.73],0.8024625172740555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A14,Protein S100-A14,11674,86,0.81 [0.54-1.22],0.3190699204834506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A16,Protein S100-A16,13137,97,0.73 [0.54-0.98],0.0393939396176992
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A3,Protein S100-A3,11611,85,0.82 [0.48-1.40],0.4667641922433893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A4,Protein S100-A4,13527,102,0.91 [0.67-1.23],0.524963159461208
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100G,Protein S100-G,11674,86,0.66 [0.39-1.11],0.1146797954296911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100P,Protein S100-P,13267,101,0.82 [0.57-1.17],0.2727686411595756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAA4,Serum amyloid A-4 protein,11702,87,0.48 [0.14-1.66],0.2436913899186663
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAFB2,Scaffold attachment factor B2,11674,86,0.44 [0.19-1.03],0.0592957360957537
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAG,S-arrestin,11347,80,0.85 [0.55-1.31],0.4614770791477984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAMD9L,Sterile alpha motif domain-containing protein 9-like,13483,101,0.90 [0.70-1.14],0.3809092664333583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAP18,Histone deacetylase complex subunit SAP18,11438,86,1.06 [0.81-1.37],0.6872480169576443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SARG,Specifically androgen-regulated gene protein,11652,85,0.88 [0.73-1.06],0.1902464143641756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SART1,U4/U6.U5 tri-snRNP-associated protein 1,11332,84,0.77 [0.39-1.52],0.4513748955884312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAT1,Diamine acetyltransferase 1,11332,84,1.18 [0.82-1.69],0.3716255568168132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAT2,Thialysine N-epsilon-acetyltransferase,11438,86,1.06 [0.80-1.40],0.6814228119541321
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SATB1,DNA-binding protein SATB1,11674,86,0.53 [0.23-1.21],0.1292674682778084
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SBSN,Suprabasin,11647,86,1.06 [0.57-1.95],0.8637929632731574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCAMP3,Secretory carrier-associated membrane protein 3,13429,102,0.84 [0.68-1.04],0.1151952668404609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARA5,Scavenger receptor class A member 5,13626,102,0.51 [0.28-0.92],0.0254790465782705
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARB1,Scavenger receptor class B member 1,13156,97,1.11 [0.85-1.45],0.4430406299035266
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARB2,Lysosome membrane protein 2,13159,101,0.47 [0.24-0.92],0.0270536808462421
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARF1,Scavenger receptor class F member 1,13658,103,0.73 [0.49-1.11],0.1440727215583598
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARF2,Scavenger receptor class F member 2,13626,102,0.61 [0.37-1.01],0.0545230790891271
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCG2,Secretogranin-2,13558,99,0.48 [0.27-0.86],0.0139805801785589
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCG3,Secretogranin-3,13518,104,0.68 [0.40-1.15],0.1461881181126053
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB1A1,Uteroglobin,13519,104,0.86 [0.64-1.17],0.3472924939335587
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB2A2,Mammaglobin-A,11332,84,0.51 [0.23-1.15],0.1056104354211029
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB3A1,Secretoglobin family 3A member 1,11422,85,2.00 [0.84-4.73],0.116449321766295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB3A2,Secretoglobin family 3A member 2,13534,104,1.02 [0.83-1.26],0.8314625180851019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGN,Secretagogin,13235,101,0.91 [0.60-1.37],0.644606699060944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCIN,Adseverin,11347,80,0.79 [0.57-1.09],0.1453290349112186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCLY,Selenocysteine lyase,13583,99,1.01 [0.70-1.46],0.9601018810333354
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN2A,Sodium channel protein type 2 subunit alpha,11347,80,0.82 [0.50-1.36],0.4463318240066611
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN2B,Sodium channel subunit beta-2,11351,84,0.35 [0.15-0.82],0.0158782465436554
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN3A,Sodium channel protein type 3 subunit alpha,11351,84,0.96 [0.56-1.65],0.8923159553196214
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN3B,Sodium channel subunit beta-3,11347,80,0.93 [0.57-1.53],0.7703629731774113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN4B,Sodium channel subunit beta-4,11368,85,0.83 [0.50-1.38],0.4629250644077465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCP2,Non-specific lipid-transfer protein,13187,100,0.99 [0.80-1.23],0.9361868301745044
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCPEP1,Retinoid-inducible serine carboxypeptidase,11326,85,0.96 [0.63-1.47],0.8659077031974017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCRG1,Scrapie-responsive protein 1,11692,85,0.78 [0.35-1.73],0.5419126031859343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCRIB,Protein scribble homolog,11368,85,0.96 [0.77-1.21],0.75251670235933
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCRN1,Secernin-1,13483,101,0.82 [0.59-1.12],0.2133473041523161
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCT,Secretin,11351,84,0.80 [0.49-1.30],0.3661569316663566
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDC1,Syndecan-1,13500,104,1.10 [0.71-1.71],0.664225177105491
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDC4,Syndecan-4,13500,104,0.93 [0.64-1.37],0.7266764104033524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDCCAG8,Serologically defined colon cancer antigen 8,11611,85,0.85 [0.71-1.02],0.0759488470719104
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDHB,Succinate dehydrogenase,11626,86,1.07 [0.81-1.41],0.6246572505141066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDK2,Protein sidekick-2,11422,85,0.88 [0.49-1.56],0.656966316668381
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEC31A,Protein transport protein Sec31A,11368,85,0.92 [0.71-1.21],0.5612612319981791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEL1L,Protein sel-1 homolog 1,11368,85,0.35 [0.14-0.87],0.0239008904543285
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELE,E-selectin,13658,103,0.92 [0.65-1.30],0.6398439071977169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELENOP,Selenoprotein P,11702,87,0.61 [0.24-1.60],0.3158674145743546
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELL,L-selectin,11702,87,0.63 [0.26-1.52],0.303878847466034
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELP,P-selectin,13507,102,0.89 [0.66-1.21],0.4618940537141462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELPLG,P-selectin glycoprotein ligand 1,13483,101,0.93 [0.51-1.71],0.8165100495115283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA3F,Semaphorin-3F,13500,104,0.55 [0.28-1.10],0.0935314392341434
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA3G,Semaphorin-3G,11422,85,0.94 [0.58-1.51],0.791650809746035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA4C,Semaphorin-4C,13429,102,0.85 [0.44-1.63],0.6292841385189362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA4D,Semaphorin-4D,13626,102,0.55 [0.31-0.95],0.0334018798004876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA6C,Semaphorin-6C,11358,82,0.48 [0.19-1.19],0.1137038436688075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA7A,Semaphorin-7A,13607,100,0.67 [0.33-1.37],0.277709941868491
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN3,Neuronal-specific septin-3,11674,86,0.91 [0.68-1.21],0.5114118295119563
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN7,Septin-7,11438,86,0.77 [0.48-1.24],0.2850608885788016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN8,Septin-8,11628,85,0.69 [0.35-1.36],0.2805610375141226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN9,Septin-9,13429,102,1.20 [0.67-2.16],0.5364885792160481
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA1,Alpha-1-antitrypsin,11474,85,1.59 [0.12-20.84],0.7225279375044584
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA11,Serpin A11,13658,103,0.90 [0.59-1.38],0.6293763588056592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA12,Serpin A12,13137,102,1.05 [0.92-1.20],0.4982628466142361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA3,Alpha-1-antichymotrypsin,11662,87,2.31 [0.64-8.30],0.2014469924744616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA4,Kallistatin,11475,85,1.33 [0.55-3.20],0.5278687027580449
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA5,Plasma serine protease inhibitor,11519,86,1.08 [0.60-1.96],0.7989749900873897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA6,Corticosteroid-binding globulin,11702,87,2.08 [0.79-5.46],0.1383507227729051
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA7,Thyroxine-binding globulin,11702,87,2.06 [0.72-5.91],0.1780008219826912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA9,Serpin A9,13349,101,0.98 [0.77-1.26],0.8970065216627845
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB1,Leukocyte elastase inhibitor,13454,100,0.92 [0.75-1.12],0.3823207527718704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB5,Serpin B5,13267,101,0.97 [0.68-1.39],0.8865926846288226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB6,Serpin B6,13584,102,0.83 [0.62-1.11],0.213994664261509
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB8,Serpin B8,13652,101,1.09 [0.81-1.46],0.5664449623748846
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB9,Serpin B9,13411,102,0.99 [0.59-1.64],0.9597164090294852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINC1,Antithrombin-III,11676,87,4.86 [1.25-18.89],0.0224333550981235
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPIND1,Heparin cofactor 2,11676,87,1.71 [0.82-3.54],0.1503248259401415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINE1,Plasminogen activator inhibitor 1,13658,103,0.91 [0.71-1.16],0.4409887590570231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINE2,Glia-derived nexin,11692,85,0.85 [0.61-1.18],0.3242019198485181
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINF1,Pigment epithelium-derived factor,11528,86,1.82 [0.87-3.80],0.1120681252596715
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINF2,Alpha-2-antiplasmin,11477,86,1.79 [0.41-7.86],0.4384549248250535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPING1,Plasma protease C1 inhibitor,11676,87,2.61 [0.90-7.55],0.077947839998143
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINH1,Serpin H1,11438,86,0.91 [0.77-1.07],0.2346878285872023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINI1,Neuroserpin,11393,85,1.00 [0.53-1.92],0.9901951661561536
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINI2,Serpin I2,11626,86,0.99 [0.69-1.42],0.939813034974356
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,13156,97,0.89 [0.67-1.19],0.4308778971192557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SETMAR,Histone-lysine N-methyltransferase SETMAR,13375,102,0.71 [0.38-1.33],0.2898144671296923
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEZ6,Seizure protein 6 homolog,11351,84,0.33 [0.16-0.68],0.0030442942139798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEZ6L,Seizure 6-like protein,13527,102,0.73 [0.38-1.39],0.3365094759936572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEZ6L2,Seizure 6-like protein 2,13429,102,0.76 [0.36-1.59],0.4710019775865637
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SF3B4,Splicing factor 3B subunit 4,13429,102,0.80 [0.62-1.01],0.0645780827025548
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFRP1,Secreted frizzled-related protein 1,13367,102,0.65 [0.42-0.99],0.0443820190324213
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFRP4,Secreted frizzled-related protein 4,11422,85,0.99 [0.61-1.61],0.968366901248336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFTPA1,Pulmonary surfactant-associated protein A1,13187,100,0.91 [0.66-1.27],0.5799878505144536
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFTPA2,Pulmonary surfactant-associated protein A2,13187,100,1.10 [0.76-1.57],0.6162094713184793
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFTPD,Pulmonary surfactant-associated protein D,13500,104,1.43 [1.10-1.86],0.0079066193116858
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SGSH,N-sulphoglucosamine sulphohydrolase,11499,82,0.97 [0.66-1.44],0.8965906425286062
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH2B3,SH2B adapter protein 3,13187,100,0.88 [0.74-1.06],0.1788295548033361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH2D1A,SH2 domain-containing protein 1A,13483,101,0.83 [0.59-1.18],0.3057475704684393
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,11347,80,0.99 [0.70-1.40],0.9629592212285776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3BP1,SH3 domain-binding protein 1,11626,86,0.94 [0.62-1.44],0.790561748439029
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3GL3,Endophilin-A3,11377,86,0.85 [0.67-1.07],0.1571237992160533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3GLB2,Endophilin-B2,11656,85,0.79 [0.58-1.07],0.1277619046847358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHBG,Sex hormone-binding globulin,11690,85,0.69 [0.48-1.00],0.0501059071042789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHC1,SHC-transforming protein 1,11269,84,0.98 [0.82-1.18],0.833706355288323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHD,SH2 domain-containing adapter protein D,11312,84,1.07 [0.86-1.33],0.5519015703027595
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHH,Sonic hedgehog protein,11358,82,1.32 [0.87-2.01],0.1884579592498575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHISA5,Protein shisa-5,11671,86,0.65 [0.26-1.63],0.3564865369772291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHMT1,"Serine hydroxymethyltransferase, cytosolic",13534,104,0.95 [0.78-1.16],0.6126283070715401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHPK,Sedoheptulokinase,11438,86,0.87 [0.52-1.46],0.6075340577046566
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIAE,Sialate O-acetylesterase,13503,100,0.90 [0.62-1.31],0.5895516212820895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC1,Sialoadhesin,13555,104,0.83 [0.55-1.24],0.3555906754295497
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC10,Sialic acid-binding Ig-like lectin 10,13483,101,1.11 [0.64-1.93],0.7105405939047875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC15,Sialic acid-binding Ig-like lectin 15,13156,97,0.90 [0.71-1.15],0.4141921425915307
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC5,Sialic acid-binding Ig-like lectin 5,13496,100,0.92 [0.81-1.05],0.2158631327621993
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC6,Sialic acid-binding Ig-like lectin 6,13620,100,0.76 [0.44-1.31],0.3249884316381682
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC7,Sialic acid-binding Ig-like lectin 7,13500,104,1.22 [0.66-2.24],0.5268419457115607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC8,Sialic acid-binding Ig-like lectin 8,11368,85,0.64 [0.40-1.01],0.0571811407259982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC9,Sialic acid-binding Ig-like lectin 9,13604,99,1.22 [0.67-2.22],0.5132869638292663
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIL1,Nucleotide exchange factor SIL1,11368,85,1.10 [0.62-1.98],0.7388907322171336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,13516,100,1.19 [0.86-1.64],0.2984405256512589
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRPB1,Signal-regulatory protein beta-1,13465,104,0.83 [0.56-1.24],0.3674171528593302
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRT1,NAD-dependent protein deacetylase sirtuin-1,11358,82,0.91 [0.70-1.18],0.4820169941559026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRT2,NAD-dependent protein deacetylase sirtuin-2,13429,102,0.84 [0.69-1.02],0.0779268494240938
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",13156,97,0.97 [0.71-1.34],0.8710398630283012
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIT1,Signaling threshold-regulating transmembrane adapter 1,13235,101,1.22 [0.89-1.67],0.2177681620194266
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SKAP1,Src kinase-associated phosphoprotein 1,13382,102,1.00 [0.79-1.27],0.998120772622872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SKAP2,Src kinase-associated phosphoprotein 2,13555,104,0.85 [0.72-1.00],0.0491422522100489
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SKIV2L,Helicase SKI2W,11332,84,0.95 [0.56-1.59],0.8310603413641481
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLA2,Src-like-adapter 2,11674,86,0.87 [0.71-1.05],0.1513701538976021
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF1,Signaling lymphocytic activation molecule,13235,101,0.79 [0.60-1.05],0.1077551997076172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF6,SLAM family member 6,13187,100,0.84 [0.52-1.36],0.4853417782726287
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF7,SLAM family member 7,13483,101,0.91 [0.67-1.25],0.5595721209268985
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF8,SLAM family member 8,13187,100,0.97 [0.69-1.36],0.8585894885413207
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC12A2,Solute carrier family 12 member 2,11332,84,0.86 [0.39-1.89],0.7036603429547863
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC13A1,Solute carrier family 13 member 1,11611,85,0.71 [0.45-1.13],0.1468559800930907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC16A1,Monocarboxylate transporter 1,13156,97,0.84 [0.60-1.17],0.3057988468133583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC1A4,Neutral amino acid transporter A,11351,84,0.80 [0.51-1.24],0.3150055037822352
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC27A4,Long-chain fatty acid transport protein 4,13156,97,0.86 [0.63-1.16],0.3161219308741239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC28A1,Sodium/nucleoside cotransporter 1,11269,84,0.90 [0.62-1.30],0.5580443073974393
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC34A3,Sodium-dependent phosphate transport protein 2C,11269,84,1.12 [0.76-1.66],0.5554492952754331
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC39A14,Zinc transporter ZIP14,13156,97,0.97 [0.55-1.70],0.9026973555311496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC39A5,Zinc transporter ZIP5,13483,101,0.96 [0.69-1.33],0.793843751531649
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC44A4,Choline transporter-like protein 4,11351,84,0.80 [0.55-1.15],0.2298143160980336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC4A1,Band 3 anion transport protein,11671,86,0.89 [0.57-1.37],0.592586970473262
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC51B,Organic solute transporter subunit beta,11332,84,0.86 [0.64-1.15],0.298705863227838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,11422,85,0.87 [0.67-1.11],0.2578043043606275
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,11626,86,1.04 [0.72-1.50],0.8435609531301309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",11269,84,0.83 [0.55-1.25],0.3686426433809235
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLIT2,Slit homolog 2 protein,13156,97,0.98 [0.69-1.39],0.9200068818251712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLITRK1,SLIT and NTRK-like protein 1,11358,82,0.50 [0.25-0.96],0.0382513890130895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLITRK2,SLIT and NTRK-like protein 2,13620,100,0.75 [0.47-1.19],0.2197120110303495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLITRK6,SLIT and NTRK-like protein 6,13267,101,0.82 [0.48-1.39],0.4615186288630118
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLK,STE20-like serine/threonine-protein kinase,11438,86,0.87 [0.64-1.18],0.3711987588132245
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLMAP,Sarcolemmal membrane-associated protein,11626,86,0.81 [0.63-1.05],0.1189377341498328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLURP1,Secreted Ly-6/uPAR-related protein 1,11583,85,0.96 [0.55-1.68],0.8844725313535994
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD1,Mothers against decapentaplegic homolog 1,13187,100,0.83 [0.66-1.05],0.112527860305596
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD2,Mothers against decapentaplegic homolog 2,11611,85,0.79 [0.57-1.09],0.1451159767912397
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD3,Mothers against decapentaplegic homolog 3,11611,85,0.86 [0.57-1.32],0.4970878381141124
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD5,Mothers against decapentaplegic homolog 5,13429,102,1.03 [0.44-2.39],0.9441577092647868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMARCA2,Probable global transcription activator SNF2L2,13156,97,0.84 [0.64-1.09],0.1855524019015061
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMC3,Structural maintenance of chromosomes protein 3,11269,84,1.03 [0.71-1.51],0.8598019521292505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMNDC1,Survival of motor neuron-related-splicing factor 30,11626,86,0.85 [0.58-1.24],0.3949448932322041
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMOC1,SPARC-related modular calcium-binding protein 1,13620,100,0.66 [0.39-1.12],0.1250394178256245
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMOC2,SPARC-related modular calcium-binding protein 2,13555,104,0.45 [0.28-0.73],0.0012777630306092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPD1,Sphingomyelin phosphodiesterase,13560,102,0.75 [0.51-1.08],0.1249334281496415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPD3,Sphingomyelin phosphodiesterase 3,11358,82,0.73 [0.46-1.16],0.1869760429124582
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,13527,104,0.95 [0.73-1.24],0.7284007758151911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,11611,85,0.96 [0.72-1.27],0.76627573055974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMS,Spermine synthase,11347,80,0.71 [0.47-1.07],0.0977636290741136
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMTN,Smoothelin,11630,85,0.83 [0.66-1.04],0.1141956636445907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAP23,Synaptosomal-associated protein 23,13500,104,0.88 [0.73-1.07],0.1977924119466308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAP25,Synaptosomal-associated protein 25,11347,80,0.62 [0.39-0.99],0.0469975419673661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAP29,Synaptosomal-associated protein 29,13527,102,0.88 [0.73-1.07],0.1910186843442547
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAPIN,SNARE-associated protein Snapin,11674,86,0.76 [0.53-1.10],0.1435769976129261
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNCA,Alpha-synuclein,11422,85,0.89 [0.74-1.07],0.2120008514915117
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNCG,Gamma-synuclein,13411,102,0.81 [0.62-1.05],0.1159706907692106
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",11368,85,0.90 [0.47-1.70],0.7350598512497506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNRPB2,U2 small nuclear ribonucleoprotein B'',11656,85,0.68 [0.35-1.30],0.2384671834965786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNU13,NHP2-like protein 1,11332,84,0.92 [0.65-1.30],0.6268893403622037
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX15,Sorting nexin-15,11422,85,0.77 [0.52-1.13],0.1826253146161513
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX18,Sorting nexin-18,11626,86,1.09 [0.71-1.67],0.6991129144716322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX2,Sorting nexin-2,11611,85,0.86 [0.65-1.15],0.3104933073764661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX5,Sorting nexin-5,11368,85,1.12 [0.57-2.19],0.7445899396325665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX9,Sorting nexin-9,13500,104,0.89 [0.69-1.14],0.3518488631197075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOD1,Superoxide dismutase [Cu-Zn],13172,102,0.93 [0.65-1.33],0.6792131186054113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOD2,"Superoxide dismutase [Mn], mitochondrial",13496,100,1.04 [0.65-1.67],0.866662283302353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOD3,Extracellular superoxide dismutase,11690,85,0.96 [0.67-1.37],0.808156469967706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORBS1,Sorbin and SH3 domain-containing protein 1,11674,86,0.77 [0.41-1.43],0.4101711569204211
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORCS2,VPS10 domain-containing receptor SorCS2,13187,100,0.45 [0.27-0.74],0.0015330522809779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORD,Sorbitol dehydrogenase,13557,99,0.90 [0.70-1.17],0.4300258781545768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORT1,Sortilin,13482,104,0.72 [0.44-1.16],0.1777357670575673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOST,Sclerostin,13482,104,0.72 [0.46-1.12],0.1415168202496907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,11351,84,0.56 [0.31-1.00],0.049531734876579
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOX2,Transcription factor SOX-2,11660,86,1.13 [0.49-2.60],0.7818787257621674
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOX9,Transcription factor SOX-9,11351,84,0.53 [0.24-1.16],0.1137703881204105
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,11674,86,0.36 [0.15-0.82],0.0158322713015423
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPAG1,Sperm-associated antigen 1,11674,86,0.82 [0.56-1.21],0.3140224611118524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPARC,SPARC,13527,102,0.87 [0.69-1.09],0.2229150752665595
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPARCL1,SPARC-like protein 1,13465,101,0.99 [0.52-1.88],0.9816686758764592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPART,Spartin,11422,85,0.80 [0.60-1.05],0.1063761384733007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPESP1,Sperm equatorial segment protein 1,11692,85,0.89 [0.41-1.93],0.7712659886508476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK1,Serine protease inhibitor Kazal-type 1,13496,100,0.80 [0.50-1.27],0.3404298527564833
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK2,Serine protease inhibitor Kazal-type 2,11422,85,0.80 [0.46-1.39],0.4361805848898396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK4,Serine protease inhibitor Kazal-type 4,13483,101,1.14 [0.86-1.49],0.36071472069984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK5,Serine protease inhibitor Kazal-type 5,13496,100,1.15 [0.67-1.98],0.6123424901404007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK6,Serine protease inhibitor Kazal-type 6,13620,100,0.81 [0.59-1.11],0.1825894853322875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK8,Serine protease inhibitor Kazal-type 8,11332,84,1.25 [0.83-1.89],0.2908330811865999
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINT1,Kunitz-type protease inhibitor 1,13452,100,1.40 [0.71-2.77],0.3339044207969183
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINT2,Kunitz-type protease inhibitor 2,13555,104,0.73 [0.49-1.07],0.1032640862127669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINT3,Kunitz-type protease inhibitor 3,11626,86,1.04 [0.88-1.23],0.614604053532567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPOCK1,Testican-1,13411,102,1.11 [0.55-2.25],0.7716810444144085
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPON1,Spondin-1,13518,104,0.46 [0.27-0.80],0.0057279818703372
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPON2,Spondin-2,13437,102,0.67 [0.39-1.14],0.1416725090204644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPP1,Osteopontin,13630,103,0.80 [0.56-1.15],0.2234484230634524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",11358,82,0.62 [0.36-1.07],0.0863792876657496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRING1,SREBP regulating gene protein,11269,84,1.14 [0.84-1.55],0.4127428976979984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRR1B,Cornifin-B,11438,86,0.98 [0.77-1.24],0.8387129989061961
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRR3,Small proline-rich protein 3,11656,85,0.83 [0.61-1.12],0.2185267366544303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRY2,Protein sprouty homolog 2,13235,101,0.94 [0.77-1.14],0.5164690280985655
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",11347,80,0.56 [0.26-1.18],0.1274807534653838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPTLC1,Serine palmitoyltransferase 1,11656,85,0.65 [0.32-1.30],0.224086898192265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRC,Proto-oncogene tyrosine-protein kinase Src,13504,101,0.92 [0.80-1.06],0.2300706113601469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRP14,Signal recognition particle 14 kDa protein,13429,102,0.91 [0.69-1.22],0.5322267415686734
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRPK2,SRSF protein kinase 2,13483,101,0.87 [0.69-1.09],0.2198630440694369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRPX,Sushi repeat-containing protein SRPX,11692,85,0.88 [0.46-1.67],0.6909675714490738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSB,Lupus La protein,13156,97,1.14 [0.89-1.47],0.3031494201794467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",11358,82,1.07 [0.61-1.88],0.8089111622774112
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,13482,104,1.01 [0.85-1.20],0.8775822088999715
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,13507,102,1.53 [1.02-2.31],0.041243582504651
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSH3,Protein phosphatase Slingshot homolog 3,11269,84,0.69 [0.33-1.45],0.3270787395151295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSNA1,Sjoegren syndrome nuclear autoantigen 1,11626,86,0.96 [0.64-1.44],0.8328802079515779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST13,Hsc70-interacting protein,11422,85,0.79 [0.55-1.15],0.2158334595526203
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",13429,102,0.95 [0.63-1.44],0.8148501597739316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",13658,103,0.51 [0.27-0.96],0.03807158587293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",11358,82,0.72 [0.41-1.26],0.2542953701239383
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAB2,Stabilin-2,11671,86,0.89 [0.44-1.82],0.7570319833541385
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAM,Signal transducing adapter molecule 1,11611,85,0.70 [0.38-1.28],0.2459556592855309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAMBP,STAM-binding protein,13382,102,0.83 [0.63-1.09],0.1835623123804165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAT2,Signal transducer and activator of transcription 2,11358,82,0.85 [0.64-1.13],0.2702019929834454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAT5B,Signal transducer and activator of transcription 5B,13429,102,0.92 [0.81-1.04],0.1738981063838969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,11269,84,0.74 [0.51-1.08],0.1224687227813916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STC1,Stanniocalcin-1,13626,102,0.77 [0.49-1.21],0.256639412693784
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STC2,Stanniocalcin-2,13473,100,2.28 [1.15-4.54],0.0184095093675272
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STEAP4,Metalloreductase STEAP4,11347,80,0.82 [0.59-1.16],0.2597023756370331
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STIP1,Stress-induced-phosphoprotein 1,13475,100,0.90 [0.68-1.17],0.4244820470628274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STK11,Serine/threonine-protein kinase STK11,13267,101,0.88 [0.69-1.13],0.3066153140162042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STK24,Serine/threonine-protein kinase 24,13156,97,0.90 [0.67-1.21],0.495611858523619
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STK4,Serine/threonine-protein kinase 4,13500,104,0.93 [0.76-1.14],0.48780386376399
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STOML2,"Stomatin-like protein 2, mitochondrial",11269,84,0.99 [0.79-1.24],0.9563297837859026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX16,Syntaxin-16,13187,100,0.76 [0.54-1.08],0.1239304007059156
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX1B,Syntaxin-1B,11351,84,1.14 [0.76-1.72],0.5206432168630363
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX3,Syntaxin-3,11656,85,0.80 [0.44-1.44],0.4556225601817417
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX4,Syntaxin-4,13429,102,0.68 [0.48-0.96],0.0306516867399583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX5,Syntaxin-5,11358,82,0.69 [0.38-1.27],0.235727394387081
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX6,Syntaxin-6,13187,100,0.88 [0.67-1.15],0.3429590479462989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX7,Syntaxin-7,11358,82,0.91 [0.60-1.38],0.6572058545800785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX8,Syntaxin-8,13483,101,0.72 [0.49-1.04],0.0813887891361283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STXBP1,Syntaxin-binding protein 1,11674,86,0.85 [0.66-1.10],0.2282385611458354
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STXBP3,Syntaxin-binding protein 3,13187,100,0.73 [0.46-1.15],0.171826914842785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUGP1,SURP and G-patch domain-containing protein 1,11626,86,0.82 [0.48-1.40],0.4689877803477857
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUGT1,Protein SGT1 homolog,13187,100,0.86 [0.69-1.07],0.1844139705063164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SULT1A1,Sulfotransferase 1A1,13626,102,0.94 [0.82-1.07],0.3178664494536519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SULT2A1,Bile salt sulfotransferase,13483,101,0.88 [0.61-1.25],0.471029002927562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUMF1,Formylglycine-generating enzyme,11358,82,0.94 [0.69-1.30],0.724759350283624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,13626,102,0.96 [0.70-1.33],0.8096049992266355
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUOX,"Sulfite oxidase, mitochondrial",11674,86,0.80 [0.56-1.15],0.2311178643054826
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD1,Sushi domain-containing protein 1,13267,101,0.63 [0.45-0.90],0.0102224251102225
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD2,Sushi domain-containing protein 2,13496,100,1.05 [0.55-2.00],0.8771408528570509
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD4,Sushi domain-containing protein 4,11611,85,0.57 [0.34-0.96],0.0348558350869547
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD5,Sushi domain-containing protein 5,11355,84,0.86 [0.46-1.60],0.6350428188266521
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SV2A,Synaptic vesicle glycoprotein 2A,11351,84,0.82 [0.57-1.18],0.2939205251833617
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SWAP70,Switch-associated protein 70,11626,86,1.16 [0.69-1.94],0.5752541013390808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYAP1,Synapse-associated protein 1,11422,85,0.83 [0.56-1.22],0.3417200659283393
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,11347,80,0.91 [0.60-1.36],0.6298029416583577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYT1,Synaptotagmin-1,11656,85,0.53 [0.26-1.07],0.0771818114466113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYTL4,Synaptotagmin-like protein 4,11692,85,0.87 [0.65-1.17],0.3677745433549969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,11438,86,0.85 [0.70-1.04],0.1090823022412492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TACC3,Transforming acidic coiled-coil-containing protein 3,13429,102,0.90 [0.77-1.04],0.1565012253127886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TACSTD2,Tumor-associated calcium signal transducer 2,11961,89,0.96 [0.50-1.83],0.8925467581552415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TADA3,Transcriptional adapter 3,11611,85,0.97 [0.57-1.64],0.896587123787256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAFA5,Chemokine-like protein TAFA-5,13429,102,0.43 [0.25-0.74],0.0024348426972881
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAGLN3,Transgelin-3,11269,84,1.12 [0.82-1.51],0.4824666584468382
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TALDO1,Transaldolase,11630,86,0.89 [0.56-1.40],0.6125282159871142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TANK,TRAF family member-associated NF-kappa-B activator,13235,101,0.76 [0.58-0.99],0.0384084115452348
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAP1,Antigen peptide transporter 1,11438,86,1.03 [0.74-1.43],0.861786959428425
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TARBP2,RISC-loading complex subunit TARBP2,13156,97,0.83 [0.66-1.05],0.1236776109020002
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",11351,84,0.93 [0.70-1.24],0.6188761121242453
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",11611,85,0.78 [0.43-1.39],0.398797523131482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAX1BP1,Tax1-binding protein 1,11656,85,0.77 [0.54-1.09],0.1343707765832505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBC1D17,TBC1 domain family member 17,13156,97,0.86 [0.56-1.30],0.4667957024400498
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBC1D23,TBC1 domain family member 23,13429,102,0.81 [0.67-0.99],0.0430426205864015
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBC1D5,TBC1 domain family member 5,13483,101,0.84 [0.67-1.06],0.1484408927439788
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBCA,Tubulin-specific chaperone A,11422,85,0.84 [0.66-1.07],0.1498744188894963
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBCB,Tubulin-folding cofactor B,13411,102,0.90 [0.76-1.06],0.210881814009781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBCC,Tubulin-specific chaperone C,13411,102,0.87 [0.71-1.08],0.2187874599791783
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBL1X,F-box-like/WD repeat-containing protein TBL1X,13187,100,0.84 [0.68-1.04],0.1056394001049213
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBR1,T-box brain protein 1,11351,84,0.82 [0.50-1.35],0.4372639122505265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCL1A,T-cell leukemia/lymphoma protein 1A,13384,101,0.96 [0.79-1.16],0.6444927514866172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCL1B,T-cell leukemia/lymphoma protein 1B,13267,101,0.99 [0.80-1.23],0.942921270234408
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCN1,Transcobalamin-1,11451,84,0.97 [0.52-1.82],0.9261651995067314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCN2,Transcobalamin-2,13630,103,0.84 [0.46-1.53],0.5647368214758447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCOF1,Treacle protein,11692,85,0.66 [0.32-1.39],0.2756231456224242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCP11,T-complex protein 11 homolog,11438,86,0.87 [0.58-1.30],0.4936881587603696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCTN3,Tectonic-3,11692,85,0.88 [0.43-1.81],0.7374022625634644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDGF1,Teratocarcinoma-derived growth factor 1,13156,97,0.97 [0.85-1.11],0.6845637323005662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDO2,"Tryptophan 2,3-dioxygenase",11351,84,0.71 [0.37-1.34],0.2904431970957827
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDP1,Tyrosyl-DNA phosphodiesterase 1,11611,85,0.91 [0.66-1.25],0.5565397302708956
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDRKH,Tudor and KH domain-containing protein,13156,97,0.85 [0.68-1.07],0.1578333743308784
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEF,Thyrotroph embryonic factor,11332,84,1.11 [0.70-1.76],0.6550421411841277
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEK,Angiopoietin-1 receptor,13527,102,0.49 [0.22-1.11],0.0889486804111238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TERF1,Telomeric repeat-binding factor 1,11358,82,0.92 [0.44-1.90],0.8153409098305295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TET2,Methylcytosine dioxygenase TET2,11422,85,0.83 [0.64-1.08],0.1699764908880522
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEX101,Testis-expressed protein 101,11351,84,1.10 [0.65-1.86],0.7116056060795486
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEX33,Testis-expressed protein 33,11438,86,1.27 [0.87-1.88],0.2201160918240009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TF,Serotransferrin,11702,87,1.11 [0.45-2.74],0.8189427858584746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFAP2A,Transcription factor AP-2-alpha,11347,80,1.18 [0.87-1.59],0.2865099482014899
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFF1,Trefoil factor 1,13429,100,0.90 [0.70-1.17],0.4352746260033224
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFF2,Trefoil factor 2,13534,104,0.82 [0.59-1.14],0.2364284058073083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFF3,Trefoil factor 3,13452,100,0.81 [0.55-1.19],0.2784440469096628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFPI,Tissue factor pathway inhibitor,13417,99,1.63 [1.05-2.53],0.0295788410137471
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFPI2,Tissue factor pathway inhibitor 2,13477,100,0.81 [0.48-1.35],0.4082744902659405
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFRC,Transferrin receptor protein 1,13520,102,0.79 [0.51-1.23],0.2928294492946162
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TG,Thyroglobulin,11611,85,0.94 [0.78-1.13],0.5305958134848037
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFA,Protransforming growth factor alpha,13483,101,0.85 [0.57-1.27],0.4369814587149024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFB1,Transforming growth factor beta-1 proprotein,13625,100,0.59 [0.37-0.96],0.0331653572054204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFB2,Transforming growth factor beta-2 proprotein,11611,85,1.35 [0.99-1.86],0.060641128965536
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBI,Transforming growth factor-beta-induced protein ig-h3,13378,98,1.43 [0.74-2.73],0.2850448844220806
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBR1,TGF-beta receptor type-1,11358,82,0.85 [0.31-2.28],0.7432867341099001
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBR2,TGF-beta receptor type-2,13527,102,0.62 [0.33-1.17],0.1397751877297289
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBR3,Transforming growth factor beta receptor type 3,13658,103,0.89 [0.53-1.48],0.6573682480975274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGM2,Protein-glutamine gamma-glutamyltransferase 2,13479,104,1.22 [0.98-1.53],0.080967061283504
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGOLN2,Trans-Golgi network integral membrane protein 2,11690,85,0.99 [0.43-2.30],0.9832140798257648
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THAP12,52 kDa repressor of the inhibitor of the protein kinase,11246,84,0.97 [0.76-1.22],0.7703312116335544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THBD,Thrombomodulin,13500,104,0.64 [0.33-1.24],0.1836464383322639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THBS2,Thrombospondin-2,13496,100,1.00 [0.60-1.68],0.984833410481326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THBS4,Thrombospondin-4,13468,102,0.97 [0.66-1.43],0.873616895990994
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THOP1,Thimet oligopeptidase,13450,104,0.99 [0.56-1.74],0.9643132809582632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THPO,Thrombopoietin,13267,101,0.67 [0.42-1.08],0.1024778822063327
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THRAP3,Thyroid hormone receptor-associated protein 3,11332,84,0.93 [0.76-1.13],0.439628809908456
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THSD1,Thrombospondin type-1 domain-containing protein 1,11276,82,0.87 [0.46-1.63],0.6542470769890765
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THTPA,Thiamine-triphosphatase,11595,85,0.85 [0.67-1.08],0.1793347801193918
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THY1,Thy-1 membrane glycoprotein,13626,102,0.63 [0.32-1.22],0.1681951653106196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIA1,Nucleolysin TIA-1 isoform p40,13125,99,0.89 [0.76-1.04],0.1396308533982049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIE1,Tyrosine-protein kinase receptor Tie-1,13658,103,1.02 [0.67-1.53],0.9393095119141716
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",13127,97,0.93 [0.64-1.36],0.7118817351949033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,11438,86,0.75 [0.40-1.39],0.3569381913139434
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,13507,102,1.17 [0.79-1.73],0.4426026326884873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,11692,85,0.78 [0.45-1.34],0.3674853642724061
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,11656,85,0.88 [0.69-1.12],0.3018545757835127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP1,Metalloproteinase inhibitor 1,13298,96,0.96 [0.50-1.87],0.9135828323196346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP2,Metalloproteinase inhibitor 2,11692,85,0.33 [0.12-0.91],0.0323534489726967
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP3,Metalloproteinase inhibitor 3,13555,104,0.94 [0.82-1.07],0.3612108405544989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP4,Metalloproteinase inhibitor 4,13496,100,0.73 [0.46-1.16],0.1880076162148626
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TINAGL1,Tubulointerstitial nephritis antigen-like,13455,104,0.74 [0.33-1.62],0.4470882730773851
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TJAP1,Tight junction-associated protein 1,13527,102,0.88 [0.71-1.09],0.2317675216313379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TJP3,Tight junction protein ZO-3,11347,80,0.41 [0.22-0.78],0.0065394344186477
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TK1,"Thymidine kinase, cytosolic",11438,86,1.23 [0.82-1.84],0.3199408220165164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR1,Toll-like receptor 1,11358,82,0.60 [0.25-1.40],0.2362788843411884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR2,Toll-like receptor 2,11438,86,1.26 [0.52-3.02],0.6054350249661461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR3,Toll-like receptor 3,13652,101,0.91 [0.69-1.21],0.5250257308325234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR4,Toll-like receptor 4,11358,82,0.46 [0.21-0.99],0.0477720009257323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,11351,84,0.99 [0.67-1.46],0.9446052674142872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED1,Transmembrane emp24 domain-containing protein 1,11438,86,0.90 [0.60-1.34],0.5933877815883073
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED10,Transmembrane emp24 domain-containing protein 10,11332,84,1.05 [0.72-1.51],0.8081161536857341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED4,Transmembrane emp24 domain-containing protein 4,11332,84,1.30 [0.99-1.71],0.0568882904705433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED8,Protein TMED8,11626,86,0.94 [0.77-1.14],0.5088648018964461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMEM106A,Transmembrane protein 106A,11611,85,0.95 [0.71-1.28],0.7381247554217346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMEM132A,Transmembrane protein 132A,11368,85,0.96 [0.69-1.33],0.7907632166405411
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMEM25,Transmembrane protein 25,11674,86,0.85 [0.52-1.39],0.511841337065651
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMOD4,Tropomodulin-4,11269,84,1.13 [0.69-1.84],0.6313606625768748
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS11B,Transmembrane protease serine 11B,11347,80,1.05 [0.81-1.36],0.7242788812179884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS11D,Transmembrane protease serine 11D,11628,85,0.69 [0.39-1.22],0.1980360943596634
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS15,Enteropeptidase,13429,102,0.93 [0.77-1.13],0.4613191232111535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS5,Transmembrane protease serine 5,13343,101,0.90 [0.57-1.43],0.6681458416971517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMSB10,Thymosin beta-10,13496,100,0.89 [0.70-1.12],0.3098916221654916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNC,Tenascin,13507,102,1.12 [0.77-1.62],0.5638156408099242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNF,Tumor necrosis factor,13247,101,0.90 [0.55-1.47],0.672509873230086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,11626,86,0.89 [0.57-1.39],0.6092333423023502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,13235,101,0.69 [0.42-1.14],0.1437094760215687
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,11422,85,0.84 [0.60-1.18],0.3109577579612914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,13411,102,0.81 [0.46-1.44],0.4724251412055112
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,13411,102,0.58 [0.30-1.13],0.1087323144850718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,13504,101,1.07 [0.75-1.53],0.7093055687511592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,13652,101,0.57 [0.34-0.95],0.031723037807888
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,13493,104,0.69 [0.38-1.26],0.2263214453550315
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,13527,102,0.80 [0.47-1.37],0.4147603377192325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,13518,104,0.82 [0.45-1.48],0.5038263440716828
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,13235,101,0.87 [0.55-1.36],0.5359923038558345
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,13518,104,0.60 [0.32-1.13],0.1148171041565185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,11422,85,0.86 [0.50-1.47],0.5702110483555842
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,13620,100,0.61 [0.32-1.14],0.1185530570912639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,13496,100,0.83 [0.42-1.64],0.5937298405029829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,13496,100,0.78 [0.44-1.38],0.3941479980440376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,13626,102,0.72 [0.37-1.38],0.3210765112316289
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,13625,100,0.63 [0.37-1.05],0.0771974516802514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,13411,102,0.76 [0.54-1.09],0.1339949204117949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,13626,102,0.96 [0.65-1.43],0.849473386448618
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,13411,102,0.56 [0.34-0.92],0.0233330623540849
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF10,Tumor necrosis factor ligand superfamily member 10,13652,101,1.12 [0.57-2.18],0.746299433135187
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF11,Tumor necrosis factor ligand superfamily member 11,13483,101,0.76 [0.57-1.01],0.0595626343455297
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF12,Tumor necrosis factor ligand superfamily member 12,13652,101,0.70 [0.39-1.28],0.2520763040986485
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF13,Tumor necrosis factor ligand superfamily member 13,13555,104,0.72 [0.37-1.40],0.3331560844495539
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,13628,101,0.81 [0.40-1.63],0.5507552665102616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF14,Tumor necrosis factor ligand superfamily member 14,13411,102,0.89 [0.65-1.21],0.44723121084949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF8,Tumor necrosis factor ligand superfamily member 8,11671,86,0.85 [0.47-1.52],0.5775364037598623
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNIP1,TNFAIP3-interacting protein 1,11656,85,0.85 [0.67-1.07],0.1720106785710692
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNN,Tenascin-N,11671,86,0.96 [0.60-1.52],0.8503290999671997
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNNI3,"Troponin I, cardiac muscle",13267,101,1.12 [0.90-1.40],0.3199333726356855
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNPO1,Transportin-1,11438,86,0.69 [0.38-1.27],0.2374192228974694
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNR,Tenascin-R,13411,102,0.83 [0.55-1.26],0.3877157243025549
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNXB,Tenascin-X,13496,100,1.51 [0.77-2.97],0.2324799779945212
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,11692,85,0.90 [0.69-1.19],0.4760427751552017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOP1,DNA topoisomerase 1,11626,86,0.98 [0.81-1.18],0.8399139715895092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOP1MT,"DNA topoisomerase I, mitochondrial",11269,84,1.02 [0.67-1.55],0.944111068795798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOP2B,DNA topoisomerase 2-beta,11358,82,0.91 [0.69-1.20],0.5075752744145164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOR1AIP1,Torsin-1A-interacting protein 1,11368,85,0.94 [0.62-1.41],0.7612560096443043
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53,Cellular tumor antigen p53,13187,100,0.95 [0.63-1.44],0.8113322314205265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53BP1,TP53-binding protein 1,11358,82,0.66 [0.51-0.86],0.0021138890127944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53I3,Quinone oxidoreductase PIG3,11165,85,0.83 [0.56-1.24],0.3703884950902258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53INP1,Tumor protein p53-inducible nuclear protein 1,13267,101,0.84 [0.46-1.55],0.5806838724404733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP73,Tumor protein p73,11351,84,0.58 [0.32-1.07],0.0818455888019525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPBGL,Trophoblast glycoprotein-like,11351,84,0.77 [0.44-1.34],0.3484067814839401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPD52L2,Tumor protein D54,11422,85,0.88 [0.73-1.06],0.1778289495714639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPK1,Thiamin pyrophosphokinase 1,11692,85,0.76 [0.36-1.59],0.4605645081290912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPM3,Tropomyosin alpha-3 chain,11332,84,0.66 [0.37-1.16],0.1485693255745706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPMT,Thiopurine S-methyltransferase,13187,100,0.71 [0.55-0.92],0.0085630590711076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPP1,Tripeptidyl-peptidase 1,13413,104,0.65 [0.42-1.01],0.0541399745834898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPPP2,Tubulin polymerization-promoting protein family member 2,11438,86,1.03 [0.81-1.32],0.7881962464425726
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPPP3,Tubulin polymerization-promoting protein family member 3,13156,97,0.88 [0.54-1.43],0.6109286559103306
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPR,Nucleoprotein TPR,11332,84,0.70 [0.41-1.20],0.1948726224515613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPRKB,EKC/KEOPS complex subunit TPRKB,11269,84,0.69 [0.45-1.05],0.0828998900130068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPSAB1,Tryptase alpha/beta-1,13628,101,0.80 [0.58-1.10],0.169942344019739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPSD1,Tryptase delta,11674,86,1.00 [0.58-1.72],0.997731452937195
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPSG1,Tryptase gamma,11358,82,0.61 [0.26-1.44],0.2597360978291254
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPT1,Translationally-controlled tumor protein,13235,101,1.13 [0.90-1.41],0.2979430130505552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRAF2,TNF receptor-associated factor 2,13483,101,0.92 [0.72-1.18],0.5294814899196101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRAF3,"TNF receptor-associated factor 3, Isoform 2",11358,82,0.89 [0.50-1.61],0.7106436328879177
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,11332,84,0.69 [0.40-1.19],0.1805209006230234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,11438,86,1.03 [0.80-1.32],0.8167186371344158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREH,Trehalase,11671,86,1.08 [0.82-1.43],0.5842726695478412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREM2,Triggering receptor expressed on myeloid cells 2,13493,104,0.85 [0.60-1.21],0.3680970168686839
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREML1,Trem-like transcript 1 protein,11690,85,0.96 [0.65-1.42],0.8450066459226251
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREML2,Trem-like transcript 2 protein,13496,100,0.90 [0.53-1.56],0.7175793391166212
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIAP1,TP53-regulated inhibitor of apoptosis 1,13620,100,0.78 [0.59-1.04],0.0894600994173724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM21,E3 ubiquitin-protein ligase TRIM21,13483,101,0.87 [0.70-1.08],0.1970224357155292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM24,Transcription intermediary factor 1-alpha,11412,86,1.04 [0.77-1.41],0.7994450848025154
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,11626,86,0.90 [0.74-1.09],0.2683045935332413
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM26,Tripartite motif-containing protein 26,11269,84,0.97 [0.67-1.41],0.887531171077794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM40,E3 ubiquitin ligase TRIM40,11351,84,0.94 [0.70-1.26],0.6713633527609862
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM5,Tripartite motif-containing protein 5,13483,101,0.97 [0.79-1.20],0.795545651901671
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM58,E3 ubiquitin-protein ligase TRIM58,11611,85,0.80 [0.63-1.03],0.0795825335154004
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRPV3,Transient receptor potential cation channel subfamily V member 3,11332,84,0.80 [0.50-1.29],0.3668799675140087
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSC1,Hamartin,11358,82,0.83 [0.60-1.15],0.2674558195744193
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSC22D1,TSC22 domain family protein 1,11674,86,0.69 [0.49-0.97],0.0306939487165696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSHB,Thyrotropin subunit beta,13500,104,1.13 [0.92-1.38],0.2594483652826
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSLP,Thymic stromal lymphopoietin,13267,101,1.08 [0.83-1.41],0.5514320241838471
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSNAX,Translin-associated protein X,11332,84,0.61 [0.35-1.06],0.0814927315161576
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN1,Tetraspanin-1,13267,101,0.79 [0.43-1.47],0.4628559943295107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN15,Tetraspanin-15,11332,84,0.89 [0.58-1.38],0.6058233052921509
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN7,Tetraspanin-7,11347,80,0.84 [0.64-1.10],0.2127031641000227
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN8,Tetraspanin-8,11626,86,0.93 [0.76-1.14],0.4918803259976793
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPYL1,Testis-specific Y-encoded-like protein 1,11358,82,1.33 [0.82-2.17],0.2479488544121647
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TST,Thiosulfate sulfurtransferase,13140,96,0.86 [0.68-1.10],0.2335239205430005
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TTF2,Transcription termination factor 2,11351,84,0.63 [0.40-1.00],0.0482141814489888
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TTN,Titin,11332,84,0.85 [0.59-1.20],0.3526284845555529
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TTR,Transthyretin,11568,85,1.54 [0.68-3.50],0.3017348999364707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TUBB3,Tubulin beta-3 chain,11347,80,0.47 [0.22-1.03],0.0608115085571535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TWF2,Twinfilin-2,11671,86,0.89 [0.70-1.14],0.3620918314737149
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXK,Tyrosine-protein kinase TXK,11438,86,0.78 [0.56-1.09],0.1496093644728316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXLNA,Alpha-taxilin,13411,102,0.93 [0.77-1.14],0.4971140206580907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXN,Thioredoxin,11478,84,0.87 [0.52-1.43],0.5733444237580049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNDC15,Thioredoxin domain-containing protein 15,13527,102,0.78 [0.40-1.49],0.4453585322997724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNDC5,Thioredoxin domain-containing protein 5,13626,102,0.84 [0.64-1.09],0.1967071119482197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNDC9,Thioredoxin domain-containing protein 9,11656,85,0.74 [0.48-1.12],0.1563557722709979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNL1,Thioredoxin-like protein 1,11325,79,0.84 [0.64-1.10],0.2140517557186723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",13496,100,0.87 [0.59-1.27],0.4641752911587671
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TYMP,Thymidine phosphorylase,13421,104,0.91 [0.70-1.18],0.4748056636599739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TYRO3,Tyrosine-protein kinase receptor TYRO3,13500,104,1.16 [0.63-2.13],0.6400485856683383
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",11358,82,1.05 [0.74-1.50],0.7691714252446004
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBAC1,Ubiquitin-associated domain-containing protein 1,13429,102,0.86 [0.53-1.40],0.5566103179608379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBE2B,Ubiquitin-conjugating enzyme E2 B,11611,85,0.52 [0.24-1.11],0.0892835198054645
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,11692,85,0.80 [0.57-1.13],0.2049666317815903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,11358,82,0.88 [0.61-1.29],0.5188229749663771
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBQLN3,Ubiquilin-3,11332,84,0.90 [0.54-1.49],0.679635644989423
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBXN1,UBX domain-containing protein 1,11422,85,0.82 [0.60-1.12],0.2107707517596377
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,11626,86,0.94 [0.81-1.08],0.3813601769009891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UGDH,UDP-glucose 6-dehydrogenase,11332,84,0.89 [0.69-1.13],0.3297348915645132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UHRF2,E3 ubiquitin-protein ligase UHRF2,11332,84,0.59 [0.28-1.21],0.1481770304996784
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ULBP2,UL16-binding protein 2,13411,102,0.81 [0.50-1.32],0.391421220438643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UMOD,Uromodulin,13616,103,1.27 [0.90-1.79],0.1815750357324198
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UNC5D,Netrin receptor UNC5D,11358,82,0.63 [0.27-1.45],0.277841414169199
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UNC79,Protein unc-79 homolog,11269,84,0.93 [0.64-1.37],0.7251454770780644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UNG,Uracil-DNA glycosylase,11611,85,0.86 [0.47-1.61],0.6449595209710858
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UPB1,Beta-ureidopropionase,11692,85,1.08 [0.87-1.35],0.4665220933538883
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UPK3A,Uroplakin-3a,11347,80,0.93 [0.60-1.45],0.7554200994276038
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UPK3BL1,Uroplakin-3b-like protein 1,11424,86,1.12 [0.83-1.52],0.4613318858252198
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UROD,Uroporphyrinogen decarboxylase,11422,85,0.85 [0.63-1.15],0.2893034022342743
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UROS,Uroporphyrinogen-III synthase,11351,84,1.08 [0.82-1.43],0.5896750929749015
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USO1,General vesicular transport factor p115,13429,102,0.88 [0.73-1.07],0.1892584387449306
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP25,Ubiquitin carboxyl-terminal hydrolase 25,11611,85,0.77 [0.57-1.03],0.0753766024139605
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP28,Ubiquitin carboxyl-terminal hydrolase 28,11656,85,0.83 [0.46-1.49],0.5399200296946287
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP47,Ubiquitin carboxyl-terminal hydrolase 47,11332,84,1.01 [0.79-1.28],0.9331976639027232
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP8,Ubiquitin carboxyl-terminal hydrolase 8,13267,101,0.89 [0.74-1.07],0.227633163665844
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UXS1,UDP-glucuronic acid decarboxylase 1,13187,100,1.05 [0.77-1.45],0.7498742240343812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAMP5,Vesicle-associated membrane protein 5,13267,101,0.91 [0.64-1.28],0.5770076996734281
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAMP8,Vesicle-associated membrane protein 8,11358,82,0.87 [0.68-1.11],0.2738273003275755
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VASH1,Tubulinyl-Tyr carboxypeptidase 1,13483,101,0.86 [0.69-1.07],0.1785055069634632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VASN,Vasorin,13243,97,0.97 [0.50-1.88],0.939188241287632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VASP,Vasodilator-stimulated phosphoprotein,11690,85,0.90 [0.67-1.20],0.4717428546142129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,13429,102,0.56 [0.23-1.35],0.1953161461201428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAV3,Guanine nucleotide exchange factor VAV3,11347,80,0.82 [0.66-1.02],0.0742155823807467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VCAM1,Vascular cell adhesion protein 1,13489,102,0.94 [0.48-1.84],0.8607449588146912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VCAN,Versican core protein,13626,102,0.65 [0.36-1.17],0.1494337086886039
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VCPKMT,Protein-lysine methyltransferase METTL21D,11269,84,0.82 [0.61-1.09],0.168418783700053
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFA,Vascular endothelial growth factor A,13610,100,0.86 [0.63-1.18],0.3504190842752305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFB,Vascular endothelial growth factor B,11358,82,0.62 [0.29-1.31],0.2105527493620272
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFC,Vascular endothelial growth factor C,13527,102,0.82 [0.60-1.12],0.2048998561201024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFD,Vascular endothelial growth factor D,13631,101,1.11 [0.65-1.90],0.6929511439525139
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VGF,Neurosecretory protein VGF,11674,86,0.50 [0.25-1.02],0.0566649330826578
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VIM,Vimentin,13267,101,1.03 [0.89-1.20],0.6662182832474487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VIPR1,Vasoactive intestinal polypeptide receptor 1,11368,85,0.72 [0.30-1.73],0.4676366041414636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VIT,Vitrin,11692,85,1.02 [0.58-1.79],0.946749102546322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VMO1,Vitelline membrane outer layer protein 1 homolog,13429,102,0.98 [0.76-1.28],0.9046146891418584
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VNN1,Pantetheinase,11690,85,1.07 [0.80-1.42],0.6511410734998933
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VNN2,Vascular non-inflammatory molecule 2,13429,102,0.87 [0.60-1.25],0.4391044956197955
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS28,Vacuolar protein sorting-associated protein 28 homolog,11438,86,0.89 [0.65-1.23],0.4867119724251847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS37A,Vacuolar protein sorting-associated protein 37A,13429,102,0.79 [0.63-0.99],0.0430079500844576
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS4B,Vacuolar protein sorting-associated protein 4B,11611,85,0.84 [0.67-1.05],0.1232651115701972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS53,Vacuolar protein sorting-associated protein 53 homolog,13429,102,0.81 [0.64-1.03],0.0860228398913689
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG10,V-set and immunoglobulin domain-containing protein 10,11611,85,1.12 [0.68-1.83],0.6549022255603778
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,11332,84,0.97 [0.52-1.81],0.929126028967943
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG2,V-set and immunoglobulin domain-containing protein 2,11611,85,1.24 [0.85-1.79],0.2654587178106585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG4,V-set and immunoglobulin domain-containing protein 4,13473,100,0.75 [0.46-1.24],0.2702677068693367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,13482,104,0.75 [0.55-1.01],0.0602792756440281
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSNL1,Visinin-like protein 1,11656,85,1.12 [0.64-1.94],0.6921823778887009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSTM1,V-set and transmembrane domain-containing protein 1,13156,97,1.10 [0.76-1.60],0.617250039492715
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSTM2B,V-set and transmembrane domain-containing protein 2B,11438,86,0.82 [0.47-1.42],0.4790702636198231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,13267,101,1.06 [0.79-1.43],0.6808113524979611
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,13626,102,0.87 [0.68-1.11],0.2611621351891431
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VTCN1,V-set domain-containing T-cell activation inhibitor 1,13187,100,0.80 [0.45-1.40],0.4256993771038897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,11422,85,0.75 [0.52-1.09],0.1287296498349435
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWA1,von Willebrand factor A domain-containing protein 1,13599,100,0.69 [0.45-1.06],0.0888863253053635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWA5A,von Willebrand factor A domain-containing protein 5A,11269,84,0.90 [0.67-1.20],0.4710201020690837
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWC2,Brorin,13361,102,0.58 [0.37-0.93],0.0224079808826657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWC2L,von Willebrand factor C domain-containing protein 2-like,11674,86,0.56 [0.29-1.06],0.0732564275202525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWF,von Willebrand factor,13658,103,1.02 [0.81-1.30],0.8532957594943467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WARS,"Tryptophan--tRNA ligase, cytoplasmic",13496,100,0.89 [0.56-1.44],0.6436886305699818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WAS,Wiskott-Aldrich syndrome protein,13235,101,0.85 [0.65-1.12],0.2546556230196313
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASF1,Wiskott-Aldrich syndrome protein family member 1,13267,101,0.86 [0.71-1.05],0.1366556309243054
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASF3,Wiskott-Aldrich syndrome protein family member 3,13156,97,0.79 [0.65-0.96],0.0197858684669335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASHC3,WASH complex subunit 3,11656,85,0.79 [0.59-1.06],0.1102683293693709
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASL,Neural Wiskott-Aldrich syndrome protein,11358,82,0.73 [0.48-1.10],0.1367820855341323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WDR46,WD repeat-containing protein 46,11611,85,0.60 [0.32-1.15],0.1249698242041851
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFDC1,WAP four-disulfide core domain protein 1,11400,83,1.18 [0.85-1.64],0.3257319907530684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFDC12,WAP four-disulfide core domain protein 12,13601,100,0.93 [0.71-1.22],0.594743148328269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFDC2,WAP four-disulfide core domain protein 2,12774,96,0.69 [0.38-1.25],0.2182041288205237
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",13375,102,0.86 [0.56-1.34],0.5162799934089299
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",13518,104,0.65 [0.39-1.09],0.1003718263494094
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WIF1,Wnt inhibitory factor 1,13620,100,0.63 [0.37-1.06],0.0817375202948952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WNT9A,Protein Wnt-9a,13235,101,0.47 [0.24-0.91],0.0256402223537988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,13411,102,0.81 [0.59-1.13],0.2176890536540206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XCL1,Lymphotactin,13620,100,0.94 [0.68-1.30],0.7001828913814958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XG,Glycoprotein Xg,13586,101,0.51 [0.27-0.96],0.0357963366303107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XIAP,E3 ubiquitin-protein ligase XIAP,11358,82,0.81 [0.55-1.18],0.2680740537738859
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XPNPEP2,Xaa-Pro aminopeptidase 2,13527,102,1.08 [0.88-1.31],0.4767120390768659
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XRCC4,DNA repair protein XRCC4,13156,97,0.76 [0.45-1.26],0.287289247615192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YAP1,Transcriptional coactivator YAP1,11656,85,0.65 [0.28-1.51],0.3180987017758886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",11626,86,0.96 [0.83-1.10],0.5304548904264388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YES1,Tyrosine-protein kinase Yes,13429,102,0.87 [0.75-1.02],0.0795954817085358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YJU2,Splicing factor YJU2,11611,85,0.68 [0.34-1.34],0.260892810047811
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YOD1,Ubiquitin thioesterase OTU1,11332,84,0.90 [0.65-1.25],0.5320457051786942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YTHDF3,YTH domain-containing family protein 3,13235,101,0.81 [0.65-1.01],0.0561597320551884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YWHAQ,14-3-3 protein theta,11422,85,0.82 [0.61-1.10],0.1838350390174495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YY1,Transcriptional repressor protein YY1,11358,82,1.07 [0.50-2.28],0.865958411711741
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZBP1,Z-DNA-binding protein 1,11358,82,0.71 [0.38-1.31],0.2739687748099109
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZBTB16,Zinc finger and BTB domain-containing protein 16,13187,100,0.82 [0.63-1.08],0.1667597424801919
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZBTB17,Zinc finger and BTB domain-containing protein 17,13267,101,0.75 [0.46-1.22],0.2433229696536641
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZCCHC8,Zinc finger CCHC domain-containing protein 8,11332,84,0.95 [0.67-1.36],0.7905853980140367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZFYVE19,Abscission/NoCut checkpoint regulator,11626,86,0.93 [0.74-1.17],0.551793973571701
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZHX2,Zinc fingers and homeoboxes protein 2,11656,85,0.71 [0.33-1.55],0.3933652285136775
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNF174,Zinc finger protein 174,11358,82,0.77 [0.40-1.47],0.4239468695853303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNF75D,Zinc finger protein 75D,11438,86,0.82 [0.56-1.20],0.3053115175472488
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNF830,Zinc finger protein 830,11611,85,1.04 [0.82-1.32],0.7616100877651761
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNRD2,Protein ZNRD2,11626,86,1.03 [0.76-1.39],0.8572525464170533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,11611,85,0.80 [0.53-1.19],0.2702154640741782
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZP3,Zona pellucida sperm-binding protein 3,11368,85,1.00 [0.93-1.09],0.9568717226072916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZP4,Zona pellucida sperm-binding protein 4,11269,84,0.77 [0.37-1.59],0.4827206541848193
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZPR1,Zinc finger protein ZPR1,11347,80,1.03 [0.83-1.28],0.780807910354274
